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Abstract 
     It has become possible over the last decade to compare the primary 
structures of proteins from many hundreds of species at the push of a button. 
This rich source of information on the relationship between polypeptide 
sequence and function is however limited since there is often no experimental 
evidence for protein activity. By amplifying open reading frames using an error 
prone DNA polymerase, I have combined the power of comparative BLAST 
analysis with functional screening in order to “stress test” the relationships 
between primary structure and function in a number of “model” enzymes which 
include M.HhaI 5-cytosine methyltransferase, chloramphenicol 
acetyltransferase (CATI), and dihydrolipoamide dehydrogenase (E3). These 
enzymes models represent quite different structural and functional classes, and 
to strengthen any general conclusions, they have been chosen here to make the 
evaluation of any impact on changes in primary structure on enzyme activity, as 
comprehensive as possible. The results showed different patterns of tolerance 
toward the random primary structure changes. Dihydrolipoamide 
dehydrogenase appeared to be the most resilient enzyme, followed by M.HhaI 
and CATI respectively. This suggests that enzymes of different structural and 
functional types will have different degrees of tolerance and/or flexibility (in 
term of activity maintenance) in accommodating primary structure changes. 
Comparing the present mutagenesis and activity screening data with the 
available biochemical data of the related enzymes, as well as plotting the 
positions of mutations on the relevant secondary and three dimensional 
structures, showed interesting traits in all enzymes to tolerate primary structure 
changes even in regions of the enzymes normally considered to be sensitive 
points, while some amino acid residues of no previously assigned importance 
could abolish enzyme activity completely. 
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A Adenine 
Amp Ampicillin 
AmpR Ampicillin resistant 
ATP Adenosine triphosphate  
 
bp Base pair(s) 
C Cytosine  
 
CFUs Colony forming units 
C-terminus Carboxyl terminus  
 
dATP Deoxyadenosine triphosphate  
 
dCTP Dideoxycytidine triphosphate  
 
DNA Deoxyribonucleic acid  
 
DNase Deoxyribonuclease 
dNTP Deoxynucleoside triphosphate  
 
DTT Dithiothreitol  
 
EDTA Ethylenediaminetetra acetic acid  
 
EP Error-prone 
G Guanine  
 
IPTG Isopropyl -1- thio- β-D- galactoside 
 
Kan Kanamycin  
KanR Kanamycin resistant  
 
Kb  Kilo base pair (1000bp)  
kcat  Overall enzymatic catalytic rate  
kDa  
 
Kilo Dalton  
 
Km Michaelis constant  
LB Luria Bertani Medium  
 
mcr Modified cytosine restriction  
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mRNA Messenger ribonucleic acid  
 
MW Molecular weight  
 
N-terminus  
 
Amino terminus 
OD Optical density  
 
Oligo Oligodeoxynucleotide  
 
ORF Open reading frame 
PCR Polymerase Chain Reaction  
 
PAGE Polyacrylamide gel electrophoresis  
 
Pfu Pyrococcus furiousus 
Pol Polymerase 
Pho Pyrococcus horikoshii 
RM Random mutagenesis 
SAM S-adenosyl-L-methionine  
 
SDS Sodium dodecyl sulphate  
 
S-PhoEP  
 
Fusion error prone Pho polymerase  
 
T Thymine  
 
TAE Tris-acetic acid-EDTA  
 
Taq Thermus aquaticus 
TEMED  
 
Tetramethylethylenediamine  
 
TRD Target recognition domain  
 
Tris Tris-(hydroxymethyl)-methylamine  
 
U Uracil  
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Chapter1 General Introduction 
1.1. Introduction 
     The process of evolution in living organisms over the last fifty years, as first 
proposed coherently by Charles Darwin (Darwin, 1872), has been examined at 
the molecular level. This was first made possible by the development, largely 
thanks to Sanger, of methods for protein and nucleic acid sequencing (Sanger 
and Tuppy, 1951; Sanger and Coulson, 1975; Sanger et al., 1977). This has 
been further enhanced by the last twenty years of genome science, during which 
many bacterial genomes and an ever-growing number of eukaryotic genomes 
are being sequenced at the nucleotide level. What has become clear during this 
period is that these studies support the key principle underlying Darwin’s theory 
that is adaptation is driven by Natural Selection and slow genetic change. Thus, 
within a group of related organisms, there is a high level of conservation of 
protein primary structure which reflects the relatedness of organisms. The 
striking level of conservation of histone proteins among all eukaryotes for 
example, suggests that the reversible processes of genome condensation and 
unpacking, are clearly fundamental to all eukaryotes. The remarkable success of 
Nurse’s group in demonstrating the cross-compatibility of the cell cycle 
regulator gene cdc2, illustrates again the fundamental levels of conservation of 
gene function amongst eukaryotes as far apart in evolutionary terms as yeast 
and vertebrates (Nurse and Thuriaux, 1980). 
1.2. Experimental evolution 
     The last twenty years of experimental molecular biology has witnessed the 
introduction of tools to mimic the process of evolution but critically in a 
significantly reduced time, so that several millions of years are compressed into 
only a few days or even hours. Such in vitro generation of genetic variants is 
achieved by means of random mutagenesis and DNA recombination (Chen and 
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Arnold, 1993; Stemmer, 1994; Reetz et al., 1997; Zhao et al., 1998). Starting 
with a target gene sequence it is possible to build mutant libraries that may then 
be screened phenotypically within a short time scale (artificial selection) for 
different applications such as industrial, therapeutic, or for fundamental 
research (Jespers et al., 1994; Coelho et al., 2013; McIsaac et al., 2014). This 
process of randomising and diversifying genes has been called ҅ ҅directed 
molecular evolution ҆ ҆. The schematic diagram in Figure 1.1 shows a comparison 
of directed versus Darwinian evolution. The outcome of Darwinian genetic 
selection is achieved by directed evolution in a powerful manner especially 
when the screening and selection methods mimic the natural sieving and 
selection of new traits that often accompany spontaneous evolutionary 
mutations.  
 
Figure 1.1: A schematic diagram comparing Darwinian evolution with the 
directed evolution at the molecular level. 
     Directed evolution has become the method of choice by which molecular 
biologists attempt to improve enzyme function for industrial or pharmaceutical 
purposes. It is therefore, an excellent strategy to generate a novel functional 
enzyme property or to investigate the catalytic and functional properties of 
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primary structures by exploring a much greater part of the protein sequence 
space within a greatly minimized time scale compared with the natural 
evolution and selection (Williams et al., 2004; Packer and Liu, 2015). Such 
strategies offer an alternative approach to rational design of protein engineering 
(Dahiyat and Mayo, 1997; Root et al., 2001). 
     Accordingly, directed evolution is a powerful strategy for studying the 
function of proteins where no crystal structures are available as well as proteins 
of known structure in order to expand  knowledge regarding the relationship 
between the structure and activity (Wang et al., 2006). The key objective of any 
directed evolution experiment is to generate as much genetic diversity as 
possible within a library of multi-sequence variants as well as developing 
suitable method(s) for high throughput screening of phenotype in addition to the 
genotype that must be linked in these experiments (Arnold, 2001; Wahler and 
Reymond, 2001).    
The key elements of a successful directed evolution experiments are: 
1- A suitable method for introducing mutation at a controllable frequency. 
2- A target gene that provides a reliable screening methodology enabling 
scanning of large number of the generated mutant clones.  
3- Ideally, a three dimensional protein structure should be available for 
interpretation.  
     It is not surprising, therefore, that researchers have developed many methods 
for gene randomisation each of which, has its pros and cons. Physical and 
chemical mutagens such as methanesulfonate (EMS); an alkylating compound, 
nitrous acid; a deaminating compound, 2-aminopurine; a base analogues 
compound, or UV light have all been used to provoke mutations by randomly 
damaging DNA. However, the spectrum of bias introduced by such chemical 
reagents and physical mutagenic agents makes them less useful in directed 
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evolution experiments (Freese, 1959; Bridges and Woodgate, 1985; Myers et 
al., 1985; Lai et al., 2004). Non-chemical random mutagenesis methods mostly 
rely on using DNA polymerases such as polymerase III as well as Tap or pfu 
polymerases. Polymerase III has a mutagenesis ability rate of 10-10 per base per 
replication and has been used within E. coli mutator strains such as mutS, mutD, 
and mutT where the proofreading and the enzymatic DNA repair system have 
been abolished leading to an enhanced mutagenesis ability for such DNA 
polymerase (Cox, 1976; Scheuermann et al., 1983; Greener et al., 1997b). For 
example, a mutator E. coli called XL-1 red strain showed a mutagenesis 
incidence of about 10-6 per base per DNA replication after transformation with 
plasmid carrying the gene of interest to be randomised (Greener et al., 1997a). 
However, the disadvantage about using the mutator strains is that such strains 
are most likely introducing some deleterious mutations within their genomic 
DNA because it is vulnerable to the low fidelity DNA polymerase exactly the 
same as the plasmid carrying the gene of interest that is required to be mutated, 
therefore, some efforts have been performed to find a strategies by which only 
the gene of interest is targeted by random mutagenesis other than the genomic 
DNA in those mutator strains, such strategies of isolating the genomic DNA 
from the mutagenic effect of the host polymerase should reduce the limitation of 
in vivo mutagenesis especially when host is intolerant toward the accumulation 
of deleterious mutations within its genome. It seems that such mutagenesis 
isolation is hard to be applied in bacteria while in eukaryotes like yeast it is  
efficiently applied when Kluyveromyces lactis naturally-occurring cytoplasmic 
pGKL1/2 linear plasmids have been used as vectors to clone the genes of 
interest so that the genomic DNA in nucleolus is completely isolated and away 
from the mutagenesis effect due to the specific action of TP-DNA polymerase 
which is a cytoplasmic enzyme required specifically for those plasmids 
replication in the cell cytoplasm. Those plasmids with their TP-DNA 
polymerase have been used in an engineered Saccharomyces cerevisiae as an 
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efficient mutator host for gene diversification (Ravikumar et al., 2014). In spite 
of all the enhancements for the in vivo random mutagenesis methods, they still 
impose limitations especially by being hard to control and by providing low 
rates of mutations, therefore, researchers prefer using the in vitro methods to 
introduce random mutations by DNA amplification as an artificial replication 
using polymerase chain reaction technique to obtain enhanced mutagenesis 
throughputs (Packer and Liu, 2015).  
1.3. Error-prone PCR (EP PCR) 
     In the last decade, advances in the area of nucleic acid amplification, 
primarily driven by diagnostic methods employing the Polymerase Chain 
Reaction (PCR), have made it possible to begin to explore molecular evolution 
on a manageable time-scale. Much of the development of PCR enzymes has 
centred on their intrinsic fidelity. Fidelity is simply defined as a quality control 
index for the amplification reaction: how accurate is the amplification. If a 
single copy of a given amplicon is copied 1000000 times, are all copies 
identical in terms of nucleotide sequence? Many different approaches to 
benchmarking fidelity have been reported and the most common methods utilise 
microbiological screening for colour sensitive colony formation in bacterial 
transformation experiments that can detect changes at the frequency of 
approximately 1 per 1000000 events. It is clear from the last thirty years of PCR 
development, that some DNA Polymerases are more “faithful” than others and 
companies produce comparator data for applications. However, in this thesis, 
the focus is on a PCR enzyme, capable of efficient amplification of template 
DNA, in high yields, but exhibiting low fidelity. Such an enzyme has been 
described by Biles and Connolly (Biles and Connolly, 2004) and has also been 
developed by (Alharbi, 2010) . Two point mutations in either Pfu DNA 
Polymerase (a recombinant form of the enzyme from Pyrococcus furiosus), or 
in the closely related enzyme Pho DNA Polymerase (from Pyrococcus 
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horikoshii), produce such an error prone DNA polymerase. The characteristics 
of both EPPfu and EPPho have been described by  and (Alharbi, 2010) 
respectively, and form part of the following discussion on the experimental 
approaches to in vitro evolution.  
     Polymerase chain reaction (PCR) is an efficient technique by which any 
sequence of nucleotides, especially DNA, can be propagated into billions of 
copies starting from relatively small amounts of that DNA (Mullis and Faloona, 
1987; Erlich, 1989; Sun, 1995). Principally, PCR depends on three steps: 
denaturation; during which the hydrogen bonding, that stabilises the two strands 
of the DNA duplex, are destroyed by raising the reaction temperature so that the 
resulting two strands of the DNA template are available to base pair with short 
complementary oligonucleotides (primers) in the second step which is annealing 
when the temperature is lowered appropriately. The 3ʹ ends of the annealed 
primers then provide the starting point for the DNA polymerase to begin 
elongation, where a complementary new DNA strand is synthesised, thereby 
recapitulating the DNA double helix. Each of the PCR three steps (denaturation, 
annealing, and elongation) is performed with an appropriate temperature: 
generally the temperature of denaturation step is always the highest followed by 
the elongation and annealing respectively. Each PCR cycle is composed of these 
three steps, so that one DNA molecule of a certain length will be two molecules 
after the first cycle. The key point of PCR in amplifying a segment of DNA in a 
logarithmic manner is that the number of reaction cycles are repeated several 
times, so the final number of DNA molecules copies after a certain number of 
PCR cycles is calculated using the relationship (2n-2n)x, where n is the number 
of cycles and x is the number of initial template DNA molecules and 2n is the 
number of variable length DNA fragments of undefined length that are 
produced initially during the first and second round of PCR (Newton and 
Graham, 1997).  
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     Originally, PCR was developed for accurate amplification of DNA, but the 
requirements for random mutagenesis and directed evolution has extended the 
original purpose of PCR from accurate to error-prone DNA amplification, 
which was introduced for the first time by (Leung et al., 1989) and is now 
considered to be a another invaluable application of the PCR technique.  
     All the known DNA polymerases act on their DNA substrates to build a new 
nucleotide strand accurately by incorporating the correct dNTPs into the 
growing DNA strand according to the sequence in the DNA template strand, so 
that Watson-Crick base pairing is maintained most of the time, however, the 
accuracy, which is commonly termed “fidelity”, in amplifying the DNA without 
introducing mutations, is actually dependent on the DNA polymerase employed. 
So DNA polymerases have lower fidelity when compared among different 
organisms. For example, Taq DNA polymerase from Thermus aquaticus is of 
lower fidelity among all commercially available, thermostable DNA 
polymerases used in PCR; introducing a single error every 9000 base per PCR 
cycle, primarily  because it lacks 3ʹ→5ʹ  proofreading exonuclease activity 
(Tindall and Kunkel, 1988). However, error-prone PCR requires a much lower 
fidelity than even that of  wild Taq- polymerase, which is still too accurate for 
mutagenesis applications (Neylon, 2004), therefore, changes to the standard 
PCR conditions have been used to enhance the error rate of PCR as follows: 
1- Manipulation of the reaction components: 
     Equimolar dNTPs are normally used in non-mutagenic PCR, but for epPCR, 
dNTPs are often included at unbalanced concentrations. For example dCTP and 
dTTP are supplemented in amounts exceeding the concentration of the other 
nucleotide triphosphates to drive Taq-pol to mutate AT to GC base pairs 
(Cadwell and Joyce, 1992; Cadwell and Joyce, 1994; Vartanian et al., 1996b; 
Shafikhani et al., 1997). Mutagenesis of dihydrofolate reductase (DHFR) 
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expressed from R67 E. coli plasmid by introducing biased deoxypyrimidine 
triphosphate concentrations in a hypermutagenic error-prone PCR reaction 
(where dTTP is supplied in a higher concentration than dCTP) has led to a 
complicated mutant DHFR gene library enriched in dATP and dTTP taking the 
advantage of the mismatched G:T base pairing which is stably present. While 
using different combinations dNTPs unbalanced concentrations such as [dTTP] 
> [dCTP] and [dGTP] > [dATP] unexpectedly lead to a low mutational 
frequency. However, a relatively efficient mutational frequency of 10% per 
PCR cycle, with a relatively homogenous distribution of mutations along the 
nucleotide sequence of the DHFR gene. A much more unfavourable situation 
(with respect to fidelity) has been seen with a low level bias toward transition 
than transversion, when Mn2+ cations were used in place of, or alongside Mg2+ 
ions (Vartanian et al., 1996b). 
     In spite of the key role of manganese cations in the reduction in fidelity of 
the PCR (Lin-Goerke et al., 1997; McCarthy et al., 2004), these ions impose 
some limitations, especially for the subsequent cloning steps that follow the 
PCR mutagenesis, such as the formation of complex structures at the terminal 
ends of the PCR amplicons constituting a bad scenario for restriction digestion 
of the PCR product, as restriction sites are usually engineered into both ends of 
the PCR product, therefore, such complexes formed owing to the presence of 
Mn2+ could easily interfere with the restriction enzymes and therefore disrupt 
ligation and cloning. Indeed, ligation has been shown to be inhibited by 
Mn2+cations, owing to their inhibitory effect on T4 DNA ligase. However, this 
could be overcome by incorporating a  PCR product clean-up step before 
ligation (Wang et al., 2006). Overall, manganese ions decrease the accurate 
recognition ability of DNA polymerase during the elongation, so that the 
number of mismatches in the growing DNA strand will increase subsequently 
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especially when unbalanced dNTP concentrations are applied (Beckman et al., 
1985; Leung et al., 1989; Vartanian et al., 1996a). 
     Magnesium cations are crucial for the Taq-pol reaction to proceed in the 
non-mutagenic PCR project, so this ion is always added to all PCR 
amplifications within optimum amounts depending on the PCR system, but 
excessive concentrations of Mg2+have been applied in epPCR to stabilise the 
base pairing of uncomplimentary nucleotide bases (Eckert and Kunkel, 1991; 
Ling et al., 1991). 
2- Using unusual nucleotides: 
     Nucleotide analogues, exhibiting comparable kinetic characteristics and 
binding to conventional ones, are incorporated into the elongated DNA strand, 
which is stable under PCR conditions: these analogueues have been 
demonstrated to promote, significant levels of mutagenesis and have been used 
in EP-PCR for random mutagenesis. Two 5'-triphosphate compounds: 6-(2-
deoxy-beta-D-ribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-C] [1,2]oxazin-7-
one(dP) and 8-oxo-2' deoxyguanosine (8-oxodG) have been designed and 
synthesised and shown to have excellent substrate properties for the Taq-pol, 
which incorporated  both of them very efficiently into the newly synthesized 
DNA: the dPTP analogue replaced dTTP and dCTP where the 8-oxodG 
analogue base pairs with adenine. The method for random mutagenesis in this 
case comprises two stages of PCR amplification. In the first one, both dPTP and 
8-oxodG analogues or just one of them are incorporated in the presence of the 
all normal dNTPs. The analogues compete with the normal dNTP substrates, 
and are incorporated during DNA strand elongation. In the second PCR round, 
only the four normal DNA deoxynucleotides triphosphates are added to the 
reaction so that the analogues incorporated during the first reactions are 
replaced by normal ones during this stage to enable the subsequent cloning and 
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experimental steps by avoiding the E. coli host cell machinery of DNA repair 
that could exert its action on the DNA containing nucleotides analogues. After 
the second round of PCR the sequencing data showed, especially when both 
analogues were added, that a significant number of clones, containing at least 1-
2 transition and/pr transversion mutations, along with extremely rare events of 
deletions and insertions as a result of the wobble-related replacement of the 
nucleotide analogues during the second PCR round were obtained (Zaccolo et 
al., 1996). 
     The nucleotide dITP (2'-deoxyinosine-5'-triphosphate) containing the 
deoxyinosine base analogue has been used by (Spee et al., 1993) to develop 
mutations in a random manner, since Taq-pol has been shown previously to 
efficiently utilise ITP (Innis et al., 1988). The method involves using the four 
normal dNTPs in four independent PCR mixtures each of which has one of the 
dNTPs in a reduced concentration so the depleted pool of any dNTP will result 
in misincorporation of a wrong dNTP in the growing DNA strand being 
synthesized by Taq-pol, however, this could be enhanced when the dNTPs of 
the limited concentration were compensated for by dITP which is supplied 
simultaneously to the PCR mixture, resulting in efficient incorporation of this 
nucleotide analogue. A second round of PCR with only normal dNTPs in 
equimolar amounts, is necessary so that any position in a single DNA strand 
containing dITP from the first round will be possible to have any of the four 
dNTPs as a complementary in the opposite DNA strand being elongated by 
Taq-pol, therefore, gene randomisation will be the final result.  
     A combination of the manganese divalent cation and dITP as two factors of 
EP-PCR has been used in order to randomise the cutinase gene of Fusarium 
solanipisi in two PCR steps using Taq-pol. In the first PCR round, only Mn2+ 
has been added to reduce the dNTPs recognition ability of Taq-pol, then dITP is 
added in the second PCR step to induce the mispairing events and eliminate the 
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mutagenesis bias introduced during the first step by increasing the incidence of 
GC to CG transversions leading finally to 1-2 random mutation per clone  
(Bluteau et al., 1999). 
3- PCR sequence mutagenesis saturation:  
     The use of the PCR technique has been extended to include gene mutational 
randomisation in a saturation like manner via the mutation-saturated DNA 
sequence method (SeSaM). This technique was applied by (Wong et al., 2004) 
to generate mutant libraries of green fluorescent protein (GFP) via four 
technical steps (Figure 1.2). The first step involves generation of DNA 
fragments of different lengths for the gene of interest. Using α-phosphothioate 
nucleotide with normal nucleotides and biotin-containing forward primer with a 
non-biotinylated reverse primer in PCR, will results in PCR amplicons 
containing α-phosphothioate nucleotides at several positions. Treating this PCR 
product with iodine under alkaline conditions will result in hydrolysis at every 
α-phosphothioate position because phosphothioate bond is readily reduced 
under alkaline conditions, in the presence of iodine, thereby generating several 
DNA fragments of a wide variety of lengths. Biotinylated single strands are 
then specifically isolated from the rest of the unwanted DNA species using 
streptavidin beads that bind the biotin moiety in every biotinylated DNA strand 
so that the final purified fraction of interest will be single-stranded DNA 
molecules of different lengths.  
     The second step in SeSaM is to add deoxyinosine, a universal nucleotide 
analogue, to the 3ʹ terminal ends of the previously generated single-stranded 
DNAs. This elongation step is catalysed enzymatically by terminal transferase. 
Deoxyinosine has a strong bias to complement with cytosine (Kawase et al., 
1986; Spee et al., 1993) so it is used to replace dGTP in DNA sequencing 
(Dierick et al., 1993; Motz et al., 2000). 
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     The third step involves extension of the DNA fragments of the terminal 
universal analogue to the full length double stranded gene. The full length 
3ʹ→5ʹ DNA strand is required to be used as a template in this step, so PCR is 
performed using biotinylated reverse primer for this purpose to produce full 
length DNA amplicons, biotinylated with respect to the 3ʹ→5ʹ strandwhich is 
then isolated by the same methods described in the first step. Then one cycle of 
PCR is performed using the 3ʹ→5ʹ product as a template and the DNA 
fragments generated previously act as primers for the elongation step, initiated 
from the 3ʹ terminus containing the deoxyinosine base analogue. The final 
product will be a full length double stranded DNA containing a universal bas 
analogue in one strand. Additional PCR cycles will lead to annealing of the 
reverse primer to the newly synthesised 5ʹ→3ʹ DNA strand to be used as a 
template to synthesise a complementary 3ʹ→5ʹ strand, but now with a 
possibility of different nucleotide being incorporated opposite to the 
complementary strand containing the deoxyinosine base analogue which is 
located in the 5ʹ→3ʹ DNA template strand. The deoxyinosine within the DNA is 
then replace by the normal dNTPs by applying another round of PCR 
amplification in a final fourth step resulting in a full length double stranded 
mutant DNA gene library containing mutations distributed randomly throughout 
the whole gene length. There will also be a  noticeable bias of replacements at 
adenine positions,  due to the  exclusive use of dATPαS as a nucleotide 
analogue that has a strong preference for base pairing with cytosine, so that the 
vast majority (95.8%) of adenine substitutions are of the type A→G (Kawase et 
al., 1986; Spee et al., 1993). Further improvements to the method include using 
different nucleotide universal analogues with different base pairing preference 
to provide a less biased and better distributed mutations and a better distribution 
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Figure 1.2: Schematic diagram showing the four main steps of the sequence 
saturation mutagenesis method (SeSaM). In step 1, the gene is cut to generate 
pools of random DNA lengths. In step 2, the DNA fragments are elongated with 
a universal base. In step 3, the full length gene is synthesized. Step 4 involves 
replacement of the universal base with the standard nucleotides. Adapted from 
(Wong et al., 2004). 
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so that an improved control of the mutagenesis can then be obtained using what 
is called “tuned” SeSaM (Wong et al., 2004). 
 
4- Mutagenic DNA polymerases: 
     According to the sequence similarity and phylogenetic correlations, DNA 
polymerases can be classified into seven major groups: A (such as E. coli DNA 
polymeraseI), B (such as E. coli DNA polymeraseII), C (such as E. coli DNA 
polymeraseIII), D (such as eukaryotic polymeraseII), X (such as human β-DNA 
polymerase), Y, and RT (such as reverse transcriptase) (Burgers et al., 2001). 
DNA polymerases have two main roles in the cell represented by DNA 
replication and DNA repair varying in fidelity from error-free to error-prone 
(Kim et al., 2008). 
     Understanding the contribution of the protein structure to polymerase 
function is key to modifying such enzymes and in controlling their functions in 
respect of random mutagenesis. As shown by many structural studies, 
polymerases are commonly multi-domain enzymes composed of three main 
parts: fingers, palm and thumb (Kim et al., 2008). Elucidation the role of DNA 
polymerase from DNA substrate binding to the recognition and incorporation of 
the dNTPs (fidelity and processivity) has been verified by the structural studies 
that have shown common conformational changes occur upon polymerase 
binding to the DNA substrate, and in this process the enzyme fingers and thumb 
have been shown to be mobile and able to adjust their conformation to get 
closer to the palm domain during DNA recognition, thereby  providing a 
compact, closed conformation for the enzyme to better hold on to its substrate 
(the DNA template and the primer), while the open conformation prevailed 
when the enzyme was not bound to its DNA substrate (Brautigam and Steitz, 
1998; Li et al., 1998). In addition to the three main domains, archaeal 
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polymerase possess two additional domains called exonuclease and N-terminal 
domains (Figure 1.3). The exonuclease part has the capacity for conformational 
change depending on the momentary action required by the polymerase to 
perform with DNA whether it is a replicative or editing role. When a wrong 
dNTP is incorporated to the DNA strand being synthesized, a weakness in 
binding between the DNA (the template and the primer) and the polymerase 
will emerge causing the DNA double strand to be disassembled at this vicinity 
so that the mismatched nucleotide will be pushed into the active site of the 
exonuclease domain where it is sheared. However, the steric properties of the 
closed DNA polymerase conformation (when the enzyme binds DNA tightly) 
prevent the 3ʹ end of the growing DNA strand from being presented into the 
exonuclease domain active site, so the multi-domain structure is clearly 
important in providing the catalytic harmony of the multifunctional DNA 
polymerases (Freemont et al., 1988; Hopfner et al., 1999; Hashimoto et al., 
2001a; Kim et al., 2008).  
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Figure 1.3: The three dimensional structure of pfu DNA polymerase as a 
canonical example to show the domain structure and organisation of the family 
B archaeal DNA polymerases. Green, N-terminal domain; yellow, exonuclease 
domain; blue, palm domain; red, fingers domain; and magenta, thumb domain. 
The figure is modified from (Kim et al., 2008) (PDB code 2JGU). 
 
      It has been shown that the exonuclease domain of archaeal polymerases has 
a unique conserved loop containing a conserved His-147 residue playing 
important role in fixing the relatively wide gap which is required for the ssDNA 
3ʹ end to reach the exonuclease active site. Therefore changing His-147 into 
Glu, which introduces a negatively-charged side chain, causes electrostatic 
interactions between the loop of exonuclease domain and the edge of the thumb 
domain, which is positively-charged, so that the thumb domain moves 1.5 °A 
closer to the exonuclease domain, thereby preventing access of the 3ʹ end of the 
growing DNA strand to the exonuclease domain active site. This rationalises the 
necessity for the wide open polymerase conformation for performing DNA 
editing (Wang et al., 1997; Kuroita et al., 2005a, b). However, crucial DNA 
polymerases properties such as the fidelity, processivity, robustness differences 
in performing the replicative and/or DNA repair role, which are all important in 
controlling  genome stabilisation and evolution, mainly depend on minor amino 
acid diversity in the active site, unique loop and the edge of the thumb domain 
(Kim et al., 2008).  
     As they have originally been isolated  from different thermophilic organisms, 
many DNA polymerases provided invaluable advantages to be used in PCR 
technology, where high temperatures (slightly less than boiling) are applied 
during thermo-cycling. Furthermore, low fidelity, which is considered as a 
major drawback in standard PCR, is by contrast, critical to the success of 
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random mutagenesis by epPCR. Taq-pol from Thermus aquaticus and 
Mutazyme (Stratagene) are commonly used in epPCR (Wong et al., 2004). Taq-
Pol is the best known regarding the low accuracy in DNA amplification when 
used in PCR, even under standard reaction conditions, because it lacks the 
5ʹ→3ʹ proof reading exonuclease activity for removing the wrongly 
incorporated dNTPs so that it provides an error rate of 2.7×10-5 per base per 
amplification cycle under standard non-mutagenic PCR conditions, making it 
the polymerase of choice in many epPCR experiments (Neylon, 2004). It has 
been shown that providing increased concentrations of Taq-pol should increase 
the rate of errors and important to ensure unruffled extension when the dNTPs 
misincorporation occurs (McCabe, 1990). The disadvantage of Taq-pol in 
epPCR is the bias in introducing transitions rather than transversions and it has 
been recorded that the about 40.9% of the nucleotide mutations are of A→T and 
T→A replacements (Cline and Hogrefe, 2000). 
     The relatively poor efficiency of Taq-Pol in epPCR such as subdued yield, 
low mutational frequencies, and most importantly bias in mutations motivated 
the research wheel for looking for and engineering a better mutagenic 
polymerase that could provide a vehicle for random mutagenesis. The 
requirements for such and epPol include providing unbiased mutational patterns 
since a protein sequence must ideally be changed at every codon to generate all 
20 possible amino acids, at least this is the goal in producing highly diversified 
mutational libraries. 
     Alongside the commonly used bacterial Taq-Pol, the DNA polymerase from 
Pyrococcus furiosus (Pfu-pol), which is related to family B polymerases, is the 
most commonly used thermostable archaeal enzyme in PCR (Biles and 
Connolly, 2004). Unlike Taq-Pol, Pfu-Pol possesses extremely high accuracy in 
amplifying DNA, exhibiting a  very low mutational frequency of 1.3×10-6 
mutation per base per replication (eight fold higher than Taq-Pol fidelity) 
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(Capson et al., 1992) as it has a 3ʹ→5ʹ proof reading property, so that it provides 
the high fidelity in standard PCR amplifications (Lundberg et al., 1991; Cline et 
al., 1996). Such high fidelity should make related polymerases unlikely 
candidates for use in epPCR, but engineering these enzymes to turn their high 
fidelity into a low one has been successfully achieved. The crystal structures of 
many of the family B polymerases reveal a couple of long anti-parallel helices 
separated by a short loop as the elements of the fingers sub-domain (Figure 1.4). 
This element is critical for high fidelity and recognition and incorporation of the 
correct dNTP during cellular DNA replication. These two helices have been 
named N and O respectively (Joyce and Steitz, 1994; Brautigam and Steitz, 
1998; Doublie et al., 1999; Zhao et al., 1999; Rodriguez et al., 2000; Hashimoto 
et al., 2001b). 
 
 
Figure 1.4: The two helices (green and orange) forming the fingers sub-domain 
with the short loop (blue) that links them. This is from the crystal structure of 
Pfu DNA polymerase resolved by (Kim et al., 2008) (PDB code 2JGU). 
 
     The two helices and the intervening short loop are actually highly conserved 
among the archaeal family B DNA polymerases. This suggests that the same 
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mechanism is followed in all these enzymes, that share the helix-loop-helix 
conformation, in recognizing and incorporating the correct dNTPs during DNA 
replication and PCR amplification (Biles and Connolly, 2004). In this manner 
and during the DNA polymerase catalysis in replicating the DNA, the incoming 
dNTP is retained by the enzyme-DNA complex only when its association is 
Watson-Crick competent, otherwise, it will be rejected: in this way, enzymatic 
fidelity is ensured. Therefore, and as shown kinetically, any structural 
modifications to this region of the enzyme could reduce its fidelity (Wong et al., 
1991; Kunkel and Bebenek, 2000; Kunkel, 2004). 
     According to the available kinetic and structural data, it has been concluded 
by (Biles and Connolly, 2004) that the orientation of N and O helices is a 
determinant for Pfu DNA polymerase’s high fidelity; so changing their 
orientation should result in reduced enzyme accuracy. The three amino acids 
forming the short loop that links the two helices were targeted for mutagenesis: 
each was replaced by either Gly or Ala, which possess the smallest side chains 
possible and it was thought that they would make the loop junction more 
flexible and consequently reduce the rigidity that is believed to be behind the 
fixing of the long helices. The carboxyl side chain, together with the backbone 
carbonyl-oxygen of Asp-473 are involved in hydrogen bonding with the nearby 
Leu-Glu-Lys residues of the O-α-helix. These interactions are crucial in 
maintaining the orientation of the helices (anti-parallel) and hence the 
incorporation of the correct dNTPs. By changing the loop Asp-473 into Gly, the 
loop becomes flexible enough to change the orientation of the helices by 
removing hydrogen bond stabilisation which is a key part of the fidelity 
mechanism during DNA amplification. Unlike Asp-473, the other two loop 
residues (Thr-471 and Gln-472) have been not been shown to play a role in 
making any significant structurally determining interactions, therefore, mutating 
them should result in either no effect or a minor one in respect of enzyme 
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fidelity (Biles and Connolly, 2004). The Pfu 5ʹ→3ʹ proof reading ability is 
required to be abolished as well by theAsp215Ala companion mutation or the 
wrongly incorporated dNTPs will be excised (Evans et al., 2000). So the double 
mutant enzyme: Asp473Gly and Asp215Ala enzyme was produced as an error-
prone thermostable polymerase that works efficiently under the same reaction 
conditions as the wild-type polymerase, generating a mutational load of about 
7.2 error/kb with no need to manipulate the reaction conditions. The 
mutagenesis bias has been shown to be toward T→A change but it is considered 
as a tolerant bias with no hot spots noticed and it is much less than the biased 
behaviour of Taq-Pol when utilised under non-standard conditions(Biles and 
Connolly, 2004). 
 
1.4. Error-prone pho DNA polymerase 
     As mentioned previously, family B archaeal DNA polymerases are 
extremely similar on both levels of primary and tertiary structure so that the 
structural data of many of them appeared common structural general features of 
being composed of multi domain structure with high degree of analogy in 
sharing sub domain structural properties especially those which are considered 
as a fidelity determinant features, such as the helix-loop-helix structure and the 
exonuclease structural determinants. Such structural analogy should provide the 
flexibility advantage in designing and modifying other DNA polymerase using 
the same mutational strategy at the same positions.   
     In our laboratory, another high fidelity thermostable archaeal family B DNA 
polymerase from Pyrococcus horikoshii (Pho polymerase) has been engineered 
for random mutagenesis (Alharbi, 2010). This enzyme shows a high degree of 
similarity to the pfu polymerase especially at the fidelity determinant residues of 
the helix-loop-helix motif, therefore, the same residues that were targeted 
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previously in pfu have been targeted in pho in term of two companion mutations 
one of them is Asp473Ala in the short loop junction between the O and N 
helices fingers in order to reduce enzyme fidelity by making the helical fingers 
more flexible and less rigid due to the reduction of the hydrogen bonding 
network that involves Asp-473 in the wild type enzyme. The other mutation is 
Asp215Ala which acts as an exonuclease activity reducer and is exactly the 
same mutation as that introduced into the pfu polymerase as mentioned 
previously. The result was an error-prone pho DNA polymerase (PhoEP) with a 
mutational load of 7 errors per kilo base with a bias towards G→A change, 
while C→G mutation is under represented. Transitions were more frequent than 
transversions accounting for 54.8% and 45.2% respectively.  
     It has been emphasized that reducing the fidelity of polymerases is 
accompanied with the simultaneous efficiency reduction in amplifying long 
DNA substrates and producing high yield of PCR product. The problem of low 
efficiency of low accuracy polymerases (especially the engineered ones) has 
been suggested to be related to impaired DNA binding of mutants, especially in 
the fingers domain. Furthermore, the misincorporated nucleotides act as barriers 
in the path of the polymerase while travelling along the DNA, making it less 
stable in holding on to the DNA, and consequently facilitating enzyme 
dissociation (Kelman et al., 1998; Biles and Connolly, 2004; Pavlov et al., 
2004; Wang et al., 2004; Berman et al., 2007; de Vega et al., 2010). Therefore, 
in our laboratory, enhancements have been made to the PhoEP by fusing it with 
a DNA binding protein Sso7d-2 to provide an additional “grip” to the DNA 
template. This DNA binding protein is a monomer of 7 KD (64 residues) 
originally expressed in the Sulfolobus solfataricus with a significant affinity in 
DNA binding to increase the DNA melting temperature of the latter 
thermophilic archeon (Baumann et al., 1994; McAfee et al., 1995; White and 
Bell, 2002). The idea of PhoEP fusing with Sso7d-2 in one polypeptide was 
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inspired by the previous work of (Wang et al., 2004) that includes enhancement 
of the processivity and performance of polymerases by fusing with DNA 
binding proteins to produce novel engineered enzymes with a combined two 
advantages including increased robustness in amplifying long DNA strands 
within less time required for PCR elongation, and mutagenic ability. The 
polypeptide results from the fusion of PhoEP with Sso7d-2 was referred to as S-
PhoEP. The results have actually demonstrated a better efficiency of S-PhoEP 
in amplifying the same length of DNA in a shorter elongation time compared 
with the not fused PhoEP. The error rate has been shown to be increased by 
40% after the fusion with bias behaviour similar to that of not fused version 
with the exception of showing more transversions than transitions (Alharbi, 
2010). In the present random mutagenesis study, S-PhoEP has been used as a 
mutagenic tool to generate libraries of mutations in three different enzyme 
models. 
The aim of the study 
     This study aims to apply the concept of directed evolution to interrogate the 
relationship between primary structure and the function and activity of several 
enzymes starting from the following questions: 
1- Is it the case that the primary structure of a given protein should be 
maintained for that protein to remain functional, or there is a level of 
flexibility that leads to different variants of the same protein performing 
the same function as the wild type? 
2- If the answer is yes, then what level of change can the protein tolerate 
without loss of function? 
3- How do enzymes of different functional and structural classes respond to 
the primary structure changes? 
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     We know that Nature typically introduces changes in a given protein 
sequence over long time scales, by natural selection, in response to 
changes in certain environmental condition, or through natural fidelity 
defects. However, in the present study, the ability of the protein to 
perform its function is investigated while the environmental conditions 
are the same but the primary structure is varied experimentally in vitro.  
     The method chosen to generate mutations is error-prone PCR using 
the S-PhoEP mutagenic DNA polymerase as the randomising agent. By 
combining mutagenesis with a range of microbiological and biochemical 
screening methods, the impact of mutations on the activity of specific 
enzymes and on the growth of the host organism, was examined. Finally, 
attempts were made to rationalise the data using aligned primary 
structures and 3D models derived from available crystallographic studies. 
In short, this study aims to “stress-test” a group of unrelated enzymes in 
order to assess the relationship between Darwinian Natural Selection and 
the precision that chemistry teaches us, underlies catalytic mechanism. 
The experimental plan is outlined below. 
1- Gene design and synthesis to introduce convenient restriction sites for 
region-specific mutagenesis of the target gene. 
2- Sub-cloning of segments of the open reading frame (orf) for error-prone 
PCR amplification followed by, double restriction digestion of the 
products, ligation to reconstitute the complete orf, and transformation. 
3- Systematic “plating” of mutant libraries on selective media (where 
appropriate), recovery of plasmids from individual clones following 
transformation). 
4- Functional screening (to be described for each target gene in the relevant 
Chapter) using microbiological and biochemical techniques. 
36 
 
5- DNA sequencing and data analysis to characterise the mutants recovered. 
Note that any clones that harbour deletions insertions or rearranged ORFs 
are not analysed further in this work. 
6- Evaluation of the position and nature of the mutations alongside the wild-
type DNA sequence and subsequent analysis of the amino acids changes 
predicted by the changes to the DNA sequence in silico. 
7- Interpretation of the results in conjunction with published structural and 
biochemical data. 
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Chapter 2 Materials and Methods 
2.1. Materials 
2.1.1. Buffers, culture media, solutions, chemicals and kits 
     All chemicals, reagents used in this study are of a molecular biology 
standard manufactured by Sigma Aldrich®, Thermo Fisher®, Anala®, Difico®, 
Bioline®, Qiagen®, Novagen®, and New England Biolabs®. Materials are 
mentioned as contents of buffers, solutions, kits as well as individual chemicals 
and reagents as shown within the following table: 
Name Contents 
LB medium (liquid/ solid) 10 g/litre tryptone; 5 g/litre yeast 
extract; 10 g/litre NaCl. If 
solidification required, 1.5% (w/v) 
agar is added. 
SOC outgrowth medium 2% (w/v) tryptone; 0.5% (w/v) yeast 
extract; 10 mM NaCl; 2.5 mM KCl; 
10 mM MgCl2; 10 mM MgSO4; 20 
mM glucose. 
1X M9 glucose minimal medium          
(1 litre) (liquid/ solid) 
11.28 g of 5X minimal M9 salts 
(supplied by DifcoTM), 20 ml of 20% 
(v/v)  glucose solution, 2 ml of 1 M 
MgSO4 solution, 0.1 ml of 1 M 
CaCl2 solution, and 30 ml of 
10mg/ml thiamine solution. If 
solidification required, 1.5% (w/v) 
agar is added.  
M9 glucose + acetate minimal medium 
(liquid/ solid) 
The same contents of M9 glucose 
minimal medium supplied with 2 
mM potassium acetate. If 
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solidification required, 1.5% (w/v) 
agar is added. 
 
M9 glucose + succinate minimal 
medium (liquid/ solid) 
 
The same contents of M9 glucose 
minimal medium supplied with 2Mm 
sodium succinate. If solidification 
required, 1.5% (w/v) agar is added. 
Ampicillin stock solution 100 mg/ml in ddH2O 
Chloramphenicol stock solution 50mg/ml in absolute ethanol 
Kanamycine stock solution 25 mg/ml in ddH2O 
Glycerol solution 10% (w/v) glycerol in ddH2O 
 
TFB1 buffer 100 mM RbCl; 50 mM MnCl2; 30 
mM potassium acetate; 10 mM 
CaCl2; 15% (w/v) glycerol. pH=8 
TFB2 buffer 10 mM MoPS; 10 mM RbCl; 75 mM 
CaCl2; 15% (w/v) glycerol. pH=6.8 
BugBuster protein extraction reagent Supplied by Novagen® 
Wash buffer 50 mM NaH2PO4; 300 mM NaCl; 20 
mM imidazole. pH=8 
Elution buffer 50 mM NaH2PO4; 300 mM NaCl; 
250 mM imidazole. pH=8 
Protein storage buffer 20 mM HCl; 0.1 mM EDTA; 1 mM 
DTT; 100 mM KCl; 200 µg/ml BSA; 
50% (w/v) glycerol. pH=7.4 
2X SDS-PAGE sample loading buffer 0.09 M Tris.Cl; 20% (w/v) glycerol; 
2% (w/v) SDS; 0.02% (w/v)  
bromophenol blue; 0.1 M DTT. 
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33% Acrylamide-bis acrylamide solution Provided by Bio-rad® 
Protein dialysis buffer 50 mM Tris-base; 0.1 mM EDTA; 
0.1 mM DTT. pH=7.5 
 
 
Ni-NTA Provided by Qiagen® 
50X TAE buffer 242 g/litre Tris base; 57.1 ml/litre 
glacial acetic acid; 100 ml/litre of 0.5 
M EDTA. pH=8 
5X Tris-glycine buffer 125 mM Tris; 1.25 M glycine; 0.4% 
(w/v) SDS. pH=8.3 
Agarose Provided by Bioline® 
Ethidium bromide Provided by Sigma® 
DNA markers (Ladders) Provided by Bioline® 
DNA Gel loading dye blue (6X) Provided by New England Biolabs® 
(NEB) 
4X SDS-PAGE resolving buffer 1.5 M Tris; 0.4% (w/v) SDS. pH=8.8 
4X SDS-PAGE stacking buffer 0.5 M Tris; 0.4% (w/v) SDS. pH=6.8 
Ammonium persulphate solution (APS) 10% (w/v) APS in ddH2O  
NNNNTetramethylenediamine (TEMED) Provided by Sigma® 
Coomassie staining solution 0.05% (w/v) comassie brilliant blue 
R-250; 40% (v/v) ethanol; 10% (v/v) 
glacial acetic acid 
De-staining solution 25% (v/v) ethanol; 5% (v/v) glacial 
acetic acid; 70% (v/v) ddH2O 
10% SDS-PAGE resolving gel 2.5 ml of 4X SDS-PAGE resolving 
buffer; 4 ml ddH2O; 3.3 ml of 33% 
(w/v) acrylamide-bis acrylamide 
solution; 200 µl of 10% (w/v) APS 
solution; 40 µl  TEMED.   
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SDS-PAGE stacking gel 
 
1.5 ml of 4X SDS-PAGE stacking 
buffer; 3.4 ml ddH2O; 1 ml of 33% 
(w/v) acrylamide-bis acrylamide 
solution; 100 µl of 10% (w/v) APS 
solution; 20 µl  TEMED.     
IPTG stock solution 1 M IPTG 
Qiagen plasmid miniprep kit Provided by Qiagen®. Contains: 
buffer P1; buffer P2; buffer N3; 
buffer PB; buffer PE; buffer EB; 
LysBlue reagent; RNase A; silica 
spin columns; and collection tubes (2 
ml). 
QIAquick Gel Extraction Kit Provided by Qiagen®. Contains: 
buffer QG; buffer PE; buffer EB; 
QIAquick spin columns; loading dye; 
and collection tubes (2 ml).  
QIAquick PCR Purification Kit Provided by Qiagen®. Contains: 
buffer PB; buffer PE; buffer EB; 
QIAquick spin columns; loading dye; 
and collection tubes (2 ml). 
Phusion high-fidility PCR kit Provided by NEB®. Contains: Phusion 
DNA polymerase; Deoxynucleotide 
solution mix; 5X Phusion HF buffer; 
5X Phusion GC buffer; MgCl2 (50 
mM); DMSO. 
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2.1.2. Modification and restriction enzymes 
2.1.2.1. Modification enzymes 
Enzyme Source 
Benzonase Novagen® 
T4 DNA ligase NEB® 
Shrimp Alkaline 
Phosphatase (rSAP) 
NEB® 
S-PhoEP DNA polymerase Prepared during this study from a construct 
provided by Prof. David Hornby 
 
2.1.2.2. Restriction enzymes 
HindIII; BcII; BmtI; AflII; XbaI; NcoI; BamHI; EcoRI; SpeI; and EagI. 
All restriction enzymes have been provided by New England Biolabs®. 
 
2.1.3. Oligonucleotides 
All DNA oligonucleotides were designed using clone manager 
software with annealing temperature of 55°C and sent for the 
synthesis facility of Eurofins MWG®. They are all listed in the 
following table:  
Name 
of oligo 
Sequence and use 
 
1st set 
F New 
5'-ATGCGTTCGCGTTTCTGCGGAATAC-3' 
Amplification the first third part (flanked by HindIII + BmtI) of 
M.HhaI gene. 
1st set 
R New 
5'-GGCAGTGAGCGCAACGCAATTAATG-3' 
Amplification the first third part of M.HhaI gene and sequencing over 
the mutagenesis area between HindIII and BmtI. 
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3rd set 
F New 
5'-GCACATTCACGCGGATGCAGTTTAC-3' 
Amplification the second third part (flanked by BmtI + AflII) of 
M.HhaI gene. 
 
3rd set 
R New 
 
5'-CCGGCTTTCCGTGTCAGGCATTTAG-3' 
Amplification the second third part of M.HhaI gene and sequencing 
over the mutagenesis area between BmtI and AflII. 
4th set 
F New 
5'-TGTGCTGCAAGGCGATTAAGTTGGG-3' 
Amplification the last third part (flanked by AflII + XbaI) of M.HhaI 
gene. 
4th set 
R New 
5'-GCCGGATAGCGAAGTTGAACATCTG-3' 
Amplification the last third part of M.HhaI gene and sequencing over 
the mutagenesis area betweenAflII and XbaI. 
1st At 
F 
5' TCAAGGCCACGTGTCTTGTCCAGAG 3' 
Sequencing to check the CATI gene sequence integrity after E. coli 
transformation with pAtase2 synthetic plasmid construct (this primer 
covers the sequencing for the first part of the gene). 
3rd At 
F 
5' CCAGGACGTCGCATGTTATGG 3' 
Sequencing to check the CATI gene sequence integrity after E. coli 
transformation with pAtase2 synthetic plasmid construct (this primer 
covers the sequencing for the second part of the gene). 
2nd At 
F 
5' CAGACCGTTCAGCTGGATATCAC 3' 
Amplification the part of CATI gene targeted in mutagenesis and 
sequencing over the mutagenesis area betweenEcoRI and XbaI. 
3rd At 
R 
5' CAGGTTTCCCGACTGGAAAGC 3' 
Amplification the part of CATI gene targeted in mutagenesis (flanked 
by EcoRI and XbaI). 
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1st lpd 
F 
5' CAAGGTAGCAAGCGCCAGAATCC 3' 
1- Amplification the part of lpd gene flanked by NcoI and Af1II 
and sequencing over this mutagenesis area. 
2- Amplification the part of lpd gene flanked by NcoI and EagI 
and sequencing over the first part of this mutagenesis area.  
3- Covering the first part in the gene sequencing to check lpd gene 
sequence integrity after E. coli transformation with pLpd1 synthetic 
plasmid construct.   
1st lpd 
R 
5' CTAGTAGACGTTCCGGCACTTCC 3' 
Amplification the part of lpd gene flanked by NcoI and Af1II. 
 
2nd lpd 
F 
5' ATTGCAGCCGGTAGCCGTCCGATTC 3' 
1- Amplification the part of lpd gene flanked by Af1II and XbaI 
and sequencing over the first part of this mutagenesis area.  
2- Covering the second part of sequencing after mutating the area 
flanked by NcoI and EagI of the lpd gene. 
3- Covering the second part in the gene sequencing to check lpd gene 
sequence integrity after E. coli transformation with pLpd1 synthetic 
plasmid construct.  
 
2nd lpd 
R 
5' CGGTCAGACCAACCCATGCAACTTC 3' 
Amplification the part of lpd gene flanked by NcoI and EagI. 
3rd lpd 
F 
5' CAGCTGCGTACCAATGTTCC 3' 
1- Covering the second part of sequencing after mutating the area 
flanked by Af1II and XbaI of the lpd gene. 
2- Covering the third part in the gene sequencing to check lpd gene 
sequence integrity after E. coli transformation with pLpd1 synthetic 
plasmid construct.   
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3rd lpd 
R 
5' AGCTGGCACGACAGGTTTCC 3' 
Amplification the part of lpd gene flanked by Af1II and XbaI. 
 
 
2.1.4. Plasmids 
     All the plasmids listed in the following table were either stored at      
-20°C as plasmid DNA minipreps in ddH2O for a short term use or 
kept inside suitable E. coli strains which in turn were stored at -80°C 
with 20% (w/v) glycerol for the long term use. 
Name Source  Description 
pUC19 New England Biolabs® Cloning vector 
S-PhoEP Prof. David Hornby Carries S-PhoEP gene 
pMJA01 Developed in this work Carries M.HhaI gene 
pAtase2 Developed in this work Carries CATI gene 
pLpd1 Developed in this work Carries lpd gene 
 
 
2.1.5. Bacterial strains 
     All bacterial strains listed in the following table were stored on 
agar plates sealed by parafilm at 4°C for short term use or within 20% 
(w/v) glycerol at -80°C for the long term storage. 
Name  Source Genotype 
E. coli BL21 
(DE3) 
Novagen® F-ompT hsdSB (rB
-mB
-) dcm gal λ (DE3)  
 
E. coli DH5 
alpha 
New England 
Biolabs® 
fhuA2 Δ(argF-lacZ)U169 phoA glnV44 
Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 
endA1 thi-1 hsdR17 
E. coli K12 New England F- glnV44 e14-(mcrA-) rfbD1? relA1? 
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ER1821 Biolabs® endA1 spoT1? thi-1 Δ(mcrC-mrr)114::IS10 
E. coli K12 
JM109 
New England 
Biolabs® 
F´ traD36 proA+B+ lacIq Δ(lacZ)M15/ 
Δ(lac-proAB) glnV44 e14- gyrA96 recA1 
relA1 endA1 thi hsdR17 
E. coli K12 
W3110 
(JRG3503) 
Prof. Jeff Green 
(MBB University 
of Sheffield) 
F- lambda- IN(rrnD-rrnE)1 rph-1 
(lpdA::kanR) 
 
 
2.1.6. Equipment 
 
Equipment Provider 
Eppendorf tubes of 0.5 ml and 1.5 ml          Sarstedt® 
PCR tubes of 0.2 ml Bio-Rad® 
Falcon tubes Sarstedt® 
Universal tubes Sarstedt® 
Flasks, cylinders, beakers, bottles and durans 
of different sizes 
 
Protein affinity separation columns Qiagen® 
Protein dialysis tubes Novagen® 
Pipette tips RAININ instrument 
Co. 
 
Pipettes Costar® 
Micropipettes Gilson Pipetman® 
 
Petri dishes Thermo 
Scientific® 
Parafilm Pechiney 
Plastic 
Packaging® 
Autoclave tape  
Gloves Glove plus® 
Autoclave Phoenix® 
Water bath Grant Instruments® 
 
Deep freezer Scientific 
Laboratory 
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Supplies® 
Refrigerators  
Incubator room (37°C) MBB 
department 
 
 
Manual 
Ultra-violate transilluminator model TM40 
 
 
 
Genetic Research 
Instruments® 
 
Computerized gel documentation Syngene® 
UV and Visible Spectrophotometer Perkin Elmer® 
Spectrophotometer 10X4X45 mm cuvettes Sarstedt® 
Magnetic stirrers and shakers  
Heat block Grant Instruments® 
 
Vortexer Labnet® 
Agarose gel electrophoresis unit Bio-Rad® 
SDS-PAGE electrophoresis unit Bio-Rad® 
Electrophoresis power supplies 
Power Pac 300 
 
 
Bio-Rad® 
PCR machine Senso Quest® 
Loops and spreaders  
Centrifuges: 
Centaur 2, and Microcentaur 
Beckman J-251, J-6M/E and J201 
CentriconY10 centrifugal concentrator 
Sanyo/MSE® 
Beckman® 
Amicon® 
Syringes 
 
Becton Dickinson® 
 
Syringe filters 
 
Nalgene® 
 
Balances: 0-100g Model AJ 100 and 0-800g Model 
K7 
 
Mettler® 
 
pH meter Basic with Tris Electrode 
 
Denver Instrument 
Company® 
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MicroPulser electroporator Bio-Rad® 
electroporation cuvettes of 0.1 cm and 0.2 cm 
electrode gap width 
Bio-Rad® 
Rotary shaker  
 
 
2.2. Methods 
2.2.1. Storage of bacterial strains 
     Whether transformed by plasmid(s) or not, all bacterial strains were stored 
for both short and long term purposes. The short term storage was carried out by 
streaking the bacteria on an appropriate agar plate with or without antibiotic(s) 
and incubated overnight then the plates were sealed with parafilm and kept at 
4°C to be used for no longer than two weeks. While the long term storage was 
performed by culturing the bacterial strain in 5ml liquid LB with or without 
antibiotic(s) (according to their resistance) and incubated overnight at 37°C with 
vigorous shaking at 250 rpm then 800 µl of the bacterial growth is mixed with 
200 g of autoclaved sterile glycerol and frozen at -80°C.   
 
2.2.2. Preparation of competent E. coli cells for chemical transformation  
     Competent cells were prepared according to (Hanahan, 1983). Bacterial cells 
were taken from their original glycerol stocks and streaked on LB agar then a 
single colony was taken and grown on LB medium overnight, a 250µl aliquot 
from the latter growth was used to inoculate 250ml of LB then incubated at 
37°C until OD600nm= 0.45-0.5. The cells were harvested by centrifugation 
(4000xg for 15minutes at 4°C) then resuspended in 8ml TFB1 buffer an 
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incubated on ice for 10-15min. The cells were precipitated again by 
centrifugation as above then resuspended in 2 ml TFB2 and incubated on ice for 
15 min. Finally, competent cells were aliquoted in Eppendorf tubes (100 µl in 
each tube) and stored at -80°C until use. 
 
2.2.3. Preparation of electrocompetent E. coli cells 
     A conical flask containing 50 ml LB and 25 µg/ml kanamycin was 
inoculated by 500 µl of E. coli K12 W3110 (JRG3503) from an overnight 
culture and incubated at 37°C with vigorous 250 rpm shaking until OD600 
reached 0.5-0.7, then the cells were chilled on ice for 20 minutes and harvested 
by cooled centrifugation (4000xg for 15 minutes at 4°C) while LB supernatant 
was discarded. The cell pellet was resuspended in 50 ml of 10% (w/v) glycerol 
solution, mixed by vortexing and pelleted again as above then 25 ml of 10% 
(w/v) glycerol solution was added to the cells for a second resuspension, 
pelleted as before and resuspended a third time in 5 ml of 10% glycerol solution 
and then harvested as above. Finally, the cells were resuspended using 1-2 ml of 
10% (w/v) glycerol solution, aliqouted as 50-100µl in microcentrifuge tubes and 
stored at -80°C until required.  
 
2.2.4. Transformation efficiency estimation 
     Prior to the experimental transformation, the efficiency of competent cells in 
accepting new plasmid DNA was tested by transforming (following either 
chemical or electroporation transformation protocols as mentioned above) the 
bacteria with pUC19 plasmid vector of an estimated concentration (which is 
estimated by using DNA nanodrop) then the bacterial CFUs are counted and the 
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unit of efficiency is designed as the number of CFUs per 1 µg of pUC19 DNA 
plasmid.  
2.2.5. Plasmid DNA preparation 
     Plasmid DNA was prepared according to Qiagen® protocol by using the 
Qiagen® miniprep kit. Firstly, bacteria from a single colony were grown in 5 ml 
LB with appropriate antibiotic(s) (100 µg/ml ampicillin, 25 µg/ml 
chloramphenicol, 25 µg kanamycin or combinations according to the selection 
required) overnight. Cells were precipitated by centrifugation (4500 rpm for 10 
min at 4°C). The cell pellet was resuspended in 250 µl P1 buffer and mixed by 
vortex. Two hundred and fifty µl of P2 buffer was added then mixed by 
inverting gently until the mixture turns blue indicating cell lysis. Three hundred 
and fifty µl of buffer N3 was added and mixed by inversion 6 times until the 
colour turns white. The mixture was centrifuged at full speed 14000 rpm for 10 
min. The supernatant was taken and applied into the silica spin column (left for 
1min for binding) then centrifuged at full speed for 1min, the flow through was 
discarded and 750 µl of buffer PE was applied into the column for washing then 
centrifuged at full speed for 1 min, the flow through was discarded and another 
centrifugation was done to remove ethanol traces from buffer PE. Finally, the 
silica column was put into a fresh Eppendorf tube, plasmid DNA was eluted 
from the silica column by adding 30-100 µl ddH2O or TE buffer to the centre of 
the silica then centrifuged at full speed and stored at -20°C. 
 
2.2.6. Chemical transformation of E. coli 
     Bacterial transformation was done according to protocols provided by 
Novagen. The competent cells of known transformation efficiency ware 
defrosted on ice until the last ice particle disappeared then mixed with an 
estimated DNA quantity and left on ice for 30 min. Heat shock was done by 
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placing the transformation mixture in 42°C water bath for 90 seconds then 
returned back to the ice immediately and kept on it for 2 min. 500 µl of LB or 
SOS medium was added to the mixture and incubated for 1hour at 37°C. 
Finally, 100 µl of the mixture was spread on an appropriate selection agar plate 
containing antibiotic(s) and incubated overnight at 37°C. 
 
2.2.7. Electroporation 
     Electroporation was performed according to guidance from Bio-Rad® as 
follows: Electrocompetent E. coli cells were thawed on ice for approximately 10 
minutes. Electroporation cuvettes of either 0.1 or 0.2 cm gap width are kept on 
ice as well prior use. Once the competent cells thawed, the plasmid DNA or the 
ligation mixture was mixed with the E. coli cells in a microcentrifuge tube and 
kept on ice for about 1 minute. Then an appropriate amount of the cells and 
DNA mixture was transferred into a cooled electroporation cuvette with tapping 
to ensure the settlement of the mixture in the bottom of the cuvette and to avoid 
bubbles formation. Then the cuvette was put in the chamber slide and pushed 
into the electroporation chamber to be between the micropulser contacts then 
pulse was applied once at appropriate voltage (KV) and milliseconds time 
constant according to the gap width of the cuvette. However, voltage that should 
be used with E. coli is already set in the micropulser from Bio-Rad® to be 1.8 or 
2.5 KV with 0.1 and 0.2 gap width cuvettes respectively, while the millisecond 
time constant is auto optimised by the micropulser depending on the 
conductivity of the mixture (i.e. the salt content). After the pulse application, 
500-900 µl of SOC or LB was quickly added to the mixture while still in the 
cuvette then the whole mixture was transferred into a 1.5 ml microcentrifuge 
tube and incubated with rotation at 37°C for one hour then the transformed cell 
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were centrifuged at 10000 rpm for 1 minute and plated on an appropriate 
selection plate.       
 
2.2.8. Protein purification 
     Error-prone Pho DNA polymerase is expressed from a lac T7 promoter 
expression vector S-PhoEP.  BL21 (DE3) Rosetta strain was used for 
expression. The purification was done according to guidance provided by 
Qiagen. 
 
2.2.8.1. Cells growth and induction 
     Five hundred ml of LB (containing 100µg/ml ampicillin and 34 µg/ml 
chloramphenicol) was inoculated with 10 ml of fresh BL21 (DE3) Rosetta 
growth and incubated at 37°C until OD600nm=0.6. The cells were induced to 
express the protein by adding IPTG to a final concentration of 1mM then 
incubation proceeded for 4-5 hours. Cells were harvested using pre-weighted 
tubes by centrifugation (4000 xg for 20 min at 4°C), then cell pellet was frozen 
at -20°C overnight to aid cell breakage. 
 
2.2.8.2. Cell breakage 
     Cell lysis was done by BugBuster (primary amine-free) Protein Extraction 
Reagent from Novagen® (5ml BugBuster per 1 gm cells), 25 units of benzonase 
were added for each 1 ml of BugBuster to get rid of the viscosity caused by 
nucleic acids, the cell suspension was kept on rotating mixer at a slow setting 
for 10–20 min at room temperature. Cell debris was removed by centrifugation 
(16000 xg for 20 min at 4°C), the supernatant was transferred to a fresh tube. 
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Since our target is heat resistant protein, the supernatant was heat treated at 
85°C for 10 min (to remove heat sensitive proteins) then centrifugation (16000 
xg for 20 min), the supernatant was taken in a fresh tube for affinity 
chromatography purification. 
2.2.8.3. Nickel-NTA affinity chromatography 
     Since our target protein is 6xHis-tagged, Ni-NTA was used to specifically 
bind and purify it. The protocol was carried out according to Qiagen®. The 
second supernatant obtained after cell lyses was mixed with 1ml of Ni-NTA 
slurry and kept with rotary shaker for 60 min at 4°C for binding. The lysate-Ni-
NTA mixture was loaded into a column with the bottom outlet capped. The 
bottom cap was removed allowing the flow-through to leave the column. The 
column was washed twice with 4 ml wash buffer. Finally, the protein was eluted 
4 times with 0.5 ml elution buffer each time.  
 
2.2.8.4. Protein dialysis 
     The elution fraction was dialyzed by putting it in a dialysis tube from 
Novagen which was in turn kept floating and rotating on a magnetic stirrer 
overnight at 4°C in 2 litters of freshly prepared protein dialysis buffer. 
 
2.2.8.5. Protein storage 
     Storage buffer was added to the protein after dialysis and stored at -20°C. 
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2.2.9. Sodium dodecyl sulphate-polyacrylamidegel electrophoresis (SDS-
PAGE) 
     Sodium dodecyl sulphate-polyacrylamidegel electrophoresis (Laemmli, 
1970; Maniatis et al., 1982) was performed for the whole cell lysate, soluble 
fraction before heating, soluble fraction after heating, Ni-NTA flow-through, 
washing fraction and elution fraction to track the protein through the 
purification steps. Ten µl from each sample was mixed with 10 µl of 2x protein 
loading buffer, heat treated (95°C for 10 min) then loaded into polyacrylamide 
gel (which is prepared as two layers: stacking and resolving layer) and 
electrophoresed under denaturing conditions at 160 V in the presence of tris-
glycine buffer until the dye reached the bottom of gel. Proteins bands were 
visualized by keeping the gel in staining solution for 1-2 hours then de-staining 
overnight to remove the stain from the gel except proteins bands. 
 
2.2.10. DNA agarose gel electrophoresis 
     Agarose electrophoresis was used to visualize DNA bands of: plasmid 
minipreps (to estimate DNA concentration and to ensure about minipreps), PCR 
products (to ensure about amplification) and restriction digestion. The gel was 
almost always prepared as 1% (w/v) agarose which is microwave heat dissolved 
in 1X TAE buffer until the mixture is clear then transferred to a water bath to 
cool to 50°C then supplied with ethidium bromide at final concentration of 0.5 
µg/ml and poured in the gel template containing a comb of an appropriate size 
to form the required number of wells. DNA samples were mixed with 6X 
loading buffer, loaded into the wells and electrophoresed under 100 V for 1 
hour in presence of 1x TAE buffer. After that, DNA bands were visualized by 
U.V. trans illuminator. 
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2.2.11. DNA restriction digestion 
     Restriction enzymes from New England Biolabs® were used to cut plasmid 
vectors and inserts to provide compatible ends prior ligation as well as to check 
the consistency of constructs after ligation. The reactions were done according 
to the leaflets of the enzymes supplier with some modifications. DNA 
concentration was always estimated prior to the restriction digestion so that an 
appropriate number of enzyme units was added. The reaction volume was 
almost always 20 µl with an incubation time between 1-2 hour at 37°C taking 
into consideration the star activity behaviour of some restriction enzymes which 
could be always avoided by using the high fidelity versions of those enzymes.  
 
2.2.12. Removal of 5ʹ phosphates from the DNA 
     The dephosphorylation of the 5ʹ ends of the linearized vectors was 
occasionally carried out to avoid vector self-ligation. For this purpose, Shrimp 
Alkaline Phosphatase (rSAP) from NEB® was used and the reaction was set 
according to the manufacturer guidance. rSAP is working in its full activity in 
all NEB® restriction enzymes buffers, therefore, there was no need to purify the 
linearized vectors from the restriction digestion reaction prior to the 
dephosphorilation reaction so that rSAP was add directly just after the 
incubation period of the restriction digestion reaction. 1 unit of rSAP has been 
added for every 1 pmol of DNA ends (about 1 μg of a 3 kb plasmid) and 
incubate at 37°C for 30–60 minutes then heat inactivated at 65°C for 5 minutes. 
 
2.2.13. DNA ligation 
     Bacteriophage T4 DNA ligase from New England Biolabs® was used to 
ligate plasmid vectors and inserts (PCR products) of compatible cohesive 
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(sticky) ends. The reaction was done according to NEB® guidance. The DNA 
concentration of both insert and vector was always determined before mixing 
the reaction components. The proportion of concentration of the vector to insert 
was between 1:3 to 1:10 in a total reaction volume between 20-50 µl and 
incubation period of 4 to 16 hours at 16°C. The ratio of the vector:insert 
amounts is calculated according to the formula: required mass insert (g) = 
desired insert/vector molar ratio X mass of vector (g) X ratio of insert to vector 
lengths. 
2.2.14. PCR mutagenesis amplification 
     The mutagenesis was done by error-prone PCR using 1-3 µl of error-prone 
DNA polymerase S-PhoEP developed in our laboratory and purified during this 
study as mentioned previously. The PCR reactions (50 µl) were done following 
protocol of NEB® in term of contents amounts and concentrations. Contents of 
the NEB® PCR kit including dNTPs, MgCl2, and PCR reaction buffers were 
used. Many oligonucleotides primers were designed by Clone Manager software 
so that the annealing temperature for all of them is 55°C, therefore, conditions 
of all reactions were the same and as follows: initial denaturation at 94°C for 2 
min., denaturation at 94°C for 30 sec, annealing at 55°C for 30 second, 
elongation at 72°C for 45 sec, and final elongation at 72°C for 10 min. The 
reaction mixture was as follows: 10 µl of 5X GC phusion PCR buffer, 1 µl of 10 
mM dNTPs, 2.5 µl of 10 µM forward primer, 2.5 µl of 10 µM reverse primer, 1 
µl of plasmid DNA template of variable concentrations (˃250 ng), 1-3 µl of S-
PhoEP DNA polymerase, 1 µl of 50 mM MgCl2, and ddH2O nuclease free water 
to complete the volume to 50 µl.  
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2.2.15. PCR product clean up 
     The PCR product was cleaned according to the guidance from Qiagen® in 
order to render it pure enough for optimising the subsequent cloning reactions, 
such as restriction digestion and ligation. Five volumes of buffer PB was added 
to one volume of PCR reaction and mixed well by inverting the tube gently. The 
mixture was then applied to a silica spin column and left for 1 minute for 
binding to occur. Centrifugation was then carried out at full speed for 1 minute 
to remove the liquor. Seven hundred and fifty µl of PE buffer was applied to the 
silica column for washing, followed by a full speed centrifugation for 1 minute. 
Another centrifugation was done as before to remove any traces of PE buffer 
and the DNA was finally eluted by applying ddH2O to the centre of the silica 
column.   
 
2.2.16. DNA fragmentsrecovery from agarose gel 
     Fragments of interest of both vector and insert were recovered from the gel 
using a Qiagen® gel recovery kit and according to Qiagen® protocol. The gel 
was placed on U.V. trans illuminator, fragments were cut using a clean sharp 
surgical blade, each fragment was transferred into a pre weighted Eppendorf 
tube. The weight of the gel slice was taken and QG buffer was applied into the 
tube in a proportion of 3:1 according to the gel slice weight; for example, if the 
weight was 100 mg, 300 µl of QG was added and so on. After the QG addition 
the tube was placed in 55°C water bath for 10-15 minutes until agarose was 
completely melted. Isopropanol was added in a proportion of 1:1 depending on 
the weight of the gel slice (for example100 µl of isopropanol for 100 mg gel 
slice) and mixed by inverting. The mixture was then transferred on to a silica 
spin column and centrifuged at full speed for 1 min., the flow-through was 
discarded. Washing was done by adding 500 µl QG buffer and centrifugation at 
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full speed for 1 min., the flow-through was discarded. A second wash was done 
as above but with 750 µl PE buffer, ethanol traces were removed by a further 
spin for 1 min at full speed. Finally, the column was placed into a fresh 
Eppendorf tube and DNA was eluted by applying 30-50 µl of ddH2O on to the 
centre of the column. 
 
2.2.17. DNA sequencing and data analysis 
     The DNA sequencing facility which is situated in the Medical School at the 
University of Sheffield was used to sequence all the plasmid DNA samples 
extracted from the clones developed during this study. The sequencing 
chromatograms visualised and analysed using Chromas Lite software. Each 
nucleotide sequence was compared with the original DNA sequence to locate 
the nucleotide changes; for this purpose, the web NCBI BLAST nucleotide 
sequence comparing tool was used. The online translation tools from New 
England Biolabs® and ExPASy Bioinformatics Resource Portal were used to 
translate nucleotide sequences into their peptide chains to evaluate and allocate 
the amino acids changes patterns after comparing the mutant clones amino acid 
sequence with the wild type sequence using the web NCBI BLAST protein 
sequence comparing tool.  
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Chapter 3 M.HhaI DNA C5-methyltransferase: Random mutagenesis and 
functional screening 
Abstract 
     In this chapter, the experimental random mutagenesis using error-prone Pho 
DNA polymerase has been applied to the M.HhaI gene. This gene is naturally 
translated by Haemophilus parahaemolyticus to express M.HhaI DNA methyl 
transferase that recognizes the sequence GCGC within the DNA double helix 
and adds a methyl group (CH3) to the inner cytosine. Mutant clones were 
screened for biological and biochemical function and grouped into active, 
inactive and partially active clones which are then analysed according to the 
available three dimensional structure and the previous data related to this 
enzyme. The activity screening data showed that the enzyme is significantly 
robust and could “accept” several primary structure changes even at the 
conserved locations, without loss of activity. On the other hand, few mutant 
clones showed impaired enzyme activity unexpectedly when points of no 
conservation were mutated. The experimental work in this chapter provides a 
platform for optimising the methodology to be applied on other target genes. 
3.1. Introduction 
     There are a number of biological modifications made to genomic DNA; one 
of the earliest to be identified was methylation, which involves the addition of a 
single methyl group (CH3) on to either cytosine or adenine within the DNA 
double helix (Iqbal et al., 2011). The class of enzymes responsible for this 
activity are termed DNA methyltransferases, abbreviated here to DNA MTases 
(Adams, 1990). In some eukaryotes, it has been shown that DNA methylation is 
involved in the regulation of gene expression (Cedar, 1988). For example, it has 
been shown that methylation of cytosine within the promoter region of RNA 
polymerase II genes in higher organisms can inhibit transcription (Besser et al., 
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1990). Experimental investigations of methylation and its role in general gene 
expression, differentiation and development were clarified when Li et al. (1992) 
used gene knockout technology to demonstrate that the gene encoding DNMT1 
is essential for normal embryonic development. Since this work, the sequencing 
of a number of genomes, including mice and human, has revealed the presence 
of several cytosine-C5-specific DNA MTases (Jeltsch, 2006). Several 
publications have described more specialised roles for cytosine-C5 DNA 
MTases in recombination as well as replication phenomena (Wilkinson et al., 
1995; Goyon, 1997; Malagnac et al., 1997). 
     In a number of prokaryotes, in particular E. coli, DNA methylation is 
involved in a wide range of biological functions, including restriction and 
modification. This phenomenon, in which DNA of the host is methylated in 
order to “protect” it from host mediated “restriction” (sequence-specific 
hydrolysis) has often been described  as a primitive “immune system”(Boyer, 
1971; Wilson and Murray, 1991). One other role for DNA methylation in 
bacteria is the correction of mistakes that arise during DNA replication 
(Modrich, 1991). It has been found that some DNA adenine methyltransferases 
(Dam) are involved in the expression of certain virulence factors genes in 
enteric bacteria such as Salmonella typhimurium, therefore, Dam- strains lack 
their virulence (Heithoff et al., 1999). 
     Clearly, the biological role of restriction and modification enzymes is more 
complex than a primitive immune system, but for the purposes of this work, that 
is how it will be considered. In our methodology, we use this principle to screen 
mutants that are either proficient or deficient in methylation activity, using a 
simple restriction based method.  
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3.2. Classification of DNA Methyltransferases 
     DNA MTases have been classified by the Enzymes Commission (EC) 
according to the reaction that they catalyze as shown in Table 3.1. 
Table 3.1: Classes of DNA methyltransferases: 
DNA MTase class Description 
N-6 adenine-specific 
DNA methyltransferases 
(A-Mtases or m6A) 
These enzymes add a methyl group to the amino 
group at the C-6 of adenine. They are part of several 
types of restriction and modification systems in 
bacteria. Methylation by these enzymes protects the 
same DNA sequence from cleavage by the cognate 
restriction enzyme (Loenen et al., 1987). 
 
N-4 cytosine-specific 
DNA methyltransferases 
(C4-Mtases or m4C) 
 
These enzymes are responsible for methylation of 
the amino group at C-4 position of the cytosine ring. 
Some Type II restriction and modification 
systemC4-Mtases act to protect DNA against the 
corresponding restriction enzymes (Timinskas et al., 
1995). 
C-5-cytosine- 
specificDNA 
methyltransferases (C5-
Mtases or m5C) 
Methylate the C5 position of the cytosine ring. In 
mammals, these enzymes are known to be involved 
in modifying gene expression and cell 
differentiation, on the other hand, they are a part of 
restriction and modification systems in prokaryotes 
(Kumar et al., 1994). 
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3.3. Structure and architecture of HhaI methyltransferase (M.HhaI) 
     M.HhaI belongs to the cytosine C-5 specific group of DNA MTases (EC 
2.1.1.37), abbreviated to C5-Mtases. All enzymes in this class are built from ten 
conserved sequence motifs and appear to share a common architecture (Yen et 
al., 1992). There is a well characterised variable region in all C5-Mtases 
situated between motifs VIII and IX (Figure 3.1). This region shows the greatest 
level of amino acid sequence diversity among the majority of bacterial C5-
MTases and is referred to as the target recognition domain (TRD): this region 
recognizes the DNA sequence and the cytosine to be methylated (Klimašuaskas 
et al., 1991). 
     M.HhaI consists of 327 amino acids (molecular mass =37 kDa), and is one of 
the smallest C5-Mtases identified to date. It recognizes the sequence 5'-GCGC-
3' within double stranded DNA and methylates the middle cytosine, to form 5'-
GCCH3GC-3'. This enzyme is part of the HhaI restriction and modification 
system of Haemophilus haemolyticus (Roberts et al., 1976; Mann and Smith, 
1979). 
     Cheng et al. (1993) determined the three dimensional structure of M.HhaI 
using X-ray crystallography. The structure is illustrated in Figure 3.2. The 
enzyme is composed of three main parts: a large domain, a small domain and a 
segment called hinge region, which connects the two domains. The large 
domain constitutes two thirds of the enzyme (amino acids 1-193 of the N-
terminal and 304-327 of the C-terminal sequence). The two stretches of primary 
structure forming the large domain are separated by the TRD and the hinge 
region. The segment encoded by amino acids 1-193 twists to form a mixture of 
α and β strands, while the C-terminal segment forms α-helix. The core of the 
large domain is composed of six β strands numbered 4, 3, 1 and 2 which are 
parallel and adjacent to each other. Next to strand 4, there is a hairpin-like 
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structure formed by strands 5 and 6. The core is crammed between two “layers”: 
the upper layer, which is formed by helices C and D, and the lower layer which 
is formed by helices A and G with strand β7. These two layers form a sandwich-
like structure. 
     The small domain is composed of seven loops, some of which exhibit β-
strand character, but this is not regular. This region is encoded by amino acids 
194-275, which are arranged in a “circular” pseudo-antiparallel manner to form 
a propeller-like structure. The hinge region is a mixture of α and β structures 
joining the large and small domains, forming the lower part of the cleft. The 
AdoMet-binding site lies just beyond the C-terminus of β-sheet 1 on the large 
domain side of the cleft. 
 
3.4. M.HhaI motifs and tertiary structure 
      Since the early comparative analysis of DNA MTase sequences by (Pósfai 
et al., 1989), many more C5-Mtase genes have been sequenced. It is now clear, 
that Pósfai et al (1989) were essentially correct, as confirmed by a number of 
crystal structures of DNA MTases. Among the members of C5-Mtases; six of 
the conserved motifs are considered highly conserved: these are labelled I, IV, 
VI, VIII, IX and X. 
     By way of an illustration of the conservation of primary structure among 
methyltransferases, an alignment of 36 m5C-Mtase sequences showed that most 
motifs are present in all C5-Mtases, however motifs IX and X in M.SssI and 
M.CviJI MTases are very poorly defined. Nevertheless, in general, the 
conserved motifs generate the structural framework for catalytic function in this 
class of enzymes (Cheng et al., 1993). 
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     Analysis of the variable region between conserved motifs VIII and IX across 
this group of C5-Mtases reveals a considerable level of diversity in the TRD. 
Even though it is a variable region, a typical TRD will contain a T-L dipeptide 
(Lauster et al., 1989). A higher resolution analysis of the variable region has led 
to amino acids 171-271 being labelled as the variable region and  amino acids 
231-253 constitute the TRD, which is found on the surface of M.HhaI, forming 
a “stalk-like” structure which initially crosses over the whole protein length 
then folds to form the major portion of the small domain (Cheng et al., 1993).   
     Most of the conserved motifs are contained within the large domain of 
M.HhaI, while the major part of the variable region is included inside the small 
domain. The second half of motif IX and the first half of motif X form the hinge 
region, while the first half of motif IX is a part of the small domain and the last 
half of motif X is contained in the large domain. It has been noticed that 
M.HhaI became more active when mutants were created by exchanging 
sequences from other motifs adjacent to motif IX and the variable region 
(Klimašuaskas et al., 1991; Mi and Roberts, 1992). 
      The core structure of M.HhaI, as described by Cheng et al. (1993), is 
formed by the most highly conserved motifs which surround the active site 
cleft. These motifs include three α-helices (αA, αE and αG), four β-strands (β1, 
β3, β4 and β6) and strand β14 in the small domain in addition to four 
associating loops named: I-1A (between β1 and αA), I-3C (between β3 and αC), 
I-4D (between β4 and αD) and I-56 (between β5 and β6). These structures are 
thought to be crucial for the enzyme activity. 
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Figure 3.1.Schematic representation of the secondary structure of M.HhaI, 
showing the conserved motifs in different colours (red, motif I; yellow, motif 
IV; green motif VI; cyan, motif VIII; magenta, motif IX; dark blue, 
motifX).The invariant amino acids are circled. β-strands are represented as 
open, wide arrows labelled with numbers, while α-helices are represented as 
cylinders and letter labelled. Thick dashed lines represent hydrophobic 
interactions. Thin dashed lines represent electrostatic interactions or hydrogen 
bonds. This figure was taken from Cheng et al. (1993).  
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Figure 3.2: Ribbon diagrams showing: (A) large (red) and small domains 
(yellow), and hinge region (green). (B) Domains and motifs (coloured with the 
same colours of motifs which are shown in figure 3.1) organization from 
different angle. AdoMet is shown as pale yellow spheres. (C) Ternary complex 
showing M.HhaI, DNA substrate and AdoMet cofactor assembled together. The 
DNA double helix is shown in grey. The target cytosine is shown in blue and it 
appears clearly flipped out of the DNA helix to be within the enzyme active 
site. The AdoMet is shown as pale yellow spheres. Catalytic, TRD, and hinge 
A B 
C 
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regions of the enzyme are shown in red, yellow, and green respectively. (A) and 
(B) were developed from the three dimensional structure resolved by (Cheng et 
al., 1993), PDB code 1HMY, while (C) was developed from the three 
dimensional structure resolved by Klimasauskas et al. (1994), PDB code 
1MHT.  
 
3.5. The mechanism of methylation 
     DNA MTases catalyse DNA methylation by transferring a methyl group 
from the methyl donor S-adenosyl-L-methionine (AdoMet), to a cytosine, 
following its incorporation into DNA. In the case of C5-Mtases, the methyl 
group becomes attached via the C5 position of the pyrimidine ring (usually 
cytosine) producing modified cytosine in a series of specific stages that have 
been identified by a range of biochemical, chemical and biophysical approaches 
(Dryden, 1999).  
     Understanding the catalytic mechanism of MTases emerged from studies on 
both prokaryotic DNA MTases and mammalian enzymes in addition to the 
similarities between the mechanism of thymidylate synthase and C5-Mtases, led 
Santi’s group (Wu and Santi, 1987) to propose a mechanism incorporating a 
transient covalent intermediate for M.HhaI based largely on steady state kinetic 
studies. Subsequently, Verdine’s group using the suicide inhibitor, 
5fluorocytosine (embedded in an oligonucleotide duplex), largely confirmed 
Santi’s model using M.HaeIII. The first concrete evidence that the cytosine is 
flipped out of the double helix had to wait until the determination of the 
structure of a ternary complex for M.HhaI, incorporating a 5-fluorocytosine 
modified duplex (Klimasauskas et al., 1994). 
     The reaction commences with the enzyme (possibly pre-loaded with 
AdoMet), folding around the target DNA, followed by target base rotation into 
the enzyme’s active site. The cytosine to be methylated is firstly flipped out of 
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the DNA double helix; by flipping, cytosine is elegantly presented to the 
catalytic Cys residue and is accompanied by a significant loop displacement. 
The thiolate anion makes a transient covalent bond to the C-6 of the flipped ring 
and the cytosine is secured by several non-covalent interactions to facilitate 
methyl transfer. During this reaction, the orphan guanine is satisfied with 
compensating interactions that mimic the normal Watson Crick base pair 
interactions (Klimasauskas et al., 1994). 
      The central stage in the methylation reaction involves the formation of a 
cytosine ring, in a Michaelis complex, predisposed to nucleophilic attack, 
methyl transfer and β elimination.  The covalent bond is formed between the 
thiolate of the conserved Cys81 (in M.HhaI) and the C6 of the pyrimidine ring. 
This is apparently accompanied by a proton addition to the N3 position on the 
ring, to produce an enamine intermediate so that the C5 within the cytosine ring 
will be vulnerable to the methyl sulfonium centre attack of the AdoMet. The 
resulting intermediate of this attack is dihydro-cytosine which undergoes β-
elimination to remove the C5 proton and C6 thiolate to produce the methylated 
cytosine (Vilkaitis et al., 2001). 
 
3.6. Design and synthesis of a modified, functional M.HhaI gene for 
mutagenesis 
       The nucleotide sequence of the gene encoding M.HhaI (gene bank 
accession number J02677.1) was re-configured in order to incorporate a range 
of unique restriction sites, without impacting on activity and minimising 
changes to the protein primary structure. (See Figure 3.3). This approach greatly 
facilitates the independent mutagenesis of segments of the target gene in a 
controllable manner. In designing the synthetic gene for M.HhaI, care was taken 
not to introduce restriction sites that are present in the chosen cloning vector, 
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pUC19. Prior to synthesis, codons were optimized for expression in E. coli and 
finally the sequence was submitted to a gene synthesis service 
(www.lifetechnologies.com). 
     After synthesis, the gene encoding M.HhaI was sub-cloned into pUC19 via 
HindIII and XbaI. The resulting recombinant plasmid was labelled pMJA01 
(Figure 3.4). The success of the cloning, the sequence of the construct and the 
activity of the encoded product were verified and confirmed respectively (see 
Figures 3.4 and 3.5). 
 
Figure 3.3: Interleaved view of the total synthetic gene sequence and primary 
structure of M.HhaI (327 amino acid). The ORF is cyan-shaded. The in-frame 
and out-of-frame restriction sites are underlined in red. (HindIII =AAGCTT, 
NcoI=CCATGG, MfeI=CAATTG, BclI=TGATCA, NgoMIV=GCCGGC, 
BspEI=TCCGGA, BssHII=GCGCGC, BmtI=GCTAGC, NsiI=ATGCAT, 
BglII=AGATCT, AflII=CTTAAG, XbaI=TCTAGA, BamHI=GGATCC). 
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3.7. Methylation activity investigation 
     The methylation proficiency of pMJA01was investigated by in vitro and in 
vivo protocols. The in vitro method involves digestion of minipreps of pMJA01 
with the cognate HhaI restriction enzyme. If the plasmid encodes a functional 
GCGC specific DNA MTase, then it will be refractory to cleavage by HhaI. 
This is observed in all cases in Figure 3.6. In fact pMJA01 is clearly methylated 
at all of its 20+ HhaI sites (see Figure 3.7). The in vivo method involves 
transformation of an McrBC+E. coli strain by pMJA01: if the plasmid encodes 
an active MTase, no colonies should appear since, the McrBC restriction system 
cleaves only at sequences in which the middle cytosine of the GCGC sequence 
is methylated (Raleigh, 1992). 
 
 
 
 
 
 
 
Figure 3.4: (a) Diagram of pMJA01 encoding the synthetic M.HhaI gene and its 
ORF (a), β-lactamase, the ampicillin resistance ORF (b) and (c) is the origin of 
plasmid replication. 
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Figure 3.5: Preliminary verification of cloning the synthetic M.HhaI gene using 
agarose gel electrophoresis and restriction digestion. Lanes 1-6 are pMJA01 
minipreps digested with HindIII and XbaI. Lane 7 is a DNA hyper ladder 
marker with two strategic fragment sizes shown, to illustrate consistency with 
predicted fragment sizes. 
 
If the plasmid is methylation proficient, it will exhibit normal transformation 
efficiencies in McrBC- strains, but will yield no significant numbers of 
transformants when a McrBC+ host is used. As can be seen in Figure 3.8, and 
this is an expected outcome. 
     The same in vitro and in vivo activity tests were subsequently applied to 
examine the methylation activity of individual mutant clones obtained from the 
random mutagenesis procedure. However, the in vitro HhaI plasmid restriction 
digestion was commonly the test of choice most of the time because it 
additionally provides an indication of very low (partial) levels of M.HhaI 
enzyme activity. 
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Figure 3.6: Methylation activity check 
of M.HhaI which is expressed from 
the synthetic M.HhaI gene carried on 
pMJA01 plasmid. Lane 2-7 show 
uncut pMJA01 when treated with HhaI 
restriction enzyme. This indicates fully 
active M.HhaI. Lane 1 is hyper ladder.  
a b 
Figure 3.7: HhaI restriction sites within 
pMJA01. 
Figure 3.8: In vivo investigation of M.HhaI activity. (a) is McrBC+E. coli 
transformed by pMJA01when few colonies appeared indicating active 
M.HhaI. (b) is McrBC-E. coli transformed with pMJA01.  
72 
 
3.8. Error prone mutagenesis (EPM) of M.HhaI 
     Three sets of PCR primers were designed so that each set produces an 
amplified region of M.HhaI gene flanked by a pair of different restriction sites 
to facilitate subsequent recapitulation of the M.HhaI ORF. The general 
experimental strategy for all mutagenesis experiments is shown in Figure 3.9. 
The first phase of mutagenesis was targeted at three regions of M.HhaI orf: the 
first third of the orf (flanked by HindIII + BmtI), the second third (flanked by 
BmtI + AflII), and the last third part (flanked by AflII + XbaI) (see Figure 3.3 
and 3.4).  
     After the EPM protocol, a library of mutant pMJA01 constructs was 
generated, in the form of transformed bacterial single colonies. These clones 
were analysed for activity as described above (see Figure 3.10). As expected, a 
mixture of active and inactive mutants were recovered. The sequencing data, 
again, as expected, showed many different mutational patterns from the many 
transformants as a result of EPM. (See Appendix1). 
 
3.9. DNA sequencing 
     After scanning for methylation activity of 384 clones, plasmid minipreps 
were prepared from each colony and the plasmid DNA samples were sent for 
nucleotide sequencing. A small number of plasmids gave abnormal sequencing 
data. Some mutant clones contained truncating mutations within the open 
reading: these mutants were inactive. On the other hand, many mutant clones 
appeared with in frame TAG stop codon and methylation activity was often 
detected in many such mutants. 
 
     In order to rationalise the relationship between primary structure and 
function, mutant clones of missense nucleotide changes (leading to amino acid 
changes) and those of silent nucleotide changes (leading to no change in the 
protein primary structure), were classified according to the number of 
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nucleotide changes on one hand and the number of changes in the protein 
primary structure on the other hand (Table 3.2). Understanding the relationship 
between coding sequence and the protein primary structure, after random 
mutagenesis could demonstrate how a gene (in this case the M.HhaI gene) could 
tolerate mutations while retaining function at a biologically effective level. 
 
     Most of the mutant clones, their numbers are mentioned in Table 3.2, 
appeared with changes in DNA sequences that do not match the same number 
of changes in their protein primary structure reflecting the nature of the M.HhaI 
DNA gene sequence, which shows significant rate of mutations silencing 
especially when no clone among those of 8, 9 and 11 nucleotide changes occurs 
with the same number of amino acid changes, furthermore, high incidence of 
silencing appeared with the mutant clones of the three nucleotide changes where 
only 7 out of 34 (20.58%) of them showed the same number of amino acid 
changes (three sense mutations), while the rest appeared with only two, one 
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Figure 3.9: The general strategy of Error prone PCR random mutagenesis and 
cloning which is applied in this study on M.HhaI and the other two enzyme 
models (Chapter 4 and 5). The green part represents the gene ORF. The red dots 
represent the mutations (errors) that are generated by EPM. RS1 and RS2 refer 
to restriction site 1 and 2 respectively.  
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or even no amino acid change. All the remaining classes of clones that show 
different numbers of amino acid changes do not show the same pattern of DNA 
mutations but always showed a different number of nucleotide changes, so that 
the mutant clones of sense mutations, where the DNA changes match the 
protein primary structure changes tend to be a minority most of the time. 
However, the missense mutations of the same nucleotide changes within the 
clones of single and double DNA base pair changes are represented by 66.66% 
and 51.28%. Overall, the mutagenesis silencing incidence tends to be higher as 
more mutations occur in the DNA sequence and vice versa (Table 3.2). 
Figure 3.10: HhaI-treated pMJA01 plasmids from single bacterial colonies after 
mutagenesis. Lane 1, 2, 4 and 7 represent clones of active M.HhaI as plasmids 
resist digestion by HhaI, while lane 3, 6, 8 and 10 are clones of inactive M.HhaI 
which means that plasmids are not methylated and hence sensitive toward HhaI. 
Clones in lanes 5 and 11 exhibit different pattern of fragments arrangements 
which is caused by the incomplete activity of M.HhaI by which only some HhaI 
positions are methylated on those plasmids leaving some positions unmethylated 
and hence susceptible to HhaI action. Lane 9 is DNA marker (hyperladder I). 
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Table 3.2: Mutagenesis silencing: correlation between the nucleotide changes 
and amino acid changes: 
Amino acid change 
Per clone 
Clones 
obtained 
Nucleotide base change 
1 2 3 4 5 6 7 8 9 10 11 
0 19 14 4 1 0 0 0 0 0 0 0 0 
1 54 28 15 10 1 0 0 0 0 0 0 0 
2 45 - 20 16 8 0 1 0 0 0 0 0 
3 29 - - 7 12 7 2 0 0 1 0 0 
4 16 - - - 9 5 1 0 1 0 0 0 
5 9 - - - - 5 2 1 1 0 0 0 
6 5 - - - - - 2 1 2 0 0 0 
7 1 - - - - - - 1 0 0 0 0 
8 3 - - - - - - - 0 1 0 2 
Total 181 42 39 34 30 17 8 3 4 2 0 2 
 
 
3.10. Clonal mutation frequency and enzyme tolerance 
     The method of mutagenesis employed here is assumed to be essentially 
random and the mutation frequency produced by the error prone DNA 
polymerase is on average 9.8 per kilo base (Alharbi, 2010). However, individual 
clones recovered contained mutations numbering from none at all to more than 
7 (as expected). As pointed out earlier of course, many mutations had no effect 
on primary structure. The zero changes and silent mutation clones were not 
analysed any further, since this work was not aimed at evaluating the error 
prone polymerase itself. 
     In contrast, those clones carrying  the “significant” mutations, that have been 
shown to carry one or more nucleotide changes and accompanying amino acid 
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changes, were classified according to the number of mutations (amino acid 
changes) in each clone (the frequency) and the impact on the enzymatic activity 
of M.HhaI (see Table 3.3). This serves to provide a simple means of evaluating 
how the enzyme might retain its normal activity when one or more of its amino 
acid are changed. That is, it provides a measure of “robustness” or “resilience” 
with respect to mutation. 
     The results showed that the mutational incidence per clone is between one to 
eight among the 162 significant mutant clones analysed. The most common 
clones (54) are those containing a single mutation and the vast majority of them 
(49) express a fully active M.HhaI while one and four clones exhibited partial 
activity and abolition of methylation respectively (see Figure 3.10 for activity 
phenotypes). 
     In surveying the forty five clones of the double mutation group, it is clear to 
see that the proportion of fully active M.HhaI clones is 73.33% which is lower 
than those found to be active from the single mutation group. As would be 
expected, the more mutations, the more the enzyme activity is diminished in the 
recovered library of mutants, regardless what the mutations are and where they 
are located.  
     The above increase in susceptibility to a loss of activity in relation to the 
frequency of mutations, is confirmed by the data obtained from the remaining 
groups of mutant clones harbouring triple, quadruple, quintuple, etc mutations. 
Overall, the enzyme seems to be rather resilient toward mutagenesis, as ninety 
seven (about 60%) out of the entire batch of the 162 clones appeared to retain 
activity. To map the mutations on the M.HhaI tertiary and secondary structure, 
see Figures 3.14 and 3.15 at the end of this chapter.   
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Table 3.3: Number of mutations per clone and methylation activity: 
Mutation per 
clone 
Clone 
frequency 
obtained 
Methylation activity 
Active Inactive Partially 
active 
1 54 49 4 1 
2 45 33 11 1 
3 29 12 16 1 
4 16 2 13 1 
5 9 1 8 0 
6 5 0 5 0 
7 1 0 1 0 
8 3 0 3 0 
Total 162 97 61 4 
% 100% 59.88% 37.65% 2.47% 
 
3.11. Sites of mutation in relation to enzyme activity 
      The loss of catalytic activity of M.HhaI has been correlated with the 
mutations arising from amplification by EP-PCR in order to map the differential 
susceptibility of several specific regions of primary structure. The mutagenesis 
strategy above was designed to incorporate, in separate amplifications, all parts 
of the enzyme, by designing multiple sets of PCR primers pairs in order to 
obtain mutations in a controlled manner. In a landmark publication, Trautner’s 
group (Trautner et al., 1996) compared the phenotypes observed from a large 
scale mutagenesis study of multispecific DNA MTases, and in this way 
determined the relationship between catalytic residues and DNA specificity 
determining regions of this class of enzymes. The experiments described here 
bring a higher level of control to the random mutagenesis approach, enabling us 
to perturb regions that are expected to be sensitive to mutation: (the conserved 
motifs I-X, the TRD region as well as parts of the primary structure of M.HhaI 
whose function in folding, stability and catalysis remain unknown). Indeed in 
this experiment, whilst several expected mutations compromise activity a 
number of others also abolish activity in an unexpected manner. Whilst a 
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complete saturation mutagenesis of the gene encoding M.HhaI is possible, it 
was decided that the MHhaI experiments have demonstrated the proof of 
concept in a reasonably well understood system, it would be interesting to 
explore the methodology in respect of a wider set of genetic targets, where the 
results might extend our appreciation of the relationship between primary 
structure and function in a more sophisticated way. 
     We classified the 162 mutations obtained according to the domain in which 
they appeared and whether these mutations affect the enzyme function. Our data 
indicate that whilst mutations in conserved regions can lead to enzyme 
inactivation (as expected from structural studies), many other mutations cannot 
impact on activity. It is clear that our understanding of primary structure and 
functional relationships are limited in this class of enzyme. The data are 
presented in Table 3.4. See Figure 3.1 for more detailed annotations on the 
secondary structure. 
     As it constitutes the largest part of the primary structure of the enzyme, the 
majority (approximately two thirds) of the mutations were confined to the 
catalytic domain. Although it accommodates the vast majority of the conserved 
residues and responsible for the catalytic activity, most of the mutant clones (70 
out of 106) were fully active. 
Table 3.4: Position of mutation and methylation activity: 
     Position 
 
Activity 
C TRD H TRD+H TRD+C H+C C+TRD+H Total 
Active 70 8 8 0 9 2 0 97 
Inactive 32 2 2 2 9 1 13 61 
P. Active 4 0 0 0 0 0 0 4 
Total 106 10 10 2 18 3 13 162 
% 65.43% 6.17% 6.17% 1.23% 11.11% 1.86% 8.03% 100% 
*C= The Catalytic region, TRD= The Target Recognition Domain, H= The 
Hinge region, P.Active= Partially Active. 
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    Only ten clones were shown to have mutations within the TRD; eight of them 
encoded fully methylated plasmids, reflecting active M.HhaI. The same 
scenario was observed when the hinge region was targeted. 
     On the other hand the enzyme seems to be less tolerant when mutations are 
recovered within more than one region simultaneously. This is illustrated by the 
loss of activity in half of the clones (9 out of 18) that contain mutations in both 
the TRD and catalytic regions. Furthermore, all clones recovered in these 
experiments, harbouring mutations within the TRD, catalytic and hinge region 
lead to inactivation of M.HhaI. 
     From the above, we conclude that in addition to the clear functional role of 
those residues found in the conserved motifs and the hinge and TRD regions of 
M.HhaI, several unexpected residues impact upon activity so when they are 
combined with mutations from non-contiguous regions of primary structure, a 
more deleterious effect on activity is recorded. This analysis remains “a work in 
progress”, since we are focusing on data collection in the first part of the 
project. However, there are some reasons why exploring the more general issues 
associated with the relationship between enzyme activity and primary structure 
and this should be extended to other enzyme encoding genes, and these are 
discussed in more detail in the following chapters. 
3.12. Mutations in conserved regions of the M.HhaI primary structure 
     The analysis of data obtained from this mutagenesis study, demonstrates that 
mutations have been introduced into both conserved and non-conserved regions, 
and therefore it is very likely that enzyme activity of such mutants is on a 
spectrum from zero to 100%, with wild-type set at the 100% level, arbitrarily. It 
is of course possible to carry out a detailed kinetic comparison of all purified 
mutants, however this was not a primary objective of this work. The mutant 
sequences have been further considered as a functional BLAST comparison, 
81 
 
where natural variations amongst the C5-MTases can be analysed by 
superimposing the search data on this mutagenesis work. The results of this 
analysis can be seen in Table 3.5. 
     More than sixty bacterial C5- MTases were chosen (E.C 2.1.1.37) to build an 
alignment with M.HhaI to highlight the level of evolutionary conservation 
found in the publicly available genome data sets. This alignment was used to 
compare evolutionary variants with our mutagenesis data in order to further 
rationalise the sequence/ activity relationships that we have observed in 
M.HhaI. It should be pointed out that the biological activity of the majority of 
annotated C5- MTase genes has not been confirmed biochemically. The method 
of mutagenesis used here, technically extends the BLAST method and adds a 
powerful element of functional annotation. This alone represents a significant 
step forward and better than the use of bioinformatics alone to explore the 
relationships between coding sequences and their biological function(s). 
     The data shown in Table 3.5 reveal that 42 clones out of 43 of single change 
mutants in non-conserved residues were active. This suggests that the enzyme is 
relatively tolerant to point mutations in the non-conserved regions especially the 
single ones. Methylation activity is still apparent in the mutant clones in which 
one or more conserved residues are mutated. However, the most noticeable 
incidence of active M.HhaI could be seen in the group of single mutation 
clones; each mutant clone within this group contains a single amino acid change 
in a relatively conserved point and 7 clones out of the total 11 express full 
methylation activity.   
     As shown in Table 3.5, the three probable incidences where a conserved 
residue might or might not be targeted in mutant clones of double amino acid 
change have been obtained (0/2, 1/2, and 2/2) showing that M.HhaI is highly 
resistant even when two mutations arise but in the non-conserved points, the 
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high activity of the 0/2 double mutants is expressed by 25 out of 27 clones. The 
enzyme still exhibits activity even with the double mutations that include one or 
two conserved amino acids as about half of the total number of the 1/2 and 2/2 
clones groups showed activity. 
     When three mutations arise, the enzyme activity is more reduced in 
comparison with the single and double mutations even if these three mutations 
happened in the non-conserved residues especially when 10 out of 18 of triple 
mutation samples express complete activity but when at least one mutation 
among those three happens to be a conserved residue, the activity will be highly 
reduced as shown above with only 2 active samples out of 11 in the group of 
1/3. 
     Overall, M.HhaI tends to be less resilient as more mutations are introduced 
into its primary structure and this could be clearly noticed from the data 
presented in Table 3.5 especially when some relatively conserved residues are 
included amongst such multiple mutational changes. 
 
3.13. The impact of mutations at the catalytic site of M.HhaI  
 
     The active site Cys residue (Cys81 in M.HhaI) within motif IV is the key to 
M.HhaI and all other C5-MTases activity (Wu and Santi, 1987). This residue is 
situated in the cleft near the AdoMet binding site so that its R group sulphur 
atom is about 10 angstrom away from the carbon atom of the transferable 
AdoMet methyl group. When the ternary complex of DNA, AdoMet and 
M.HhaI is formed, the distances between the sulphur atom and C6 of the 
cytosine on one side, and between cytosine ring and the AdoMet methyl group 
on the other, are too far apart for covalent bonding to occur. This may explain 
the need for the induced reorganisation of the “loop” which is formed by 20 
amino acids residues located downstream of the P-C motif. This loop has been 
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Incidence 
found to be the most flexible part of the enzyme (Cheng et al., 1993) so that it 
can promote a conformational rearrangement of the enzyme within the active 
site region, while DNA is bound. In this way, all members of the ternary 
structure are brought close enough to each other for a successful catalytic 
reaction to take place (Cheng et al., 1993). 
 
Table 3.5: Classification of mutations according to the incidence of changes into 
the conserved residues in each clone and the effect on the activity: 
Mutation per 
clone 
Single 
(1) 
Double (2) Triple (3) Quadruple (4) Quintuple (5) 
Frequency 55 45 31 17 11 
Conservation 
        Change  
 
 
Activity                  
0/1 1/1 0/2 1/2 2/2 0/3 1/3 0/4 1/4 2/4 3/4 4/4 0/5 1/5 2/5 3/5 
Active 42 7 25 7 1 10 2 1 1 0 0 0 1 0 0 0 
Inactive 1 3 2 6 3 7 9 3 8 0 1 1 2 2 3 1 
Partially Active 0 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 
Total 43 11 27 13 5 18 11 5 9 0 1 1 3 2 3 1 
*Numerators in the ‘’conservation change incidence’’ row refers to the number of changes in the 
conserved or relatively conserved points, while denominators refer to the total number of amino acid 
changes. For example, 0/1 represents the group of mutant clones that contain single amino acid 
change but in a non-conserved point, 1/1represent the group of mutant clones that contain a single 
amino acid change in a conserved point. 
*Conservation change incidences that are not mentioned=0. 
 
     Two conserved sets of amino acids (each set is formed by three residues) are 
located around the P-C active site: E119-N120-V121 and Q161-R163-R165. A 
number of interactions (hydrogen bonds and ionic interactions) have been found 
between these two sets and the conserved catalytic P-C residues and the 
commonly found T-L motif in the  TRD (Cheng et al., 1993). 
84 
 
      Appendix 1 illustrates all mutations which are generated by error-prone 
PCR within M.HhaI gene along with functional data. Some of these mutations 
inactivated the M.HhaI, while the other did not (See Table 3.3). It is obvious 
from the positions of each residue that mutations cover both the enzyme target 
recognition domain and large domain. However, the effect of each mutation on 
the enzymatic activity is not easily rationalised from a knowledge of the tertiary 
structure and the chemistry of the enzymatic events. 
      For example, the mutation S85T appears to have an impact on the enzyme 
activity as residue S85 is a part of an interaction network which stabilizes the 
interaction between the backbone DNA sugar and the target recognition 
domain. These favourable Van der Waals interactions occur between the side 
chain hydroxyl group of residue S85, and the C4' and C5' of the deoxyribose 
ring, as well as between Cβ of the side chain and C5' of the sugar attached to the 
3' guanine of the DNA recognition site. The importance of residue S85 is 
emphasised by its strong conservation in BLAST searches (Horton et al., 2004), 
but it is not essential, or at least the BLAST data suggest that other mutations 
can compensate for loss of S85 (although it should be noted that many of the 
BLAST aligned sequences are only annotated as C5-MTases, and no 
biochemical validation exists). 
     It has been found by (Lau and Bruice, 1999) that V121 and the residues 
nearby are crucial for stabilizing the flipped out cytosine within the active site, 
therefore, mutation N123T obtained here could be a reason for enzyme 
inactivation (see the base flipping section below for more details). L100 
together with F18 form the hydrophobic face of the AdoMet binding pocket, 
however, mutating L100 to S has no effect on methylation activity as mentioned 
by Sankpal and Rao (2002), this is in agreement with the L100M mutation 
obtained here after which methylation activity has been recorded in its relevant 
mutant clone, especially when L and M are both hydrophobic amino acids. 
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     The flipped out cytosine needs to be retained transiently, but presumably in a 
suitable steric orientation at the enzyme catalytic site. In this respect, T250, 
which is not conserved among C5-MTases, has been demonstrated to be a key 
participant in the “anchoring” of the target cytosine as it appears from 
crystallographic studies to have rotated into the active site by following an 
interaction with a 5' phosphate (Vilkaitis et al., 2000). Regarding the A253V 
mutation obtained here, even though A253 is not well conserved, it is close to 
T250 TRD residue, which may explain the observed abolition of activity in this 
mutant. However, It is notable from an analysis of an alignment of  some 
bacterial C5-MTases that the position 253 in HhaI is largely occupied by either 
A or G (both are small amino acids), except for M.Eco72I which has V residue 
in this position. It seems that A and G are preferred, but that compensating 
mutations may overcome the obstruction caused by the relatively bulkier side 
chain of V. 
 
     The general kinetic steps of C5 DNA methylation  (Figure 3.11) have largely 
been resolved by (Wu and Santi, 1987). The process, however, includes 
activation of the target cytosine at the C6 position by the nucleophilic sulfhydryl 
(SH) group of the C81 M.HhaI residue. As a result, this promotes the 
nucleophilicity of the C5 of cytosine sufficiently to facilitate its attack on the 
AdoMet methyl group. In this process, C81 becomes transiently bound to the 
C5 position of the target cytosine, therefore, the H5 proton at the C5 position 
has to leave. This deprotonation leads to dissociation of the enzyme and S-
adenosyl-L-homocysteine (AdoHcy), and is thought to be mediated by R163 
or/and a network of water molecules within the enzyme active site which 
facilitate the proton to transfer to the bulk solution and out of the active site.  
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     In a molecular dynamic simulation the study of M.HhaI active site (Lau and 
Bruice, 1999), the authors proposed that conserved residues N304 and Q82 
serve as a structural channel for both protons and water molecules passage into 
and out of the active site. The conformational positioning of water molecules 
within the active site, which makes the water molecules close to the C5 of 
cytosine, appears to be important in making water bridges for the movement of 
both protons as a part of cytosine activation prior to methylation and the 
passage of the 5H proton from C5 of cytosine into the bulk solvent as a final 
step of the methylation. Hydrogen bonds are formed between water molecules 
inside the active site and side chains of N304 and Q82 so that water molecules 
are kept in their correct positions within the active site to facilitate the 
deprotonation. Interestingly, we have got an active mutant of Q82H, this might 
explain that changing Q82 with H, which is slightly larger and similar in 
containing NH in its R-group, does not affect the methylation.  
 
     The  random mutagenesis experiments presented here have also targeted the 
region encoding amino acids Q301, N304,V310, Q312 and G319, all falling 
within the highly conserved motifX. This motif, together with motifs I to III, are 
primarily responsible for AdoMet binding (Cheng et al., 1993; Klimasauskas et 
al., 1994). Mutations occur at L75 and N123, which are both conserved and 
found within motifs IV and VI respectively. These motifs, along with VIII, V 
and VII are closely involved in the enzyme’s catalytic mechanism, because they 
are responsible for active site formation (Schluckebier et al., 1995).This, 
Figure 3.11: The scheme of M.HhaI-catalysed DNA methylation. 
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however, may explain the inactivity of mutants having some of these amino 
acids changes (See Appendix 1).  
 
3.14. Enzyme interaction with DNA: base flipping and the impact of 
random mutagenesis 
     M.HhaI interacts with DNA via the cleft which is between the small and 
large domain, it is 25-30 angstrom in width and 15-20 angstrom in depth so that 
it is deep enough to accommodate double stranded DNA. Its surface is 
positively charged which complements the negatively charged DNA. Q-R-R 
residues of motif VIII within the cleft are highly conserved among C5-Mtases 
and appear to be involved in the non-specific interactions with the DNA sugar-
phosphate backbone. These interactions are assumed to be essential owing to 
the absolute conservation of this particular sequence motif in all C5-MTases. 
The specific interactions, which ensure a specific sequence of bases is 
recognised containing the target cytosine, are restricted to amino acid residues 
within the small domain. It is thought that the lower part of the cleft, which is 
about 40 angstrom in length (11bps accommodation capacity), is responsible for 
fixing the DNA helix in a correct orientation so that it makes stero-specific 
contact with the 15 angstrom-long upper part of the cleft (4bp accommodation 
capacity). The upper part of the cleft is thought to be related to specific cytosine 
C5 methylation (Cheng et al., 1993). 
     The location of the M.HhaI TRD is at the side of the small domain cleft 
which is near T250 (Lauster et al., 1989). The crystallographic study of (Cheng 
et al., 1993) proposed that the TRD, comprising weakly conserved residues, is 
separated into two parts: the first one is derived from amino acids 231-240 and 
the second one involves amino acids 249-253. 
     The high resolution ternary structure of M.HhaI, DNA and S-adenosy-L-
homocysteine (SAM) showed, for the first time, that the target cytosine is 
rotated ~180° in order to be flipped out of the DNA double helix, and situated in 
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the enzyme active site prior to nucleophlic attack by C81. It was revealed that 
such base rotation is accompanied by a movement of the catalytic loop (residues 
80-89) to be closer to the flipped out cytosine (Klimasauskas et al., 1994). High 
resolution, time-resolved NMR studies of binary complex (M.HhaI + DNA) 
formation showed that addition of the cofactor to the solution to form the 
ternary complex (M.HhaI + DNA+SAM) significantly enhances base flipping, 
indicating that target cytosine is not required to be bound in the enzyme active 
site for the flipping. This suggests that M.HhaI performs base flipping 
independently of the active site, and as another function beside its well-known 
catalysis of methylation which is of course absolutely dependent on the enzyme 
active site (Klimašauskas et al., 1998). This was confirmed after showing that 
DNA substrate recognition by M.HhaI does not need a flipped out cytosine as 
demonstrated by a sequence mismatch study where the target cytosine was 
replaced by base analogues where no flipping is possible; and the enzyme still 
binds its DNA substrate easily and even stronger than if it contains a wild 
cytosine (O'Gara et al., 1998; Serva et al., 2004). This demonstrates that base 
flipping is an independent and unique function that M.HhaI is able to perform 
beside target recognition and methylation.  
     When the enzyme acts on its natural DNA substrate, it has been shown that 
the deoxyribose sugar and its surrounding phosphates are rotated in the same 
orientation of the target cytosine during the base flipping, therefore, it could be 
a fact that the rotation pressure is not directly on the target cytosine but rather 
on the sugar-phosphate backbone which simply carries the nitrogenous base 
with it at the same conformation when pushed and rotated along its own axis 
(Luo and Bruice, 2005). 
     It was thought that the cytosine is flipped out the DNA helix through the 
minor groove as the binary structure showed that the M.HhaI catalytic loop 
accesses its DNA substrate via the major groove so that the latter will be 
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blocked towards the cytosine flipping (Klimasauskas et al., 1994). On the other 
hand, cytosine flipping from the major groove has been supported by the studies 
of molecular dynamics and free energy calculations upon base rotation (Huang 
et al., 2003; Luo and Bruice, 2005). Furthermore, after the replacement of the 
target cytosine with a basic south-constrained sugar, crystal structures have 
revealed that this sugar is rotated ~90° about the flanking phosphates to be 
within the DNA helix major groove. This represents the mid-point of complete 
rotation (180°) and is in agreement with the major groove pathway (Horton et 
al., 2004).  
     Flipping cytosine out of the DNA duplex requires ≥ 18kcal/mol free energy 
which is unfavourable for the Watson-Crick DNA structure, therefore, the role 
of M.HhaI in catalysis is to reduce this energy barrier by forming a catalytic 
complex with the DNA as substrate and AdoMet as cofactor. It has been 
suggested that the lowering of this free energy barrier cannot be provided by 
primary binding between DNA and M.HhaI to form an open binary complex, 
but requires the movement of the M.HhaI catalytic loop toward the target 
cytosine followed by the formation of a closed binary (or ternary) complex is 
actually required to overcome the unfavourable free energy of -5.1kcal/mol. The 
latter significant free energy reduction and the consequent thermodynamic 
stabilisation is consistent with the major groove pathway. Accordingly, the WC 
DNA conformation has been shown to be significantly disrupted as a result of 
hydrogen bonding and loss of stacking energies when a closed binary or ternary 
complexes are formed, especially when the hydrogen bonding distance between 
the target C N3 and the orphan G N1 (the guanine that complement the target 
cytosine) has been estimated to be significantly longer than the distance 
between the same N1-N3 atoms in the binary open complex. In other words, the 
DNA conformation around the target C has been shown to be significantly 
modified when the M.HhaI catalytic loop migrates to form the closed protein-
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DNA complex. Such DNA conformational destabilisation has been shown to be 
mediated by many hydrogen bonds emanating from M.HhaI via key residues, 
with its DNA substrate. The number of hydrogen bonds in the closed ternary 
complex are greater than hydrogen bonds in the open binary complex. Residues 
85-87 from the active site loop are involved in hydrogen bonding with DNA in 
addition to some other residue that are out of the catalytic loop such as Thr250, 
Tyr254 and Gly255. In the open binary complex such hydrogen bonding 
interactions are much less and are only recognized with Arg240 that form the 
most noticeable hydrogen bond when the catalytic loop is not yet moved to 
form the closed state complex. However, it has been suggested that such 
hydrogen bonding, especially in the ternary complex, is the reason behind the 
distortion of the DNA WC conformation and consequently facilitates base 
flipping. Residues Ser87 and Gln237 have been shown to play the most 
important role in facilitating base flipping by hydrogen bonding with target 
cytosine and its neighbours, however, Ser87 is involved in four hydrogen 
bonds; three with the orphan G and one with the target C, while G, which is 
next to target C from the 3ˋ side, is involved in two hydrogen bonds with the 
Gln237 that is positioned directly over the target C to make stacking 
interactions. On binding of M.HhaI to DNA and prior to the base flipping, 
Ser87 has been suggested to assist base flipping by blocking the minor groove 
and pushing the cytosine from the minor groove side towards the major groove, 
from which, the cytosine is most likely flipped out, in addition, this residue has 
been postulated to push the guanine, which is the neighbour of the target C, to 
the 5ˋ side providing more molecular space for C rotation (Luo and Bruice, 
2005). It has been previously suggested that Gln237 is involved in steric clashes 
that cause C to be pushed out of the DNA helix from the minor groove (Cheng 
and Blumenthal, 1996) on the other hand, molecular dynamic simulations 
reported that both of the afore-mentioned stacking and hydrogen bonding, that 
is made by Gln237, as well as the competitive hydrogen bonding, that Ser87 
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makes with the orphan G, weakens the C-G wild hydrogen bond and distorts the 
overall local DNA conformation. All together, these events destabilise the target 
cytosine to be flipped out via the major groove while the original G-C base 
pairing is now replaced by hydrogen bonds that Gln237 makes with both the 
flipped cytosine and the orphan G as shown within the ternary structure, where 
the interactions between the protein and DNA reach an optimum which has 
been suggested to be related to the stabilisation of the flipped base until 
methylation occurs. All the aforementioned details of M.HhaI-DNA interactions 
and WC structure destabilisation, in term of cytosine flipping have been 
deduced from the molecular dynamic study of (Huang et al., 2003) which are in 
accord with the crystallographic data for the ternary complex, regarding the 
final status of the completely flipped target cytosine. 
     The previous mutagenesis experiments showed that substitution of Gln237 
by any of the other possible 19 amino acids residues significantly affects the 
ability of the enzyme to form a stable complex with the DNA while still the 
enzyme is able to recognize the DNA specific binding sequence (Mi et al., 
1995). The later mutagenesis study of (Serva et al., 2004) found that 
replacement of Gln237 with short side chain residues causes a sever disruption 
on the base flipping so that Gln237Gly and Gln237Ala mutants efficiently bind 
DNA, but no base flipping is observed and, therefore, the overall rate of 
methylation was shown to be significantly reduced.  
     The present random mutagenesis work revealed three inactive M.HhaI 
clones of three, six and eight amino acid changes respectively; all of these 
include substitution of Gln237 among their mutations such as  Gln237Lys and 
Gln237His ( See Appendix 1). While Ser87 has been randomly mutated within 
three mutant clones; one of them is of three residue changes and two clones 
contain four residue changes carrying Ser87Tyr, Ser87Phe and Ser87Thr 
mutations respectively and showing no methylation activity. The multiple 
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sequence alignment (MSA) (See Appendix 4) shows that both Gln237 and 
Ser87 are not conserved but rather the latter residue is found as Ala in most of 
the C5-Mtases variants so that Ser is not only not a conserved residue, but not a 
common residue in that position (Ser87 in M.HhaI), while Ser85, which has 
been mutated to Ile within the inactive clone of double residue changes 
(Pro57Thr, Ser85Ile), is highly conserved and appears only to be replaced by 
Thr in only three variants of the aligned C5-Mtases. M.HhaI inactivation in this 
mutant clone could explain the importance of the S85 conservation as no Ile 
occurs as a replacement for the highly conserved Ser in that position according 
to the MSA (See Appendix 4). The MHhaI-DNA interaction study of (Luo and 
Bruice, 2005) has recommended the use of site directed mutagenesis to explore 
the impact of some residues such as S85 which is thought to interact with the 
DNA sugar-phosphate backbone and could be involved in rotating the nucleic 
acid backbone leading ultimately to the flipping of the target cytosine.  
     The TRD residues Arg240 and Gly255, which are not conserved but 
important in DNA binding as mentioned above, have been covered by the 
random mutagenesis within two inactive M.HhaI clones of mutational patterns 
Met168Ile, Arg240Leu, Ile247Thrand Gly255Asp. 
     NMR and protein-DNA binding electrophoresis studies (gel shift assays) 
both suggest the catalytic steps of methylation follow M.HhaI recognition and 
binding to its DNA to form the open binary complex. Remodelling of the 
catalytic loop towards the target cytosine facilitating its flipping and generating 
the closed binary complex, which is finally followed by the formation of the 
tertiary complex where the AdoMet cofactor is bound to form the final catalytic 
complex. The methyl group is then transferred to the flipped out cytosine and 
cofactor dissociation occurs recalling the closed binary complex again. Cofactor 
dissociation is thought to induce the catalytic loop to return to its original 
conformation in the open binary complex, where the flipped cytosine will be 
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less stable and, therefore, returns back to its WC status paired with the orphan G 
(Wu and Santi, 1987; Klimašauskas et al., 1998; Lindstrom, 2000; Vilkaitis et 
al., 2001). Such an equilibrium ordered bi-bi mechanism suggests that the 
enzyme would not dissociate from the DNA but rather remain bound to it and 
move along the DNA (after methylation and catalytic loop back movement and 
cofactor dissociation) to recognize and methylate another cytosine within its 
recognition GCGC sequence (Huang et al., 2003). Although the bi-bi catalytic 
mechanism is highly supported as a successive step by step methylation 
catalysis, a random-stepped mechanism of catalysis has also been suggested 
(Vilkaitis et al., 2001). However, both successive and random manner of 
M.HhaI movement in methylating its DNA substrate are proposed mechanisms 
and not fully proven.  
     The flipped-out cytosine within the ternary closed complex needs to be 
stabilised in the active site while the methyl group is transferred to it. This 
stabilisation has been suggested to be facilitated by the interactions M.HhaI 
makes with the flipped cytosine via residues Arg165 and Glu119. The random 
mutagenesis reported here has not produced mutations at Arg165, while Glu119 
has been replaced by Asp within two mutant clones of Gln46His, Gln90Leu, 
Glu119Asp and Gly20Cys, Phe79Leu, Pro80Gln, Asp95Tyr, Ser96Ile, 
Glu119Asp, Phe117Cys mutational patterns. The Glu119Asp mutation in the 
latter clone is accompanied by other mutations in sensitive parts of the enzyme 
that could reinforce the loss of activity in such a mutant clone, while the 
Glu119Asp mutation in the former mutant clone is accompanied by two 
additional mutations in parts that are not sensitive (Gln46 and Gln90), 
furthermore, these changes have been isolated within other mutant clones of 
fully active enzyme (See Appendix 1). Therefore, the inactivity of the mutant 
clone of Gln46His, Gln90Leu, Glu119Asp mutational pattern is definitely 
related to the Glu119Asp mutation proving the importance of the Glu119 as an 
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absolutely conserved residue constituting the first amino acid of the highly 
conserved ENV motif among the aligned C5-Mtases (See Appendix 4). 
Although the mutation-introduced Asp is similar to the wild Glu119 in its acidic 
properties, it seems that the length of the side chain, which is the only 
noticeable difference between the Glu and Asp, is important at this position 
since Asp is shorter in its R group when compared with Glu (see figure 3.12). 
A       B  
Figure 3.12: 3D view showing the difference between side chains of the wild 
E119 and the mutant D119 which are represented in A and B respectively.  
 
     In the mutagenesis study by Estabrook et al. (2004), the importance of 
Val121 in stabilising the extrahelical cytosine has been demonstrated. The 
contribution of the nearby residues (His127 to Tyr132), which are close to 
Val121making a network of interactions with each other and with Val121, has 
also been investigated in the above study. All the aforementioned residues, 
including Val121, have been mutated into Ala in this work. Although the 
peptide represented by residues 127-132 including Val121 are suggested to have 
a role in “compression” of the active site by forming a network of interactions, 
as interpreted by the authors, further kinetic studies showed that all mutants, 
except Val121Ala, have a comparable activity to the wild M.HhaI (Estabrook et 
al., 2004). However, the Val121Ala mutant showed a significantly reduction in 
the enzymatic reaction rate and DNA binding activity similar to the biochemical 
properties of the Cys81Gly mutant (Mi and Roberts, 1993).  
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     Molecular dynamic simulations suggest that V121 is found in the enzyme 
active site in an orientation in which its side chain is close enough to the flipped 
cytosine and the 5ˋ phosphate to form interactions with both of them. The 
positioning of V121 above the target cytosine was thought to be maintained by 
the hydrogen bonding between H127 and T132 but as mentioned above, there 
was no significant effect on the enzyme activity of both H127A and T132A 
mutants. Besides its direct role in interacting with and stabilisation of target 
cytosine, V121 may have other functions such as the positioning of some 
residues of catalytic importance like C81, E119, and R165 (Estabrook et al., 
2004). The present random mutagenesis covered V121 in four mutant clones of 
different mutational patterns (See Appendix 1). Interestingly, the single amino 
acid change V121M mutant clone appeared to show partial activity. Although V 
and M are different in size, they do share similar hydrophobic properties that 
could be related to incomplete inactivation unlike the V121A mutant, in which 
no detectable activity could be reported as mentioned previously. On the other 
hand, a mutant clone of simultaneous S87Y and V121M double amino acid 
change showed no M.HhaI activity indicating the definitive role of S87 in 
eliminating the remaining activity seen in the mentioned above mutant clone of 
single amino acid change (V121M).   
 
3.15. The impact of random mutagenesis on the M.HhaI interaction with 
AdoMet 
     The region of M.HhaI which is involved in AdoMet binding contains highly 
conserved amino acids among C5-Mtases. Residues F-Naa-G-Naa-G which are 
within motif I, have been found in many AdoMet-dependent Mtases including 
N4-cytosine, N6-adenine, RNA and this conservation even extends across to 
protein Mtases (Lauster et al., 1989; Pósfai et al., 1989). 
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     The close association of AdoMet with M.HhaI in the crystallographic study 
of (Cheng et al., 1993) has given a clear view of interactions as follows: the β1-
αA-β2 segment forms the binding site of AdoMet which occurs at the upper part 
of the cleft just beside the C-terminus of β1 strand within the large domain. The 
methionine part of AdoMet runs the cleft while the adenosyl part is packed 
inside a pocket within the cleft. When AdoMet is not available, the side chain of 
the conserved F18 or W41 will be inserted in the pocket. The binding of 
AdoMet at the right position is related to the tight loop (I-1A) formed by the 
glycine rich part between strand β1 and helix A so that the adenine ring of 
AdoMet will be as close as possible to the protein main chain. Therefore, 
introducing amino acids with large side chains within the glycine rich portion 
by mutagenesis inhibited enzymatic methylation (Wilke et al., 1988) (see 
Figures 3.13 and 3.1). 
     Although motif I is the key part of AdoMet binding, there are other motifs 
involved in the interaction. The side chain of E40 (motif II) is contained in the 
hydrophobic pocket facing the N3 of the adenine ring of the bound AdoMet; 
this residue is hydrogen bonded with main chain nitrogen atoms of residues 20 
and 42. D60 (motif III) interacts with the amino group of AdoMet methionine 
moiety, while Q82 is involved in the interaction with the carboxyl group of the 
same moiety. 
     Nitrogen of the side chain and oxygen of the main chain of N304 (motif X) 
are hydrogen bonded with N1 and N6 of the purine ring of AdoMet 
respectively. Hydrogen bonding occurs between amino groups nitrogens of 
residues 41 and 61, and O2 and O3 of AdoMet ribose ring. 
Generally, AdoMet interaction-involved residues were found to be strongly 
conserved among C5-Mtases. F18, D60, P80, Q82, and N304, for example, are 
quite conserved. E40 and N304 are relatively conserved because they have only 
D, M, or V replacements, while others like W41 are less conserved as it could 
be replaced by M, I, L, Y, N, K, F or Q (Cheng et al., 1993). 
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Figure 3.13: Three dimensional view showing the AdoMet in its binding pocket 
within M.HhaI. Some residues which are included in the interactions are 
labelled and represented as sticks with carbon atoms backbones in green, 
oxygen in red, nitrogen in blue, and sulphur in yellow colour. Secondary 
structure elements of α-helices and β-strands are numbered and labelled inside 
the figure as α and β respectively. AdoMet is represented in sticks structure with 
gray carbon backbone, red oxygen, blue nitrogen, and yellow sulphur atoms. 
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     All the aforementioned residues that are involved in the AdoMet cofactor 
binding are conserved and lie within the large catalytic domain of M.HhaI. Most 
of the mutant clones which are isolated in this study appeared with several 
amino acid changes. It seems, therefore, irrelevant with such clones to elucidate 
whether the changes in some of the AdoMet-interacting residues are the reason 
behind the inactivation of the enzyme or the enzyme is simply inactivated by 
some other mutations that are not involved in the cofactor binding but they do 
accompany mutation(s) in residues that are involved in the AdoMet binding 
within the same clone. On the other hand Table 3.6 shows a couple of mutant 
clones that have a mutational pattern of double point mutations each clone 
having a mutation at residue positions known to form part of the an AdoMet-
binding pocket: these mutants retain activity. 
     F18 and D60 are both highly conserved having few replacements as 
indicated from the multiple sequence alignment (MSA) (See Appendix 4). 
However, Y is seen as a replacement for F18 in M.HhaI as both of these 
residues are close to each other in structure and aromatic properties and this 
could explain the activity of the mutant clone containing an F18Y mutation.  
Although no N could be seen in MSA to replace the D at position 60, M.HhaI 
activity is maintained after the D60N mutation. This could be because the very 
close similarity in size and structure between D and N especially when the 
importance of the wild D60 has been shown by (Cheng et al., 1993) to come 
from the R group oxygen atom that is maintained within the amide group of N 
side chain as well.  
     The glycine-rich motif of F-X-G-X-G which is a key motif in all C5 DNA 
MTases (residues 18-22 in M.HhaI) has been shown to be crucial in the 
maintaining the adenine moiety of the AdoMet in a suitable conformation to be 
close enough to the enzyme active site during the catalysis. The flexibility of 
this glycine-rich motif is required to form a tight loop which serves the function 
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of maintaining the appropriate conformational proximity of AdoMet as 
mentioned above (Cheng et al., 1993). 
 
Table 3.6: Mutations of AdoMet-binding residues and methylation activity: 
Mutant clone ID Mutational pattern M.HhaI Activity 
2nd54 1.10.14 F18Y, K112E Active 
2nd86 1.10.14 D6N, F18C, Y49N, S87T Inactive 
2nd17 8.5.14 F18S, D42V, V116M, D103G, V121M Inactive 
2nd11 1.10.14 E40K Inactive 
2nd83 1.10.14 L26Q, E40D, L75M, C76Y, V116L Inactive 
2nd53 8.5.14 E40K, D60N, T62I, A77V, G92S, F101S Inactive 
2nd13 1.10.14 K5N, C35Y, D60V, C76S Inactive 
2nd63 1.10.14 D60N, L100P Active 
2nd109 1.10.14 G20S, D60N, D73E, D95E, R106L Inactive 
2nd6 8.5.14 G22D, E29D, G32C, D71V, D73V, F79L, P80Q, Q90H Inactive 
2nd12 8.5.14 G20C, F79L, P80Q, D95Y, S96I, E119D, F117C Inactive 
2nd55 8.5.14 I4F, G11I, N65H, P80T, V121A Inactive 
2nd25 1.10.14 D73N, Q82H, S87F, N120Y Inactive 
2nd34 1.10.14 G20S, A45T Inactive 
2nd98 1.10.14 G20R, Q63L Inactive 
2nd108 1.10.14 G20C, R25S, K122Q Inactive 
2nd80 1.10.14 G20S, D73V Inactive 
2nd12 8.5.14 G20C, F79L, P80Q, D95Y, S96I, E119D, F117C Inactive 
2nd42 8.5.14 G20C, C35F, G59D, I86F Inactive 
2nd22 8.5.14 G22C, F24C, R25S, T62S, V64D, F93C, E94D, F101L Inactive 
*Red-shaded numbers are of conserved residues. The AdoMet-interacting 
mutated residues are in bold italic.  
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Therefore, any mutational changes that introduce residues containing large side 
chains are likely to abolish the flexibility required for the AdoMet positioning 
and hence the methyl transfer may well be compromised. This was shown by 
the mutagenesis study of (Wilke et al., 1988) where they described a 
catalytically inert M.SPR C5Mtase after the loss of the loop flexibility due to 
the mutations in its glycine residues. However, the current random mutagenesis 
has shown the same inactivation phenotype with M.HhaI when G20 has been 
changed into S within two double mutant clones. The companion mutations in 
both of these clones have been obtained separately within other clones of a 
recognized methylation activity. This confirms that the definitive reason behind 
the methylation inactivation in the aforementioned double mutants is the G20S 
mutation (See Appendix 1 for more information about the mutational patterns 
and activity data). Furthermore, G20 and G22 have been covered in the random 
mutagenesis in many other mutant clones, but abolition of methylation activity 
cannot be concluded clearly and evidently as the mutations of interest are 
accompanied by several other mutations that may contribute to enzyme 
inactivation  (see the data in Table 3.6). 
     Finally, the importance of the acidic nature of the amino acid at position 40 
is emphasised by the conservation of E60 which could only be replaced by D 
(the only biological alternative). This is further confirmed by the random 
replacement of the E60 with the oppositely charged K in a mutant clone of 
single amino acid change (E60K) where no methylation activity is observed.  
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Conclusions 
     The data presented in this chapter, are consistent with the general 
observations on the key residues that play a role in the structure and function of 
M.HhaI. In addition, by analysing a set of evolutionarily related C5 DNA 
MTases (shown in as multiple sequence alignments in Appendix 4 ), it is 
possible to place some of these residues into an evolutionary framework, 
assuming the major function of this class of enzymes flows from sequence 
specific DNA methylation. This is of course not surprising, however, such 
residues and regions are supported by regions of primary structure that vary 
considerably among this class of enzymes and our results shed light on residues 
that are not immediately apparent for structural studies. In the absence of a 
comprehensive appreciation of how a set of conserved residues can be 
supported by a wide range of different residues, we require strong functional 
correlations with mutations to complement a BLAST analysis. It is clear from 
these experiments that we are beginning to gain insight into less transparent 
patterns of amino acid distributions in proteins and the constraints imposed by 
primary structure on the “successful” evolution of proteins.  
     The enzyme continues to be more sensitive toward the mutations when the 
incidence of the amino acid changes is increased that might be explained that 
the range of the mutagenesis incidence could be expanded to include more than 
one functional part, for example, catalytic and target recognition domain 
simultaneously. 
     As the extent of the mutagenesis expanded, the probability of capturing 
highly conserved sequences increases and therefore the activity is more likely to 
be affected and could be abolished. This concept is clearly demonstrated by the 
data in Appendix 1 when active mutant clones are observed containing 
quadruple and quintuple mutations in the less conserved regions of primary 
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structure. Clones harbouring more than three mutations per clone are not 
necessarily in need for more than one mutation in the conserved residues to be 
inactive but they actually just require a “little push” to express complete 
inactivity by having only one mutation in a sensitive part among their mutant 
non-conserved residues. Clones of 6, 7 and 8 mutation, however, expressed no 
activity at all regardless the presence or absence of conserved residues 
mutations accompanying the rest of their mutations in each clone. 
     It is understandable to expect maintenance of an enzyme's activity when 
single or double mutations occur in the enzyme's non-sensitive regions. Equally, 
it is not surprising to abolish activity by introducing single mutations into highly 
conserved motifs. This is especially true when the mutations are accompanied 
with others which combine in a synergistic manner perhaps, to inhibit 
methylation activity. However, interesting inactive methylation profiles have 
been recorded when single amino acid change happened in a non-conserved 
point (See Appendix 1). Furthermore, the enzyme is shown to still express 
activity when multiple amino acid changes are introduced by random 
mutagenesis to include more than one point of conservation and in an extended 
manner to involve more than one domain of the primary structure (see Table 
3.4, Table 3.5, and Appendix 1).  
     Finally, to evaluate the importance of residues to catalytic function, the 
mutations of single residue change with their relevant activity profiles were 
mapped directly into the M.HhaI three dimensional structure (Figure 3.14). 
Furthermore, the role of primary structure in the formation of secondary 
structure elements were illustrated in Figure 3.15. The latter figure could be 
used to map all the mutagenesis and functional screening data to evaluate the 
role of the mutagenesis-targeted residues in protein secondary structure.  
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Figure 3.14: M.HhaI four different views of the three dimensional structure, 
highlighting mutations recovered from M.HhaI analysis: all residues highlighted 
represent single residue change mutants. Residues that affected the enzyme 
activity are labeled in blue (view D), while those which did not affect the 
activity are labeled in cyan (view A, B and C). Catalytic, TRD, and hinge 
regions are shown in red, yellow, and green respectively. (Details of the residue 
changes are all included in the appendices). Developed from the three 
dimensional structure which was resolved by Cheng et al. (1993), PDB code 
1HMY. 
A B 
C D 
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Figure 3.15: Combination of M.HhaI primary and secondary structures showing 
the secondary structure elements and their relevant amino acid residues. β-
strands are shown in yellow arrows, α-helices are the red zigzags, loops are 
represented by green arcs, and the black lines are the regions of undefined 
secondary structure. PDB code 1HMY. 
.  
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Chapter 4 Chloramphenicol acetyltransferase typeI (CATI): random 
mutagenesis and functional screening 
Abstract 
     In this chapter, the gene encoding resistance to chloramphenicol has been 
subjected to random mutagenesis. Using a screening method in which agar 
plates are impregnated with different concentrations of the antibiotic 
chloramphenicol, it has been possible to investigate those amino acid residues 
that are essential for biological function of this enzyme. The results once again 
suggest that while the crystal structure allows interpretation of the role of 
several mutants, there are others whose role is unclear. This enzyme showed 
lower tolerance toward the primary structure changes when compared with 
M.HhaI in the previous chapter. Although mutations at absolutely conserved 
points inactivated the enzyme most of the time, exceptions of retained activity 
were noted. On the other hand, impaired activity profiles were seen when 
regions of no or limited primary structure conservation were targeted in 
mutagenesis. This is consistent with the findings of the previous chapter and 
emphasises the fact that it is not always possible to predict the importance of the 
primary structure by simply assessing natural conservation in silico. It is often 
the case that an activity test of the protein variants should be performed to 
confirm predictions. 
 
4.1. Introduction 
     Bacterial antibiotic resistance has received considerable attention recently, 
owing to the emergence of  pathogenic bacteria of clinical importance 
exhibiting resistance toward antibacterial agents especially when multidrug 
resistance appears (Wolstenholme and O'Connor, 1957). When looked at from a 
different view, the fact of bacterial antibiotic resistance seems to be a steadfast 
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in the both fields of biology and ecology. Being resistant to antibiotics is not a 
bacterial character derived by the pressure of natural selection or spontaneous 
mutations but also due to the gene transfer among bacteria. The latter 
mechanism has been shown not only to be mediated by plasmids and 
bacteriophage but also through mobile genetic elements such as transposons 
(Shapiro, 1983). Regarding genetically mediated antibiotic resistance, 
antibiotic-producing microorganisms are tolerant for the specific antibiotic that 
they produce as they are genetically adapted to survive in the presence of the 
their antimicrobial agents which are used to kill other competing 
microorganisms (Cundliffe, 1984).  
     Naturally occurring antibiotics are secondary metabolites of certain 
microorganism which have the ability to inhibit the growth of other microbes, 
therefore, the organisms, that possess the machinery of antibiotic production, 
process the appropriate mechanism to render them insensitive to these 
secondary metabolites (Bryan, 1989). 
     The inhibitory effect of antibiotics action is avoidable by resistant organisms 
by means of antibiotic exclusion from the cell interior or antibiotic target 
modification, but the most common resistance mechanism is the one through 
which the antibiotic is chemically modified by many different groups of 
enzymes such as β-lactamases  and other enzymes like chloramphenicol 
acetyltransferase (CAT) which is dealt with in the current study (Shaw and 
Leslie, 1991).  
     Interestingly, the abrupt scourge of the wide spread of antibiotic resistance 
was first reported in the middle of the 20th century in Japan when resistance to 
chloramphenicol was diagnosed and detected to be caused by plasmids carrying 
the genetic elements of chloramphenicol resistance (Watanabe, 1963). The latter 
phenotype of resistance has been biochemically demonstrated to be mediated by 
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oxygen acetylation of the primary hydroxyl group on the C-3 position of the 
chloramphenicol molecule forming acetylated inactive antibiotic which is 
chemically modified and unable to bind to its ribosomal target in bacteria 
(Shaw, 1967). Despite the other mechanisms of chloramphenicol resistance, it 
has been shown that resistance through the CATs is the most common 
widespread cause of resistance among the bacterial genera (Shaw and Leslie, 
1991) 
 
4.2. Chloramphenicol 
4.2.1. Chemistry 
     When first isolated from Streptomyces venezuelae in 1947, chloramphenicol 
was originally named as chloromycetin (Ehrlich et al., 1947) but in modern 
nomenclature it is referred to a chloramphenicol which  is named systematically 
as D-(-)-threo-l -p-nitrophenyl-2-dichloroacetamido 1,3-propanediol. It contains 
two chiral centres enabling the molecule to present in four possible forms of 
molecular asymmetrical diastereoisomers, owing to the position of the first and 
second carbon atom of the propanediol chain. The inhibitory effect of the 
antibiotic is only related to the D- threo isomer. Some advantages regarding 
chloramphenicol structure is the possibility of chemical modification such as the 
replacement of the C-3 hydroxyl group by fluorine to produce florfenicol and 
few other modifications, like the replacement of the nitro group (NO2) with a 
sulfomethyl group (SO2CH3) in thiamphenicol, without any loss of the 
antimicrobial effect of the drug (Shaw, 1983). Such modifications might be 
advantageous in reducing or abolishing some toxic side effect of the original 
putative drug structure (Schwarz et al., 2004). The simplicity of the molecule 
made it the first antibiotic to be chemically synthesised and extensively 
marketed since the1950s. Chloramphenicol is known for its long half-life at 
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room temperature and resistance to hydrolysis in vivo (Shaw, 1983). The 
amphipathic properties of chloramphenicol are explained by the presence of 
both hydrophilic (dihydroxypropane side chain) and hydrophobic (the p-
nitrophenyl and the A'-dichloroacetyl substituent) moieties, in its molecular 
structure providing a reasonable ability to be soluble and therefore transferable 
in the body fluids (Shaw, 1984). In vitro, chloramphenicol molecules tend to 
form needle-like crystals which are completely soluble in ethanol but show a 
low degree of solubility in water (Maxwell and Nickel, 1954; Hahn et al., 
1956). 
4.2.2. Spectrum 
     Having an inhibitory effect against both gram negative and gram positive 
bacteria as well as many other microorganisms such as Mycoplasma, 
Chlamydia and Rickettsia, chloramphenicol is classified as a broad spectrum 
antibiotic. Its bacteriostatic activity has been seen at a concentration of ≤ 10 
µg/ml against gram positives such as Haemolytic type A and B Streptococci, 
Streptococcus pneumoniae, Streptococcus viridians and enterococci as well as 
many other pathogenic gram negatives like Neisseria, Hemophilus and 
Salmonella. Although chloramphenicol is considered as a bacteriostatic 
antibiotic, it shows a bactericidal effect against Streptococcus pneumoniae,  
Hamophilus influenzae and Neisseria meningitides (Wehrle et al., 1967; 
Overturf et al., 1975; Rahal and Simberkoff, 1979). In spite of its toxic side 
effects, which make it sometimes avoided (Lietman, 1979), chloramphenicol is 
the drug of choice to treat many infections caused by gram-negative bacteria 
such as typhoid fever (caused by Salmonella typhi) and meningitis (caused by 
Neisseria meningitides).  
     The poor water solubility of chloramphenicol has been overcome by some of 
the chloramphenicol esters, such as chloramphenicol succinate which is 
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significantly water soluble enabling the drug to be given parenterally. The ester 
groups are removed in vivo by esterases generating the active form of the 
antibiotic, since the latter is not clinically active when esterified (Simon, 2000). 
As a natural molecule with a good lipid solubility properties, chloramphenicol is 
efficiently diffusible into the central nervous system, cerebrospinal fluid and 
even the intracellular compartment at a significant inhibitory concentration 
levels (Dunkle, 1978; Friedman et al., 1979; Shaw, 1984) to treat serious 
infections of bacterial meningitis, brain abscess and even the intracellular 
pathogenic bacteria (Kramer et al., 1969; Black et al., 1973; Shaw, 1983) 
especially when the causative agents, like Neisseria meningitides and 
Hamophilus influenzae, are β-lactam resistant or the treated patient is allergic to 
penicillin and other antibiotics (Turk, 1977; Feldman and Manning, 1983; 
Ristuccia, 1985; Mascaretti, 2003). 
4.2.3. Chloramphenicol mechanism of action and interaction with bacterial 
ribosome 
     Chloramphenicol is one of the antibiotics that inhibits  protein synthesis by 
interfering with the peptidyl transferase activity at the 50S subunit of the 70S 
ribosomes (Polacek and Mankin, 2005). Ribosomes are the key “machines” of 
protein synthesis in (prokaryotic) cells  and catalyse nearly all of the steps of the 
RNA translation into protein (Sohmen et al., 2009), while the eukaryotic 80S 
ribosomes are not targeted by chloramphenicol, there is a low level of 
chloramphenicol interference with mitochondrial ribosomal protein synthesis 
where it could cause malfunction to eukaryotic cells, especially bone marrow 
stem cells (Martelo et al., 1969; Franklin and Snow, 2005).  
     Structural studies in which crystals of chloramphenicol-bound to the 
bacterial ribosome have been solved, have clarified that the drug inhibits protein 
biosynthesis by interfering with the position of the aminoacyl-tRNA at the 
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ribosomal A-site preventing polypeptide chain elongation (Celma et al., 1971; 
Ulbrich et al., 1978; Schlünzen et al., 2001; Bulkley et al., 2010). 
     The interaction between chloramphenicol and the bacterial ribosome is 
mediated by the rRNA residues in the ribosomal peptidyl transferase centre 
(PTC). These rRNA residues are conserved among the chloramphenicol 
sensitive bacteria, so that certain mutations of these residues alter drug 
susceptibility and confer a chloramphenicol resistance phenotype. For example; 
one of the two chlorine atoms of the chloramphenicol molecule are in a position 
to make contact with the amine that is protruding from a specific purine ring of 
rRNA, A2062, a base which, when mutated, confers chloramphenicol resistance 
(Mankin and Garrett, 1991). The orientation of the antibiotic molecule at its 
binding site in the 50S subunit is maintained by the electron density associated 
with the coordination of rRNA residues that provide some extra stacking 
interactions, in particular between the nitrobenzene ring of the drug and the 
pyrimidine ring of C2452 facilitating the binding and stabilization of the 
antibiotic molecule into its site of action (Blaha et al., 2008). The ribosomal 
RNA is arranged differently as secondary structures at the PTCs of eubacteria, 
archaea and eukaryotes showing different mode of sequence conservations 
among those three domains of organisms, but the conservation is significantly 
high within the same group of organisms explaining the difference in tolerance 
and the wide range of sensitivity towards the PTC- affecting drugs like 
chloramphenicol. It has been demonstrated that some residues of bacterial PTC 
rRNA are attributed to the selective inhibitory action of chloramphenicol in 
being only active against bacteria other than eukaryotes. rRNA nucleotide 
C2055 in bacteria (which is adenosine in eukaryotes and archaea) is of 
importance by rendering the secondary structure of rRNA at the peptidyl 
transferase centre stable in a certain conformation, such that the remaining key 
chloramphenicol-interacting nucleotides are kept functionally close to the 
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chloramphenicol molecule. Therefore, mutations of C2055 have led to 
displacement of four key nucleotides and subsequent chloramphenicol 
resistance or at least a significant change to the drug minimum inhibitory 
concentration (MIC) (Davidovich et al., 2007; Gürel et al., 2009). Such 
conformational arrangements are not observed in higher organisms PTC rRNA; 
this, however, could explain the poor binding ability of chloramphenicol to 
eukaryotic and archaeal ribosomes providing efficient selective therapeutic 
properties against pathogenic bacteria (Dunkle et al., 2010).  
     The ribosomal chloramphenicol binding site has been studied extensively by 
many structural studies which proved the presence of ion(s) that play important 
role in fitting and binding of the drug into its target (Bayfield et al., 2001; Klein 
et al., 2004; Schwarz et al., 2004; Blaha et al., 2008). Potassium ion has been 
found to form a tetrahedral coordination with some adjacent rRNA bases 
(G2447, C2501, G2061) and one of the chloramphenicol's hydroxyl group 
(Vogel et al., 1971; Bayfield et al., 2001; Xaplanteri et al., 2003; Klein et al., 
2004) so that mutagenesis experiments into the latter rRNA bases causes 
alteration in the conformation of the ribosomal interacting surface and therefore 
chloramphenicol resistance proving that these bases are in crucial contact with 
the chloramaphenicol molecule either directly or through the K+ ion (Blanc et 
al., 1981; Kearsey and Craig, 1981; Bulkley et al., 2010) .   
 
4.3. Bacterial resistance to chloramphenicol 
4.3.1. Acetyltransferases (CATs) 
     Different mechanisms of chloramphenicol resistance have been acquired by 
bacteria over time. The most common mechanism is the enzymatic one in which 
the bacteria have developed a range genes encoding antibiotic modifying 
enzymes. including chloramphenicol acetyltransferases (CATs) which modify 
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the antibiotic by acetylation and abolish the drug inhibitory effect (Murray and 
Shaw, 1997). Many other Cm resistance mechanisms have been reported in 
bacteria such as mutational changes that lead to modifications of antibiotic 
target site or cell membrane, antibiotic efflux systems and resistance by 
phosphotransferases (Shaw, 1983; Murray and Shaw, 1997). 
     The acetylation is performed by CATs at the C-3 hydroxyl group of the 
chloramphenicol molecule and some of its derivatives like azidamfenicol and 
thiamphenicol but the replacement of C-3 OH group by fluorine in florfenicol 
renders these molecules  resistant toward CAT action and, therefore, these drugs 
remain active against bacteria that express CATs (Cannon et al., 1990). 
     Many CATs genes are continuously being identified in different species and 
genera of bacteria which makes it difficult in terms of uniformity of the 
enzymes nomenclature. This is reflected in the nomenclature of the identical 
CATs by different names, while enzymes of the virtual different identity have 
been designated identically. See the review by Schwarz et al. (2004) for more 
details.  
     Chloramphenicol acetyltransferases have been identified into two groups 
according to their structural and functional similarity: the classical CATs and 
the xenobiotic CATs; also referred to as the novel CATs (Murray and Shaw, 
1997). Furthermore, the genome sequencing of some microbes such as 
Rhodobacter capsulatus (Vlček et al., 1997), Mesorhizobium loti (Kaneko et 
al., 2000), Streptococcus agalactiae strain 2306 (Tettelin et al., 2002), Bacillus 
cereus (Ivanova et al., 2003) and Brucella melitensis (DelVecchio et al., 2002) 
have shown sequences assumed to be of acetyltransferases which are awaiting 
to be grouped after being fully studied catalytically as their structures reveal no 
relation to either the classic or the novel CATs, therefore, they might have been 
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sorted out temporarily as a sub-novel or xenobiotic CATs-like proteins 
(Schwarz et al., 2004). 
4.3.1.1. Classical type of chloramphenicol acetyltransferases 
     Classical CATs have been found in a wide range of bacteria conferring 
resistance toward chloramphenicol and some of its derivatives (Shaw, 1983; 
Murray and Shaw, 1997). In spite of the relative differences in primary 
structures,  all CATs share the same quaternary structure, having three identical 
polypeptide chains of between 207 to 238 amino acid residues long assembled 
together to form homotrimers of between 24 to 26 kDa (Shaw, 1983; Murray 
and Shaw, 1997). The common properties that CATs share, render them to be 
structurally related so that fully functional heterotrimers could be formed when 
more than one gene of different, but related, CATs are expressed in the same 
cell (Murray and Shaw, 1997). The classical CATs have some similarities in 
their primary structures especially when these residues are involved in enzyme 
catalysis, substrate binding, cofactor binding, monomer folding and assembly of 
the trimer (Murray and Shaw, 1997). Some CATs have been shown to have 
additional properties such as providing resistance toward substrates other than 
chloramphenicol such as fusidic acid (Völker et al., 1982; Shaw, 1983) and 
being inhibited by some thiol-reactive reagents (Murray et al., 1990). There are 
at least 16 groups of the classic CATs. Multi-sequence alignments have shown 
an amino acid similarity of about 80% between the groups of the classic CATs 
(Schwarz et al., 2004). 
4.3.1.1.1. Chloramphenicol acetyltransferases gene distribution 
     The genes of CATs have been found widely prevalent in both Gram-positive 
and Gram-negative bacteria within plasmids, chromosomes and transposons of 
many species and genera. Chloramphenicol resistant wild isolates could have 
more than one type of CATs coded by more than one gene and the functional 
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trimers could be composed of three identical polypeptide chain (homotrimer) or 
different polypeptide chains from different genes are assembled to form the 
hybrid (heterotrimer) type of CATs which are as fully active and functional as 
the parental homotrimers (Day et al., 1995).  
     The typical representative CAT which is related to the group 1, the first 
group of the 16 groups of the classical CATs (Schwarz et al., 2004), is 
genetically assigned as CATI, its gene was originally found within Tn9 
transposon of E. coli (Alton and Vapnek, 1979) then detected on the plasmids of 
many Gram-negative chloramphenicol resistant bacteria such as Acinetobacter 
spp.(Elisha and Steyn, 1991), Photobacterium damselae subsp. piscicida, 
previously named P. piscicida (Kim and Aoki, 1993), and Pseudomonas putida 
(Schwarz et al., 2004). During the last decade, the genome sequence projects of 
many bacterial species recognized CATI genes in Salmonella typhi, Serratia 
marcescens and Shigella flexneri (Luck et al., 2001; Parkhill et al., 2001; 
Schwarz et al., 2004). 
     The plasmids of Haemophilus influenzae have been found to carry more than 
one resistance gene but the chloramphenicol resistance gene among them is 
mainly CATII (Roberts et al., 1982; Murray et al., 1990). Genes that are similar 
and closely related to CATII have been found in many other bacterial species 
such as E. coli, Agrobacterium tumefaciens, Photobacterium damselae subsp. 
Piscicida, and Bacteroides fragilis (Shaw, 1983; Murray et al., 1990; Morii et 
al., 2003). Many species and genera of Enterobacteriaceae (Murray et al., 1988) 
and Pasteurellaceae (Vassort-Bruneau et al., 1996; Kehrenberg and Schwarz, 
2001, 2002) have been reported to have CATIII genes in their plasmids which 
are usually of multidrug resistance. For more review about other CAT genes 
distribution see (Schwarz et al., 2004). 
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4.3.1.1.2. Chloramphenicol acetyltransferases gene regulation 
     The expression of chloramphenicol acetyltransferases genes has been shown 
to be regulated in different ways. Gene expression of some CATs especially 
CAT86 as well as those which are carried on plasmids like pC221, pC223, 
pSCS7 and pC194 is regulated by the mechanism of attenuation by which the 
chloramphenicol itself plays the role of the gene inducer (Lovett, 1990). It has 
been shown that transcripts of the latter CAT genes have one pair of inverted 
repeats located upstream of the CAT open reading frame. The inverted repeats 
are in turn preceded by a short ORF (6-9 codon) called the stall region its 
sequence is highly conserved and complementary to the 16S rRNA sequence. In 
the absence of the chloramphenicol, the inverted repeats of the mRNA transcript 
are free to form a stable hairpin mRNA secondary structure, preventing the 
ribosome from accessing its binding site, which is located within the sequence 
of the second member of the inverted repeat and consequently no CAT gene 
expression occurs. On the other hand, when chloramphenicol is available, it 
binds to a ribosome causing a conformational changes to the latter so that the 
16S rRNA sequence will be exposed and free to hydrogen bond with its 
complementary stall region, which is near the first member (5') of the inverted 
repeats pair. As a result of the close proximity of the stall region to the 5' part of 
the inverted repeats pair, ribosomal binding to the stall region hinders the 
formation of the hair-pin mRNA enabling a second ribosome to reach the 
ribosomal binding site within the 3' part of the open inverted repeats and, 
therefore, the translation of the CAT will happen only in the presence of the 
antibiotic providing high levels of chloramphenicol resistance of MICs≥ 128 mg 
l-1. Other CAT genes have been proved to be regulated by invertible promoters 
such as in Pseudomonas mirabilis strainPM13 (Charles et al., 1985) or the 
expression could be constitutive providing different ranges of MIC according to 
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the promoter strength and the copy number of CAT gene in the bacterial cell 
(Schwarz et al., 2004).  
4.3.1.2. Xenobiotic chloramphenicol acetyltransferases 
     Some members of xenobiotic CATs have been functionally proved to carry 
out acetylation using chloramphenicol as a substrate and acetyl-CoA as a co-
factor, but others, have been shown to transfer the acetyl group to different 
substrates and, therefore, referred to as XATs. The structural relationships 
between the members of this group itself or between the classical CATs and 
xenobiotic CATs/XATs may explain the difference in the catalytic properties 
among the xenobiotic enzymes themselves and the classical CATs. 
     It has been shown that these enzymes share some common structural 
properties with the traditional CATs especially in being homotrimers composed 
of three identical polypeptide chains of 209-212 amino acid residue (Murray 
and Shaw, 1997). On the other hand, the primary structure showed significant 
differences between the classic and xenobiotic CATs, providing evidence that 
XATs could be related to the acetylation of substrates other than 
chloramphenicol such as streptogramins. Genes for streptogramin A resistance 
have been found in staphylococci and enterococci such as VatD (previously 
known as SatA) (Rende-Fournier et al., 1993), VatE (previously known as SatG 
(Werner and Witte, 1999), VatA (previously known as Vat) (Allignet and El 
Solh, 1995), or VatB (Allignet et al., 1993). Furthermore, many other CAT-like 
genes have been found widely distributed throughout many of Gram-positive 
and Gram-negative bacterial species and genera within chromosomal DNA 
(such as CATB7 in the Pseudomonas aeruginosa strain PAO222 chromosome) 
(White et al., 1999), plasmids (such as catB2 genes in plasmids isolated from 
Salmonella enteritidis) (Villa et al., 2002), transposons (such as multi resistance 
transposon Tn2424 from E. coli) (Parent and Roy, 1992). 
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     The expression of some xenobiotic CAT genes has been reported to be 
regulated by means of gene attenuation which is also a regulatory mechanism of 
the classical CATs genes. However, some xenobiotic CAT, such as CATB1 of 
Agrobacterium tumefaciens, it has been shown that the inverted repeats, which 
are key features of regulation, are four pairs instead of one regulating in more 
complicated mRNA secondary structures just upstream of the CAT open 
reading frame (Rogers et al., 2002). The CATB1 gene, however, has been 
shown to give low resistance (<20 mgl-1) to chloramphenicol (Murray and 
Shaw, 1997). Agrobacterium tumefaciens CATB1gene was first detected by 
(Tennigkeit and Matzura, 1991) in the chromosomal DNA, and its polypeptide 
chain has been shown to have significant differences when compared with the 
amino acids sequences of classical CATs, but the radiometric chloramphenicol 
acetylation assay proved it as a CAT; for all that, it has been shown to give low 
level of antibiotic resistance (when compared to the classical CATIII) even 
when its gene is cloned into multi copy in E. coli. This, however, could explain 
why CATB1 may have other physiological roles in Agrobacterium tumefaciens 
rather than chloramphenicol resistance; especially when the kinetic studies 
showed that the chloramphenicol Km constant for this XAT is 159 µM, while 
Km of the classical CATIII under the same conditions is 12 µM (Murray and 
Shaw, 1997).   
     The integron system is commonly popular in the xenobiotic CATs genes 
when such genes are parts of a gene cassettes regulated by a common promoter. 
The level of gene expression in such gene cassette integron system is dependent 
on the proximity of the gene’s ORF to the promoter, so that the closer the gene 
to the promoter the stronger the gene expression would be observed. The 
correlation between expression levels and the gene proximity to the promoter 
has been demonstrated in Vibrio cholerae. When the CATB9 gene, which is 
part of a chromosomal multi-resistance integron, was placed in either of the four 
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proximal domains of the promoter for the septuple gene cassette, so a 
significant chloramphenicol resistance was observed (≥25 mgl-1). However, 
when the  CATB9 gene was placed at the distal position away from the gene 
cassette promoter, the bacteria are rendered nearly susceptible to the drug 
(<1mg l-1) (Rowe‐Magnus et al., 2002). Multi-resistance integrons of plasmid 
origin have been reported to include xenobiotic CAT genes  in many species of 
enterobacteriacea (Schwarz et al., 2004) as well as Pseudomonas aeruginosa 
(Laraki et al., 1999). 
     Multi-sequence alignments of XATs against the aforementioned XAT from 
Agrobacterium tumefaciens showed that the latter enzyme has a conserved His-
78 residue, which, when mutated to alanine, leads to a loss of chloramphenicol 
acetylation activity. Therefore, it seems that XAT follows the same mechanism 
as classical CATs in performing the chloramphenicol acetylation, but the XAT 
efficiency in this case has been proven to be less than of classical CATs 
especially when the x-ray crystallographic reports revealed general differences 
in tertiary structures between the putative XAT and CATs (Murray and Shaw, 
1997).  
     It has been proposed from the tertiary structures of several classical CATs 
such as CATIII, and the E2 component of the pyruvate dehydrogenase complex 
PDH, that there is an evolutionary relationship between the two enzymes 
suggesting the idea that CAT evolved from an E2 ancestor. The tertiary 
structures of some well-studied XATs, however, could not find an evolutionary 
link with the PDH E2 as mentioned above. The phylogenetic difference between 
CATs and XATs could explain the difference in their catalytic properties in 
spite of the similarity of their quaternary structures.(Leslie et al., 1988; Leslie, 
1990; Mattevi et al., 1992; Mattevi et al., 1993). 
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4.3.2. Non-enzymatic chloramphenicol resistance 
     It is not necessary for bacteria to rely only on enzymatic modification 
(especially acetylation) of chloramphenicol to escape from the antimicrobial 
effect of the drug: other mechanisms that are not mediated by enzymes exist. 
Drug efflux is one of the bacterial weapons to acquire resistance: here drugs are 
excreted from the cell to avoid their lethal effect. A wide range of bacteria of 
both clinical and environmental importance have been reported to follow 
chloramphenicol efflux by encoding genes that express trans-membrane 
proteins that control drug expulsion. Such proteins are referred to as 
chloramphenicol exporters which could be specific exporters that pump only 
chloramphenicol and its derivatives such as florfenicol or general exporters that 
perform many drugs and toxic compounds of unrelated chemical identity 
excretion out of the cell. The specificity of exporters seems effective in term of 
the level of the antibiotic resistance so that the chloramphenicol -specific 
exporters are more efficient than their general counterparts (Schwarz et al., 
2004). 
 
4.4. Chloramphenicol acetyltransferase type I (CATI) random mutagenesis 
     There are three major classes of classical CATs; CATI, CATII and CATIII 
that are focused on by the experimental research especially CATIII and CATI 
which their three dimensional structures have been resolved in both apo and 
substrates bound forms. CATI is, however, less studied than CATIII, therefore, 
it has been considered in the current work as one of the model enzymes to be 
under the test of the random mutagenesis and functional analysis. 
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4.4.1. Gene synthesis and preliminary standardization experiments 
     Unlike CATIII, the CATI gene is commonly used as a chloramphenicol 
resistance selection marker in many cloning and expression plasmid vectors. 
Therefore, the wild sequence of CATI has been taken from pBR325 (the 
sequence is available at http://www.addgene.org/browse/sequence_vdb/1987/ ) 
a plasmid vector that provides chloramphenicol resistance due to the presence 
of the CATI gene. The CATI ORF is 660 bp (including the stop codon), which 
is translated into a 219 amino acid polypeptide. The nucleotide sequence has 
been modified so that many restriction sites have been introduced silently 
without affecting ORF integrity or the wild amino acid content (Figure 4.1 and 
4.2). Restriction sites for HindIII from N-terminal side and, XbaI and BamHI 
from 3’(C-terminal) side have been introduced to facilitate CATI gene cloning 
into a wide range of plasmid vectors that could be required for many purposes 
such as gene expression. Both flanking and intragenic restriction sites were 
introduced synthetically to simplify downstream analysis. In particular selection 
of regions for mutagenesis is potentially made easier in this way.  
     Although it has been shown to be naturally present in the Tn9 E. coli 
transposon (Alton and Vapnek, 1979), when synthesized, the modified ORF 
nucleotide sequence has been optimized for the E. coli K12 (the cloning strain 
used in the current work) expression to facilitate mutagenesis and functional 
screening. Unlike the AmpR gene which has its upstream regulatory promoter in 
pBR325, CATI has no promoter annotation on the same pBR325 plasmid, but 
the 50 bases in the pBR325, which are just upstream of the CATI ATG start 
codon, have been included in the synthetic gene to get the same 
chloramphenicol resistance phenotype as in pBR325 and to avoid any 
expression regulatory problem that may arise when only the CATI ORF is 
included. The synthetic CATI gene was provided by the gene synthesis 
company cloned in a cloning plasmid vector called pMA-T which has AmpR 
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marker as well. The final construct of pMA-T and CATI has been named here 
as pAtase2 (Figure 4.3). When the gene was designed and sub-cloned, it has 
been taken in consideration that each introduced restriction site should not be 
repeated in the final construct so each new restriction enzyme site is unique. 
 
Figure 4.1: Nucleotide alignment between the wild and the optimized 
(synthetic) sequence of CATI gene. The upstream 50 bp are underlined by a 
blue line. The 49th and 50th nucleotide of the upstream sequence have been 
modified from AA into CC to get the NcoI restriction site at the beginning of 
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the ORF. The start codon ATG is underlined by a green line while the TAA stop 
codon is underlined by a red line. The in-frame restriction sites are boxed. 
 
 
 
Figure 4.2: Interleaved view of the whole synthetic sequence showing the 
primary structure of the CATI (219 amino acid). The ORF is cyan-shaded. The 
in-frame and out-frame restriction sites are underlined by red dashed lines. 
(AAGCTT=HindIII,CCATGG=NcoI, CTTAAG=AfIII, GAATTC=EcoRI, 
GACGTC=AatII, ACTAGT=SpeI, GCTAGC=BmtI, TCTAGA=XbaI, 
GGATCC=BamHI). Each restriction enzyme has only one cutting site in the 
final pAtase2 construct. 
 
4.4.2. Acetylation activity test 
     The synthetic gene was received lyophilized as 5µg pAtase2 construct which 
was rehydrated using 50 µl ddH2O to get a DNA concentration of 100ng ml
-1. 
Once rehydrated, 50ng of the pAtase2 construct, which contains the CATI 
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synthetic gene, was used to transform 100µl of competent E. coli K12 
1821using the chemical transformation method according to (Hanahan, 1983) 
protocol. The transformed E. coli then plated out on an ampicillin (100µg ml-1) 
LB plate and incubated overnight at 37 °C. 
 
Figure 4.3: pAtase map as provided from the gene synthesis company showing 
ORFs of CATI and ampicillin resistance gene (AmpR). The origin of replication 
in this plasmid is Col E1. Many restriction sites are mentioned with their base 
pair cutting positions between the brackets. 
 
     Four CFUs were picked from the thousands of transformants and were sub-
cultured on LB agar plates containing both ampicillin (100µgml-1) and 
chloramphenicol (50µg ml-1) to confirm that the CATI performs its role in 
acetylating chloramphenicol and conferring antibiotic resistance (Figure 4.4). 
The results showed that CATI synthetic gene is adequately expressed and fully 
active in E. coli K12 1821and, therefore, turning the latter sensitive strain into 
one that is chloramphenicol resistant (Figure 4.4). Higher concentrations of 
chloramphenicol have been used to test the minimum inhibitory concentration 
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MIC but the results showed that the growth of the pAtase2-transformed  E. coli 
was strong even with the chloramphenicol concentration of up to 300µg ml-1. 
The high level of resistance reached after transformation could be related to the 
high copy number of the pAtase2.  
     Plasmid minipreps were prepared from the clones that showed Cm 
resistance, the DNA was quantified and sent for sequencing to check the 
sequence integrity after transformation as recommended by the cloning 
standards of the gene synthesis company. The sequencing data showed 100% 
identity with the original sequence provided by the gene synthesis company.  
 
 
Figure 4.4: Chloramphenicol and ampicillin containing LB plate for CATI 
activity test. (1) pUC19-transformed E. coli BL21 DE3 (Rosetta) which is 
originally chloramphenicol resistant while its AmpR is from pUC19 plasmid. 
(2) E. coli K12 1821 transformed with pAtase2 which has both chloramphenicol 
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and ampicillin resistance. (3) E. coli K12 1821 transformed with pUC19 only 
therefore no growth noticed because of the presence of chloramphenicol in the 
media. (4) Untransformed E. coli K12 1821showing no growth.    
 
4.4.3. Error-prone PCR 
     The mutagenesis strategy involves introducing mutations randomly into a 
segment of the CATI gene and returning this region as a restriction fragment 
library, back to the pAtase2 construct. The PCR amplification was performed 
using pAtase2 as a DNA template and a pair of primers (forward and reverse) 
that were designed so that the resulting PCR product contains EcoRI and XbaI 
sites; each of which has a single cutting site in pAtase2. The program and the 
protocol of the PCR amplification is described in chapter 2. The PCR product 
(651 bp) was purified according to the Qiagen® protocol and quantified prior to 
epPCR. DNA The purified product was double digested with EcoRI and XbaI: 
1µg of pAtase was digested side by side with the PCR product using the same 
double digestion above. The digestion products were run on a 1% ethidium 
bromide-containing agarose gel for 1 hour. The bands appeared at their 
expected sizes (Figure 4.5). 
     The fragment of 447bp (lane 7 Figure 4.5), which results from the double 
digestion of the PCR product, and the fragment of 2673bp (lane 5 Figure 4.5), 
which results from the double digestion of pAtase2, have been recovered from 
the gel using Qiagen® gel kit. The recovered fragments were quantified and the 
ligation reaction was set up at 1:3 vector to insert concentration ratio. The 
vector is represented by the 2673bp fragment, while the insert is represented by 
the 447bp band. The ligation was performed at 16°C overnight using T4 DNA 
ligase from NEB. The ligation mixture was used to transform competent E. coli 
K12 1821 that has been prepared with a transformation efficiency of 6*107 (see 
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chapter 2 for more protocol details). The transformed E. coli was then plated out 
on LB plate containing ampicillin only. The chloramphenicol was not added to 
the latter plate in order to recover all clones of both active and inactive CATI. 
The plate was incubated overnight at 37°C and transformation was successful 
(see Figure 4.6). 
 
 
Figure 4.5: Agarose gel electrophoresis. (1) Uncut pAtase2. (2) pAtase2 
digested by XbaI. (3) pAtase2 digested by EcoRI. (4) Hyperladder I. (5) 
pAtase2 digested by both XbaI and EcoRI. (6) Ladder IV. (7) PCR product 
digested by both XbaI and EcoRI. (8) Hyperladder I. 
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Figure 4.6: Colony forming units (CFUs) obtained after the transformation of 
competent E. coli K12 1821 by the ligation mixture described above.   
 
4.4.4. Activity test after the mutagenesis 
     The mutagenesis range is represented by the 447bp which is the length of the 
insert (lane 7 Figure 4.5) so the DNA bases from the EcoRI position to the XbaI 
position (Figure 4.2) are all vulnerable to random mutation which means that 
the mutagenesis includes 147 amino acid residues from C-terminal side of the 
CATI primary structure (i.e. residue 72 to 219).  
     Each colony shown in Figure 4.6 represents a clone that could be inactivated 
by mutation(s) or remains active simply because of the mutation(s) are/is of no 
significant effect or no mutation has been generated so the wild DNA sequence 
remains intact. Investigating the activity is straightforward by picking single 
colony from the original ampicillin plate and sub culturing on a plate of both 
ampicillin and chloramphenicol so that clones of active CATI will exhibit 
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visible and strong growth while inactive and partially active clones will show no 
growth at all and weak growth (represented by few colonies) respectively 
(Figure 4.7). 
 
Figure 4.7: CATI Activity test. (1) clone of partially active CATI showing small 
and few colonies. (2), (3) and (4) clones of fully active CATI showing strong 
growth. (5) clone of inactive CATI showing no growth at all.  
 
4.4.5. DNA sequencing 
     Two hundred clones from the original transformation plate (Figure 4.6) were 
randomly chosen; each of which was sub cultured in 5 ml LB containing 100µg 
ml-1 ampicillin for the sake of plasmid DNA miniprep that was being performed 
side by side with activity test. The two hundred plasmid samples were sent for 
sequencing. The results showed that 22 sample (11%) were with no change at 
all in nucleotide sequence, 17 sample (8.5%) have unclear sequence, 5 samples 
(2.5%) of silent mutation, mutants of deletions and insertions were 25 samples 
(12.5%)  and 4 samples (2%) respectively. Mutation in the gene stop codon 
were 3 (1.5%), nonsense mutants or mutant clones with in-frame stop codon 
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were 26 (13%). On the other hand missense mutations were represented by 94 
clones (47%). Since the objective was to isolate point mutations that cause 
amino acids changes as well as non-sense mutations, all clones that appeared 
with mutations of deletions, insertions and mutations in the TAA gene stop 
codon, which all abolish the gene ORF, have been ignored. Clones showing no 
change in nucleotide sequence as well as those of unclear sequence (such as 
over lapping chromatogram peaks or many Ns) have been ignored as well.  
     It has been noticed from the sequencing data that the number of amino acids 
changes is not necessarily caused by the same number of the nucleotide 
sequence point mutations. For instance, mutant clone of single amino acid 
change could have more than one (two or three) point mutation in its nucleotide 
sequence but when translated, the primary structure showed only single amino 
acid residue change putting the rest of the nucleotide base changes on the shelf 
of the silent mutations. The data regarding the correlation between the 
nucleotide changes and the amino acids changes and the consequent rates and 
incidences of the mutations silencing is provided in Table 4.1.  
     The distribution and arrangement of the CATI gene codons reflect the rate of 
silent mutations and how resistant the primary structure is toward random 
mutagenesis. Therefore, our mutagenesis strategy is a way by which the 
significance of the gene codons arrangement in term of mutational resistance or 
silencing could be estimated. However, mutations silencing could be explained 
as tool to make the enzyme able to maintain its primary structure and elude the 
function inhibitory mutations that may be caused by different factor in nature. 
The evasion of the mutational nucleotide changes is due to the presence of more 
than one gene codon (cognate codons) which are available to be translated into 
the same amino acid so that the random mutagenesis could simply change a 
certain codon into its cognate codon that is translated into the same amino acid 
and, therefore, such mutation is considered as silent.   
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Table 4.1: Silent mutations incidence. 
Amino acid change 
Per clone 
Clones 
obtained 
Nucleotide base change 
1 2 3 4 5 6 7 8 9 
0 5 3 1 1 0 0 0 0 0 0 
1 27 16 6 5 0 0 0 0 0 0 
2 19 - 7 8 4 0 0 0 0 0 
3 26 - - 11 9 5 1 0 0 0 
4 9 - - - 6 3 0 0 0 0 
5 8 - - - - 5 2 1 0 0 
6 3 - - - - - 1 2 0 0 
7 1 - - - - - - 1 0 0 
8 1 - - - - - - - - 1 
Total 99 19 14 25 19 13 4 4 0 1 
 
     The data showed some mutant clones are still expressing the wild CATI 
primary structure even when three DNA bases have been changed. In addition, 
the number of changes in DNA sequences in a significant number of mutant 
clones is more than the number of amino acid changes, in other words, 
mutations in DNA is not necessarily to be all sensed in the protein primary 
structure. For instance, 6 and 5 clones contain double and triple nucleotide 
change respectively but the primary structure showed only single amino acid 
change in all of them. 19 clones of double amino acid change have been 
obtained; 7 of them showed the same number of DNA base change but 8 and 4 
clones of them showed double and triple N changes. Interestingly, one clone has 
been shown to have 6 DNA base changes but half of these base changes were 
silent so that only 3 amino acids changes were recorded. Furthermore one 
sample of three DNA base changes was with no amino acid change at all (see 
Table 4.1 for more data details). 
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4.4.6. Mutational frequency and CATI activity 
     The enzyme activity has been correlated with the number of sense mutations 
per clone to draw the enzyme tolerance toward the amino acids changes caused 
by sense point mutation (table 4.2). 
Table 4.2: Correlation of the sense mutations’ frequency with enzyme activity: 
Mutation per 
clone 
Clone frequency 
obtained 
Acetylation activity 
Active Inactive Partially 
active 
1 27 17 5 5 
2 19 3 10 6 
3 26 3 21 2 
4 9 2 7 0 
5 8 1 6 1 
6 3 0 3 0 
7 1 0 1 0 
8 1 0 1 0 
Total 94 26 54 14 
% 100% 27.65% 57.45% 14.9% 
 
     The results revealed that CATI tends to be more sensitive toward random 
mutagenesis than being resistant especially when more than half of the mutants 
(57.45%) showed complete loss of activity alongside with 27.65% and 14.9% 
that showed complete and partial activity respectively. The only noteworthy 
resistance toward the mutations was observed with clones of single amino acid 
change mutants which represent 27 clone; 17 of them are completely active 
while only 5 clones showed absolute inactivity and 5 appeared with weak 
growth (partial activity) on the chloramphenicol plate.  
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     The remaining clones contained groups of two mutations and most gave rise 
to inactivation. The greater the level of mutation: the greater the probability of 
inactivation. Indeed, more than half of the mutant clones with the double amino 
acids changes were completely inactive, while only about 16% are totally active 
beside 32% exhibiting imperfect activity. Triple sense mutation clones, which 
are the second most  prevalent after those of single amino acid mutation, arose 
with significantly affected CATI activity so that 21 clones out of 26 were 100% 
chloramphenicol sensitive while the minority,  represented by 5 clones, divide 
into 3 and 2 mutants of 100% and partial chloramphenicol resistance 
respectively. Quadruple mutants where either 100% active or 100% inactive 
which constitute 2 and 7 clones respectively. The presence of one clone of 
quintuple sense mutation that catalysed full acetylation activity in addition to 
another one exhibiting partial activity reveals that the position of point 
mutations (which will be discussed later) in addition to their frequency are both 
playing a role in the enzyme activity alteration. Few clones of 6, 7 and 8 amino 
acid changes have been obtained showing no growth at all on the 
chloramphenicol LB plates indicating no significant CATI activity.  
 
4.4.7. Mutations in conserved residues and enzyme activity 
     The amino acid residues conserved across the CAT family has been assessed 
by multiple sequence alignment of 86 chloramphenicol acetyltransferases of 
different types from a wide variety of bacterial sources (See Appendix 5). The 
minimum conservation parameter has been set arbitrarily at 60% in this 
analysis: which means that each residue that is present in at least 60% of the 86 
sequences is considered to be conserved. According to the latter conservation 
parameters, 77 residues out of 219 of CATI appeared to be conserved. The 
random mutagenesis range incorporated 147 residue (57 of which are 
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conserved) formed by the polypeptide chain from E72 to A219. The mutants 
recovered, however, did not impact upon every single residue within this range. 
The incidence of conserved residues are relatively high; this may explain the 
observation that CATI is more sensitive to mutagenesis especially since the 
targeted region includes the active site and its environs. The activity of CATI 
has been correlated with the mutational incidence in conserved residues and the 
number of mutations per clone (Table 4.3). 
Table 4.3: Conservation mutational changes and enzyme activity: 
Mutation 
per clone 
Single 
(1) 
Double (2) Triple (3) Quadruple (4) Quintuple (5) 
Frequency 27 19 26 9 8 
 Conservation 
      Change 
         Incidence 
 
 
Activity 
0/1 1/1 0/2 1/2 2/2 0/3 1/3 2/3 3/3 0/4 1/4 2/4 3/4 0/5 1/5 2/5 3/5 
Active 13 4 1 2 0 2 1 0 0 0 2 0 0 1 0 0 0 
Inactive 1 4 2 6 2 5 7 8 1 1 1 4 1 0 2 2 2 
Partially 
Active 
3 2 1 5 0 0 2 0 0 0 0 0 0 0 0 0 1 
Total 17 10 4 13 2 7 10 8 1 1 3 4 1 1 2 2 3 
 
     The data reveal that both the density of conserved residues and the frequency 
of mutations obtained clearly determine the likelihood of CATI remaining 
active. The mutant clones in Table 4.3 have been arranged into 5 groups 
according to the number of mutation per clone. It is clear from the activity data 
that mutations of conserved residues significantly affecting CATI acetylation 
activity either completely or partially. The majority of mutant clones (13 out of 
17) of the single amino acid changes were fully active when mutations were not 
within the conserved amino acids residues, however, only one single mutation 
among the mentioned above 17 clones appeared to completely inactivate CATI 
134 
 
rendering the E. coli to be unable to grow in the presence of 5 µg/ml 
chloramphenicol. When outside of the conserved regions, single sense 
mutations could partially reduce CATI activity: 3 mutant clones out of 17 grew 
but weakly on the chloramphenicol plates.  
     The importance of sequence conservation in maintaining enzyme activity 
appeared with mutants harbouring double amino acid changes, so that only one 
mutation in a conserved residue is required to derive the most of clones (11 out 
of 13) to be affected by chloramphenicol either completely or partially.   
     Clones containing three missense mutations are generally inactive, even 
when those clones do not contain any change in the conserved positions and this 
is clearly shown by the data obtained here when only two clones out of seven 
appeared fully active. Similarly, when only one mutation happened in a 
conserved position of the clones of three amino acid changes, nearly the same 
proportion of fully active clones appeared (3 out of 10), while one more 
mutation in another conserved residue turns all clone to be fully inactive. 
     Interestingly, two mutant clones with four residue changes showed full CATI 
activity, even when one change happened in a conserved position, while 100% 
of them appeared completely inactive when two conservative mutations were 
introduced.  
     One clone was obtained carrying five amino acid changes and this grew 
strongly on chloramphenicol plates while the remaining clones of this group 
were all inactive. Furthermore, only one mutant appeared partially active when 
3 out of its 5 mutations were at conserved residues. 
     The rest of the clones containing 6, 7 and 8 sense mutations which are all 
inactive, were not generally localised to conserved positions. Two clones of the 
three hexa-mutants include two conserved substitutions and the remaining one 
incorporates a single conservation change.  
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     Finally, the role of primary structure in the formation of secondary structure 
elements in each CATI monomer were illustrated in Figure 4.8. In this figure, 
the complete set of mutagenesis and functional screening data could be mapped 
to evaluate the role of the mutagenesis-targeted residues in protein secondary 
structure. Furthermore, to evaluate the importance of conserved and non-
conserved residues to the enzyme function, the mutations of single residue 
change with their relevant activity profiles were mapped directly into the CATI 
three dimensional structure (Figure 4.9). 
 
 
 
Figure 4.8: Combination of CATI primary and secondary structures showing the 
secondary structure elements and their relevant amino acid residues. β-strands 
are shown in yellow arrows, α-helices are the red zigzags, loops are represented 
by green arcs, and the black lines are the regions of undefined secondary 
structure. PDB code 3U9B. 
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Figure 4.9: Four different views of the CATI three dimensional structure. View 
D shows the whole homotrimer structure. The three monomers are distinguished 
by colours as yellow, pink and gray. Views A, B and C highlight mutations 
recovered from CATI analysis: all residues highlighted represent single residue 
change mutants which are distributed equally within the three monomers, but 
here, they are shown only within a single monomer (the yellow one) for 
simplicity. Residues that affected the enzyme activity are labeled in red, while 
those which did not affect the activity are labeled in blue. (Details of the residue 
changes are all included in the appendices). Developed from the three 
dimensional structure which was resolved by Biswas et al. (2012), PDB code 
3U9B. 
A B 
C D 
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4.4.8. CATI catalytic mechanism and the impact of mutations  
     Like all the catalytically studied classic chloramphenicol acetyltransferases, 
CATI has been shown to perform chloramphenicol acetylation via its catalytic 
histidine residue which is numbered 193 in the primary structure. The 
homotrimeric quaternary structure creates a triple active site formation.  Each 
active site histidine lies in the cleft formed by the adjacent subunits. The R 
group of the catalytic histidine protrudes from one surface of the cleft so that the 
εnitrogen of the imidazole ring provides the required basic properties for the 
chloramphenicol 3-hydroxyl group deprotonation to produce an oxyanion 
intermediate which, in turn performs a nucleophilic attack on the second carbon 
atom of acetyl coenzyme A. This yields a tetrahedral intermediate, which then 
collapses into 3-acetoxy chloramphenicol and co-enzyme A. The acetyl group is 
then transferred to the C-1 hydroxyl of the chloramphenicol by a non-enzymatic 
reaction to produce 1-acetoxy chloramphenicol, therefore, the chloramphenicol 
3-hydroxyl group will be free again and ready for a second enzymatic 
acetylation to form the final product of 1, 3-diacetoxy chloramphenicol (Figure 
4.10) (Kleanthous and Shaw, 1984; Andreeva and Karamancheva, 2001; Biswas 
et al., 2012). However, chloramphenicol acetylation at either 3-OH or 1-OH 
position has been proved to be sufficient to prevent the drug molecule from 
binding into its ribosomal target (Shaw and Unowsky, 1968; Bulkley et al., 
2010; Dunkle et al., 2010). 
138 
 
 
Figure 4.10: Chloramphenicol acetylation (Biswas et al., 2012). 
 
     Our mutagenesis data showed three clones containing more than one 
mutation with the involvement of the catalytic H193 among these mutations. 
The mutational patterns of these clones were (1) Y120C, N130K, F171L, 
H193Y; (2) S103N, D111N, H193N and (3) D157V, H193L. All of these clones 
showed complete CATI inactivity. Although D157 is not conserved, mutation 
D157V occurred independently in another clone as a single sense mutation 
causing the CATI to be partially active but when accompanied with H193L the 
enzyme activity has been completely inhibited indicating the key role of H193 
as a catalytic active site residue. All the aligned CATs variants (See Appendix 
5) showed few replacements for the CATI D157, however, asparagine is the 
highly common residue which is very close in its structure and size to the 
aspartic acid so it is most likely for the CATI to be completely active with a 
mutation D157N. However, no valine is noticed to occur as one of the intended 
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amino acid replacements at that particular position, therefore, our mutation of 
D157V has been of partial acetylation activity especially when D157 
participates in the trimeric structural stability of CATI.  
     It has been shown by the structural study of Biswas et al. (2012) that the 
overall CATI trimer is composed of three groups of beta sheets, each of which 
contains seven strands, six of them (β6, β5, β7, β9, β10 and β2) are from one 
monomer and one (β8) from the adjacent monomer. Five α-helices and three 
small β-sheets surround strand β8. Residue D157 is found within the β8 strand 
so that the aliphatic parts of R groups of all aspartate residues from the three 
monomers are intimately interacting with each other by hydrophobic 
interactions, on the other hand, the hydroxyl moieties of these R groups are 
forming a complex network of hydrogen bonds with the R groups of both S155 
and N159. Coming together to form such hydrophobic interactions, aspartate 
residues in position 157 from each monomer are maintaining the conformation 
of the CATI trimer scaffold. The partial activity of D157V mutant could explain 
the incomplete loss of such interactions or the wild interactions has been 
replaced by other interactions which are suitable in the case of valine in the 
same position normally occupied by Asp. Maintaining the trimeric quaternary 
structure in a specific conformation, as a compact wild type CATI, is of course 
critical to providing the exact arrangement of atoms in the  active site cleft, 
especially when the latter is not formed within a single monomer but between 
two monomers. The binding monomer (represented predominantly by residues 
within strands β6, β5, β7, β9, and β8) and the catalytic monomer (formed by 
residues of strands β2 and β10) so that CATI is only catalytically active when it 
is a trimer, therefore, any mutation that potentially affect the precise assembly 
of the three monomers could consequently cause activity loss that sometimes 
appears to be incomplete. Interestingly,  CATIII which is very similar to CATI 
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in term of its quaternary structure,  has been shown to be completely inactive as 
a monomer (Shaw et al., 1970).  
     Mutants at position S155 have been obtained (accompanied by many other 
mutations) in 4 clones (See Appendix 2). All these clones showed complete 
CATI inactivity. S155 was mutated into threonine in two clones, while the other 
two clones showed S155C and S155I replacements respectively. When 
considering this residue in the context of the CAT multiple sequence 
alignments, S155 is frequently replaced by G while no T, C and I replacements 
are ever seen. As mentioned above, S155 participates in the maintenance of the 
trimer conformation: its side chain hydrogen bonds with the side chain of D157, 
however, the low conservation of S155 has been explained because of the D157 
carboxyl group’s ability to form hydrogen bond interactions with its own back 
bone amide (NH) disrupting the hydrogen bonding with the S155 side chain 
(Biswas et al., 2012). 
     The crystal structure of a CATI-chloramphenicol complex (Biswas et al., 
2012) showed that the chloramphenicol binding monomer is predominantly 
formed by residues C91, F102, S104, F134, F144, S146, L158, and V170, while 
the catalytic monomer involves the most important active site residue H193 and 
other catalytic residues such as S146 and D197. Few residues like F25 and C31 
are within the catalytic side of the active site cleft but their main role is in 
chloramphenicol binding. Our random mutagenesis experiment has covered 
both binding and catalytic parts of the enzyme. Two clones with mutation in 
C91 have been obtained as C91Y (with two additional mutations) and C91S 
(with one additional mutation). Cys-91 is not conserved but no tyrosine is 
observed as a replacement for the cysteine in that position while serine occurs 
many times throughout the CATs alignments to replace cysteine, therefore, 
partial loss of activity of C91S mutant is likely caused by the other 
accompanying mutation which is P169T especially when the P169 is conserved 
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residue. On the other hand, the mutant of the C91Y mutation is completely 
inactive.  
     F102 is one of the few absolutely conserved residues which has been 
mutated into isoleucine and tyrosine within quintuple and double mutant clones 
respectively. Both of these two clones showed 100% loss of activity. Within the 
clone of the five mutations, F102 is the only conserved among the other four 
mutated residues; one of them is F144 which is not conserved but it also 
participates in the chloramphenicol binding and mutated to Leu. Within the 
double mutant clone, the F102 mutation is found alongside another mutation at 
the conserved side chain N162. As it is absolutely conserved among the aligned 
CAT members, no replacements occur for F102. The absolute conservation 
could explain the complete CATI inactivation in two clones when F102 is 
mutated. 
     In addition to the above F144L mutation, an F144Y mutant has been seen in 
the only one clone of the seven sense mutations which encodes an inactive 
CATI. This clone involves an S146R mutation which seems inhibitory, as S146 
is highly conserved and shows only one replacement represented by tyrosine in 
CAT from the Clostridium botulinum strain Eklund 17B / Type B, while all the 
other aligned CATs show serine in this position. The mutation at the S146 
position was obtained two more times by random mutagenesis within two CATI 
inactive clones of triple and quintuple mutation as S146R and S146I 
respectively. The catalytic role of S146 in CATI has been proposed as the same 
of S148 in CATIII (Lewendon et al., 1990) which is involved in hydrogen 
bonding (probably via a water molecule) and stabilization of the oxyanion 
intermediate during the acetylation (Biswas et al., 2012). The triple mutant 
clone has another mutation in the highly conserved H192 as H192R which is 
within the catalytic face of the active site cleft. H192 is conserved in all the 
aligned CAT variants except CATIII from Klebsiella pneumoniae which has an 
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asparagine in this position. Combined together, S146R and H192R mutations 
are most likely the definite cause of the mentioned above triple mutant clone 
inactivation because the third mutation, which is E129D, is not in a conserved 
position in addition to the incidence of E129V as a single mutation in another 
fully active CATI clone.  
     The leucine at position 158 seems one of the important chloramphenicol 
binding residues because it appears conserved throughout the CAT alignments, 
with only few replacements as isoleucine which is close in structure to leucine. 
Histidine and glycine occur in only two and one CATs variants respectively at 
this position. Interestingly, random mutagenesis has reached this residue to 
replace L158 with proline; another hydrophobic residue but with significantly 
different side chain structure, to provide partially active acetylation activity in a 
context of quintuple mutation clone which has another four mutations; two of 
them are within conserved residues as well making the enzyme robust in 
performing its catalytic activity even under the pressure of high mutational 
frequency (5 simultaneous mutations in one clone) and many changes in 
conserved sequences.       
     The structural and biochemical studies have used the well-studied CATIII as 
a model to understand the catalytic and structural properties of CATI because 
they share the global conformational properties of being trimers as well as some 
detailed structural properties which emerged after the chloramphenicol-CATI 
structure was determined. This study showed a high degree of similarity 
between CATIII and CATI when both are complexed with chloramphenicol. 
The CAT structures reveal that the arrangement of the key catalytic residues of 
CATI can be more or less superimposed on to the structure of the  intensively 
studied CATIII; especially the disposition of H193, S146 and D197 when the 
enzyme is bound to its antibiotic substrate. The relative position of the CATI 
catalytic H193 in relation to the bound antibiotic molecule is exactly the same 
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as its H195 equivalent in CATIII, sucho that the catalytic distance between the 
Epsilon nitrogen atom of the histidine imidazole and the 3-OH group of the 
bound chloramphenicol is 2.7A°. The latter distance and the appropriate 
conformation of the imidazole ring, enable the latter to easily abstract a proton 
from the drug molecule 3-OH group that will be nucleophilic enough to attack 
the Acetyl Co A and to” snatch” its acetyl in a mechanism similar to that of 
CATIII (Biswas et al., 2012). 
     The proper catalytic positioning of the H193 is maintained by many residues 
within the catalytic monomer. The benzyl aromatic ring of F25 is at appropriate 
distance (3.6 °A) to provide face to face (π-π) stacking interaction to the H193 
imidazole ring. All the aligned CAT variants presented in the Appendix 5 
showed either Phe or Tyr at this position. This clearly explains the role of the 
Phe in CATI in making the mention above stacking interaction as Tyr is another 
aromatic residue with a benzyl side chain which most likely has exactly the 
same role in other CAT variants as its cognate Phe. Our random mutagenesis 
protocol, however, has not covered F25 for technical reasons.  
     Other residues that have been found to maintain H193 in its proper position 
to perform its catalytic role, D197, R18 and H193, are all involved in the 
formation of hydrogen bond networks with the oxygen of A194 carbonyl which 
is absolutely conserved in all the aligned CAT variants. The present random 
mutagenesis experiment has covered this residue in three mutant clones of 
double, triple and six amino acid changes. All these clones showed 100% loss 
of CATI activity. The clone of double amino acid change has the D164Yand 
D197C mutations; mutation in D164 residue appeared in two other clones of 
fully active CATI (see the clones of ID 4thAt33 15.2.15 and 4thAt175 15.2.15 
in Appendix 2) proving that mutation D197C is the reason behind the CATI 
inactivation most likely because of the distortion in the structural arrangement 
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of the catalytic monomer that is required for the proper positioning of the H193 
to perform the catalysis.  
     Multiple sequence alignments reflect the importance of some residues that 
are not necessarily absolutely conserved but they have only one or few 
replacement(s), for example, A194 in CATI is mostly conserved as Ala in all 
CATs but it could be replaced by Ser in many CAT variants (See Appendix 5). 
The mentioned above role of the A194 could have been performed by Ser 
otherwise, Ser wouldn’t have been seen as a replacement for Ala in this 
particular position. Although the random mutagenesis has not hit A194, we 
assume that any mutation in CATI that may arise in this position to replace Ala 
with Ser should keep the enzyme active. Therefore, multiple sequence 
alignments are being used here to rationalize the activity data obtained 
alongside the random mutagenesis experiments. 
     Although the amino acid sequence alignments between CATI and CATIII 
revealed 9 out of 20 chloramphenicol binding residues to be different between 
the two enzymes (Biswas et al., 2012), chloramphenicol bound structures of 
both CATI and CATIII showed that the antibiotic molecule is present in the 
same position in both complexes so that the p-NO2group of the drug is facing 
the solvent while the aromatic ring rests on the hydrophobic surface of the 
active site when the antibiotic molecule is bound to the active site. The 
hydrophobicity on the mentioned above active site surface required for the 
chloramphenicol interaction is provided mainly by residuesL158 and V170. The 
former has been mutated into Pro and is discussed above, while V170, which is 
found as Ile (another hydrophobic residue) in most CATs, has not been reached 
by the random mutagenesis. The correct positions of the L158, V160 and F166 
side chains, which line the lower part of the chloramphenicol binding site, are 
maintained by the assembly of the three monomers, therefore, any mutation that 
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could alter the correct assembly of the trimer is most likely affect the correct 
positioning of such residues that are enzyme’s functional determinants. 
     The distance between the Y133 side chain hydroxyl and the carbonyl group 
of the chloramphenicol molecule (2.9 °A) makes it possible for strong hydrogen 
bonding to occur between these moieties (Biswas et al., 2012). The MSA 
showed that Y133 is not conserved but has replacements that are hydrophobic 
most of the time such as Met, Leu or Ile, or of relatively similar alternative 
residue which is Phe. The random mutagenesis data showed mutations in Y133 
within three clones; two of them are of three point mutations as Y133F, G137C, 
F153I  and Y133D, G174S, D197E, and one clone of  seven amino acids 
changes as E97A, T99N, C126Y, Y127C, Y133F, A168S, E207D, Y211H. All 
these three clones express completely inactive CATI. The reason of inactivity in 
clones that have Y133F could not be the latter mutation as Tyr was mutated into 
a very similar cognate which is Phe while the mutation Y133D, however, could 
be participating in the inactivity of the CATI as MSA is not showing any Asp 
alternative in this particular position. 
 
4.4.9. Amino acid changes affecting CATI activity in relation to 
conservation 
     The enzyme tends to be inactive rather than being fully active after random 
mutagenesis, so the fully active clones are 26 (26.65%) out of the total of 94 
clones (Table 4.2). All the mutagenesis and activity data for each single mutant 
clone related to CATI are listed in Appendix 2. Here, The full activity of the 
mutant clones are correlated with multiple sequence alignments to see if the 
new residues that are introduced into CATI primary structure by random 
mutagenesis are actually present throughout the MSA and therefore the enzyme 
activity is maintained or those mutagenesis-introduce residues are just novel 
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which means that they are not seen in the aligned CAT variants (See Table 4.4 
below and Appendix 5).  
     Some mutations in some clones are discussed above in term of causing 
inactivation as these mutations happened in an absolutely conserved residues 
that could not theoretically be replaced by any other residue and, therefore, 
mutant clones of such mutations should express totally inactive CATI, or the 
mutation happened in a residue that is only possible to be replaced by another 
residue of the same properties to maintain the enzyme activity such as the 
replacement of phenylalanine by tyrosine which are both aromatic and have 
relatively the same size otherwise, inactive enzyme would be produced by any 
change in any of the absolutely conserved residue or any change in any position 
of conserved amino acid properties such as acidic, basic, aromatic or 
hydrophobic properties.  
 
Table 4.4 Correlation of the amino acid changes in the active CATI mutant 
clones with the multiple sequence alignments MSA.   
Amino acid changes Changes seen in MSA Changes not seen in MSA 
R203G - R203G 
D181V - D181V 
E129V - E129V 
N162K N162K - 
A147V, D164E, A219T D164E, A219T  A147V 
F113I, E214K F113I, E214K - 
E97V E97V - 
D86E D86E - 
R114S R114S - 
S121I S121I - 
G217S G217S - 
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G137C - G137C 
D79Y, E81D, V191I E81D, V191I D79Y 
M77K, A125S, M185L, L208V M185L, L208V M77K, A125S  
N165I - N165I 
D111E, S121G, P169S, Q179H D111E S121G, P169S*, Q179H 
V83F, T99S, H118R, Q122H, D181N T99S, H118R, D181N V83F, Q122H 
Q98H - Q98H 
V88L V88L - 
N130K N130K - 
V195I V195I  
D79Y, A132T A132T D79Y 
W215R - W215R 
T178I T178I - 
H118R, D164E, Q210H H118R, D164E, Q210H - 
Red shaded are conserved residues.  
Red shaded with star (*) are residues that are absolutely conserved.      
 
      The CAT multiple sequence alignments show residues that are conserved in 
more than 60% of the aligned CATs but they still have few alternatives; if 
replaced with, the enzyme is assumed to still active. On the other hand, few 
regions of CATI appeared with absolutely conserved residues that are not 
replaceable with any other residue alternatives and if replaced, the enzyme is 
assumed to be inactive. In other words, for the CATI to be active, new residues 
introduced to the CATI amino acid sequence by random mutagenesis in 
conserved points should be seen throughout the MSA data otherwise the 
enzyme would not be active. While mutations in any point of not conserved 
residues are likely to be tolerated by the enzyme. The data in Table 4.4 have 
been used to test this assumption and it is obvious that the enzyme is still 
expressing acetylation activity even when mutational amino acid changes 
happened in conserved points introducing new residues (novel) that could not 
148 
 
be seen throughout the MSA at these particular points. Furthermore, even 
P169S mutation which is in an absolutely conserved point appeared in fully 
active quadruple mutant clone. Therefore, the general assumption of 
inactivating the enzyme when mutation occur in a conserved point does not 
always apply. This could be explained by the specific role of each residue in 
enzyme catalysis or maintaining the proper conformation required for the full 
activity. The role of some residues in relation to the activity data obtained after 
CATI gene random mutagenesis has been discussed previously in this chapter.  
     Certain amino acid change in an absolutely conserved point could cause 
complete loss of activity while different amino acid change at the same 
absolutely conserved point could give a different enzyme activity phenotype, 
for instance, H200 is 100% conserved residue, however, the data showed that 
mutant clone containing H200Y mutation among two other mutations (S107P, 
P135S) was completely inactive, while another mutant clone containing H200Q 
mutation among four other mutations (H96L, E97K, L158P, V183L) was 
expressing partial activity.  
     Certain residue characteristics (such as aromatic, acidic, basic hydrophobic, 
nucleophilic…etc.) are indeed required (conserved) at certain positions in the 
enzyme rather than a particular residue itself, therefore, in such case, amino 
acids of the same characteristic properties are seen throughout the MSA at any 
particular position of such residue properties conservation. For instance, 
aromatic amino acid tryptophan at position 85 in CATI has phenylalanine and 
tyrosine replacements most of the time; therefore, it is assumed that any 
mutation that replaces W85 into any residue of different characteristic should 
distort the enzyme activity. This could explain the complete inactivity of the 
double mutant clone containing W85G in addition to S155I mutations which are 
obtained here. Furthermore, our mutagenesis data has supported this statement 
from the other side when fully active CATI was obtained after V191I mutation 
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introduced. V191 is a conserved hydrophobic residue having leu and Ile 
replacements which are both hydrophobic as well.  
     Phenylalanine at position 145 in CATIII (F143 in CATI) has been proposed 
to be a key residue in initiating the protein folding (Van der Schueren et al., 
1998). Multiple sequence alignments showed that F143 is found in the majority 
of CATs with only hydrophobic residue replacements including leucine, 
isoleucine and valine. This could explain the absolute inactivity of our single 
mutant clone containing F143S mutation as serine is a hydrophilic residue while 
the hydrophobicity seems to be a required characteristic in this location 
     Sometimes certain groups in an amino acid side chain are required to be 
present in a proper position to serve specific function within the enzyme, for 
example, K136 has Q replacement most of the time. Both K and Q have amine 
group in their R group so this amine group seems the key moiety of the 
conservation. However, K136N cause partial loss of activity as N has amine 
group in its side chain as well but the small size of amino acid N could be the 
reason behind the improper interaction of the NH2 as a result of changing the 
interaction appropriate distance by the overall residue small size. Another 
example is represented by an inactive triple mutant clone that 
hasT154Nmutation. T154 has only E, D and S replacements which all share the 
presence of OH group in their side chains which is probably the key reason for 
its conservation; not surprisingly then T154N is inactive . 
 
4.4.10. C-terminal truncation and mutagenic effect on CATI activity  
     One interesting nonsense (TAG) mutation was recovered in one mutant 
clone, causing a truncation at the C-terminus, from position 216, resulting in 
removal of 4 residues from the CATI carboxylic end. This mutation is 
accompanied by another mutation which is V201I in the same clone. The CAT 
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activity in this clone was full. Truncation and mutagenesis study by Van der 
Schueren et al. (1996) found that even when seven C-terminal residues are 
removed by a deletion or nonsense truncation mutation, CATI is still expressing 
wild solubility and enzyme catalytic activity as long as the C-terminal α5-helix 
is not included in such truncation. In other words all residues that are within the 
random coil following the α5-helix have shown a possibility to be truncated 
leaving CATI with a full activity and solubility similar to the wild type. On the 
other hand, extending the truncation to be eight or more residues from the C-
terminal has shown to be enzyme-inactivating and a cause behind CATI 
aggregation within inclusion bodies due to the loss of solubility. Residues 
within α5-helix have been proposed to be involved in hydrophobic interactions 
crucial to maintain the correct CATI folding so that any mutation that may 
cause truncation or changing the required hydrophobicity of this C-terminal 
helix should devoid the enzyme activity not due to direct interfering with 
catalysis and/or chloramphenicol binding (as residues in such position are not 
parts of the active site) but mainly because of affecting protein folding (Shaw 
and Leslie, 1991). This concept has been tested when the three last residues of 
the C-terminal α5-helix have been truncated and an inactive CAT was obtained 
demonstrating the importance of the full length presence of α5-helix. In addition 
to the complete length of the α5-helix, the amino acid content in this position is 
also required for correct folding. Random mutagenesis has shown the 
importance of some residues at the end of α5-helix in providing the crucial 
interactions with other residues to enable the proper folding of the α5-helix and 
consequently the global functional folding of the whole CATI scaffold(Van der 
Schueren et al., 1996).  
     The hydrophobicity at the end of the α5-helix is necessary for the folding and 
enzyme activity (Van der Schueren et al., 1996). L208 particularly provides this 
characteristic property. Our data showed L208V mutation within a fully active 
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CATI mutant clone of quadruple mutation. The enzyme has not lost the activity 
here due to the replacement of L208 with another hydrophobic residue which is 
valine confirming the importance of the hydrophobicity in this particular 
position. 
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Chapter 5 Dihydrolipoamide dehydrogenase (E3): random mutagenesis 
and functional screening 
Abstract 
     This chapter describes experiments to investigate the relationship between 
the primary structure and enzymatic activity of dihydrolipoamide 
dehydrogenase (E3). This enzyme contributes to the catalytic function of 
several multi enzyme complexes in E. coli. By applying error-prone PCR 
random mutagenesis to the E3 gene (lpd), the impact of mutations on two of 
these complexes (PDH and ODH) is investigated. While the catalytic activity of 
E3 is the same in both PDH and ODH complexes, the interaction between E3 
and the other subunits within both complexes are different. The results suggest 
that the primary structure of E3 is remarkably adaptable and it proved 
challenging to obtain mutations that would impact differently in respect of these 
two multi enzyme complexes.  
 
5.1. Introduction 
     Enzyme complexes are aggregates of several enzymes that are assembled 
together through noncovalent interactions to perform successive steps in an 
enzyme-catalysed reaction. It has been demonstrated that such catalytic 
functions can work better when assembled together, rather than being separated 
into discrete steps. Although there are many instances where Nature utilises 
separate enzymes, more complex organisms seem to favour multi-protein 
assembly over separate steps. Perhaps enzymes in such complexes provide more 
opportunities for regulation such as the simplicity of substrate channelling as 
well as intermediate stability and protection against factors, such as pH and 
temperature (Reed, 1974; Perham, 1975; Hammes, 1980). 
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     Dehydrogenase enzyme complexes that catalyse redox reactions with 2-oxo 
acids (Reed, 1974) are built from three enzymes, E1, E2 and E3; each of which 
presents as multi-copies within a complex catalysing the oxidative 
decarboxylation of 2-oxo acids as illustrated in Figure 5.1. 
     Pyruvate dehydrogenase (PDH), 2-oxoglutarate dehydrogenase (ODH) and 
branched-chain oxo-acid dehydrogenase (BODH) complexes have their own 
specific E1 and E2 components which confer the substrate specificity to a 
complex, while the same E3 commonly participates in all three complexes 
within the same organism except in Pseudomonas putida where three different 
genes of dihydrolipoamide dehydrogenase have been identified; two of them 
were shown to be part of puruvate dehydrogenase and branched-chain 2-oxo 
acid dehydrogenase complexes respectively (Burns et al., 1989). The PDH 
complex is composed of pyruvate decarboxylase (E1p), also known as pyruvate 
dehydrogenase (lipoamide) (EC1.2.4.1); dihydrolipoamide acetyltransferase 
(E2p, EC2.3.1.12) and dihydrolipoamide dehydrogenase (E3, EC 1.8.1.4). ODH 
complex is composed of 2-oxoglutarate decarboxylase (E1o, EC l .2.4.2); 
dihydrolipoamide succnyltransferase (E2o, EC 2.3.1.61) and dihydrolipoamide 
dehydrogenase (E3, EC 1.8.1.4). The oxo-acids of short branched chain 
produced from the transamination of amino acids valine, leucine and isoleucine 
are decarboxilated oxidatively by BODH complex which has analogueous 
structure as those of PDH and ODH complexes (Randle et al., 1987; Reed and 
Yeaman, 1987). A further enzyme reaction is the glycine reductase of E. coli, 
which also makes use of the same E3 polypeptide, but will not be discussed 
further here. 
     During catalysis, all the three enzyme components (E1, E2 and E3) of the 
oxo-acid dehydrogenase complexes utilse a set of coenzymes. In the PDH 
complex, which is the prototype of the 2-oxo acid dehydrogenase complexes, 
pyruvate decarboxylase is thiamine diphosphate (ThDP) dependent where the 
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thiazole ring of thiamine (vitamine B1) acts as the functional ring via its 
nucleophilic carbon atom 2 that attacks the α-carbon of the substrate 
(A) 
 
 
 
(B) 
 
Figure 5.1: (A) Schematic and the net reactions adapted from (Reed, 1974) 
illustrating the oxidative decarboxylation of 2-oxo acids by 2-oxo acid 
dehydrogenase complexes. ThDP, thiamine diphosphate; Lip, lipoic acid. (B) 
The role of PDH and ODH complexes in metabolism.   
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pyruvate to form a 2-α-lactyl derivative that is decarboxylated into acetaldehyde 
and leaves the E1-ThDP. Dihydrolipoamide acetyltransferase (E2) operates in 
conjunction with lipoic acid, a saturated fatty acid with a tail of 8 carbon atoms: 
the eighth and sixth carbon atoms are joined together by a disulfide bond 
forming a five membered ring. Lipoic acid is tightly linked to E2 by a peptide 
bond formed between its carboxyl group and the amine group of a lysine from 
E2. The –S-S- bond of the E2-lipoyl is reduced by E1 when the acetaldehyde is 
transferred from ThDP to one of the sulphur atoms of the lipoic acid causing the 
latter to lose the ring structure and present with two thiol groups at the end of 
the lipoic acid tail. E2 catalyses the transfer of hydrogen atoms from 
acetaldehyde to the disulfide bond of the lipoyl moiety; as a result the 
acetaldehyde is oxidized to acetyl and the lipoic acid is reduced to its dithiol 
form. The acetyl group is then linked by E2 to the thiol group of coenzyme A so 
acetyl-coenzyme A, which is the key component linking glycolysis to 
tricarboxylic acid cycle, is formed and leaves the enzyme complex to react with 
oxaloacetate to form citrate within the tricarboxylic acid cycle (Krebs cycle). 
The lipoyl moiety of E2 moves freely as a swinging arm in the complex 
transferring the substrate between the successive active sites of the complex 
components (Reed, 1974; Ambrose and Perham, 1976; Grande et al., 1976). 
The E2-lipoic acid which is left in its dithiol form is inactive unless reoxidized 
back to its disulfide bonded form. Lipoic acid oxidation is catalysed by the 
dihydrolipoamide dehydrogenase (E3) which works via FAD as a tightly bound 
hydrogen acceptor coenzyme abstracting the hydrogen atoms from the two thiol 
groups of lipoic acid to form FADH2in order that the –S-S- bond cyclic form of 
the lipoic acid is recovered. FADH2 is then re-oxidized by NAD
+ to recover the 
oxidative FAD again, and NADH is formed. The catalytic mechanisms of the 
other 2-oxo-acid dehydrogenase complexes is comparable with the mentioned 
above PDH mechanism (Lehninger, 1975; Perham, 1991, 2000; Patel et al., 
2014). 
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     2-oxo acid dehydrogenase complexes are 30-40 nm particles as seen by 
electron microscopy: as such they are larger than a ribosome particle (Reed, 
1974; Henderson et al., 1979; Oliver and Reed, 1982). The E2 component forms 
a central core to which E1 and E3 components are bound strongly by non-
covalent interactions. The E2 cores of ODH, branched-chain 2-oxo acid and 
gram negative bacterial PDH complexes are all composed of 24 copies of E2 
that are arranged in an octahedral symmetry, while in PDH of eukaryotes and 
gram positive bacteria, 60 chains of E2 are arranged in an icosahedral symmetry 
(Reed, 1974; Danson et al., 1979; Oliver and Reed, 1982).  
     In E. coli PDH, 24 molecule of the E1 dimers are arranged on the 12 edges 
of the octahedral core and 12 copies of the E3 dimers are arranged on the 6 
faces of the E2 core so that the E1:E2:E3 molecules ratio is 24:24:12 reflecting 
an active site ratio of 1.0:1.0:0.5, while the active site ratio in ODH is 
0.5:1.0:0.5  (Reed, 1974; Oliver and Reed, 1982; Yang et al., 1985). The 
component ratios of different complexes from other sources of organisms were 
referred to in (Perham, 1991).  
     The specific feature of such enzyme complexes is that E2 subunits are 
arranged as a cube or dodecahedron with E1 and E3 attached to it non-
covalently as peripheral proteins. The whole complex particle is up to 10 KDa 
(Reed, 1974). In eukaryotes, additional protein components may be added to the 
2-oxo acid dehydrogenase core complexes such as kinases, phosphatases and 
dihydrolipoamide dehydrogenase-binding proteins which all participate in 
metabolic regulation (Roche et al., 1989). 
5.2. Dihydrolipoamide dehydrogenase random mutagenesis 
     The aim of the work in this chapter is to apply PCR random mutagenesis 
using an error-prone pho polymerase to the lpd gene of E. coli E3, to generate 
libraries of mutations. By combining this with functional screening of pyruvate 
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dehydrogenase (PDH) and 2-oxoglutarate dehydrogenase (ODH) complexes, 
the aim is to dissect out any differences in E3 in these two related, but distinct 
complexes. 
5.2.1. Lpd gene synthesis 
     The sequence features of E. coli K12 lpd gene studied by Stephens et al. 
(1983b) have been taken into consideration when the gene was synthesised. The 
nucleotide sequence has been taken from the Escherichia coli strain K12 sub 
strain W3110 DNA complete genome (NCBI reference sequence: 
NC_007779.1, ORF sequence from base 127912 to 129336). Wild type lpd gene 
sequence is recognisable by two ATG start codons which are preceded by a 
strong promoter region within the upstream 230 bp. The first ATG is too close 
to the ribosomal binding site to be the initiation codon, furthermore, the rules of 
Stormo et al. (1982) do not agree with it to initiate the translation, therefore, the 
second ATG has been considered the actual start codon leading to the 
translation of lpd ORF into 474 amino acid residue. As first ATG is not 
considered the start codon, it has been omitted as a result of NcoI restriction site 
introduction at the beginning of the ORF leaving the second functional ATG 
intact (Figure 5.2).The ORF upstream sequence that includes the putative 
promoter region with the RNA polymerase binding site, and the -35 and-10 
pribnow regions as well as the ribosomal binding site are all included in the 
synthetic sequence within the upstream 231bp. Many restriction sites (each site 
is unique in the final construct) have been introduced silently within the ORF as 
well as flanking the ORF to facilitate downstream processing of the error-prone 
PCR products (Figure 5.2). The synthetic sequence has been further optimized 
for E. coli K12 expression using the optimization option provided by gene 
synthesis company. The synthesized sequence has been cloned into pMA-RQ 
plasmid which has ampicillin resistance. The final plasmid construct of pMA-
RQ+lpd gene has been named pLpd1 (Figure 5.3).  
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Figure 5.2: Interleaved view of the whole synthetic sequence showing the 
primary structure of the dihydrolipoamide dehydrogenase (474 amino acid). The 
ORF is cyan-shaded. The in-frame and out-frame restriction sites are shaded 
and underlined by red dashed lines. (AAGCTT=HindIII, CCATGG=NcoI, 
CTTAAG=AfIII, ACTAGT=SpeI, 
CAATTG=MfeI,CGGCCG=EagI,TCTAGA=XbaI, GGATCC=BamHI). Each 
restriction enzyme has only one cutting site in the final pLpd1 construct. 
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Figure 5.3: pLpd1 plasmid construct map as provided from the gene synthesis 
company showing lpd gene of the dihydrolipoamide dehydrogenase (E3) and 
ampicillin resistance gene (AmpR). The origin of replication in this plasmid is 
Col E1. Several restriction sites are indicated with their base pair cutting 
positions in brackets. 
 
5.2.2. E3-knockout E. coli strain and lpd gene complementation 
     The activity of E3, its gene is carried on the pLpd1 plasmid, has been tested 
by transforming the E3 null E. coli K12 W3110 strain (JRG3503, lpdA : : kanR)  
(kindly provided by Professor Jeff Green)  in which, 661 bp segment of lpd 
gene has been replaced by a kanamycin resistance gene so that it is not able to 
grow on a glucose minimal media without a dual supplementation of acetate and 
succinate to compensate both PDH and ODH impaired functions as a result of 
E3 deficiency (John et al., 2003). Acetate is a precursor of acetyl-coenzyme A, 
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therefore, it is used to overcome the disappearance of PDH function that is 
responsible for providing acetyl-coenzyme A from pyruvate oxidation. 
Succinate is supplemented to support the JRG3503 strain growth in glucose 
minimal media as a replacement for the succinate produced naturally from the 
2-oxoglutarate oxidation carried out by ODH in the wild-type W3110 strain 
within the citric acid cycle.  
     JRG3503 strain has been shown to have no growth response at all in the non-
supplemented and acetate-supplemented M9 glucose minimal media, on the 
other hand, succinate-supplemented M9 showed extremely slow growth 
turbidity while the growth was significantly visible when both acetate and 
succinate are added to M9. These growth results have been recorded after 48 
hours incubation at 37°C and they are consistent with (John et al., 2003). In LB, 
JRG3503 grows normally, but not similar to the wild type, even when no 
acetate and/or succinate is provided because E. coli in LB uses amino acid in its 
catabolism as a carbon source rather than sugars (Sezonov et al., 2007). 
     The lyophilized 5µg pLpd1 plasmid construct, which was provided by the 
gene synthesis company, was rehydrated using 50 µl of ddH2O then 1 µl from 
the plasmid solution was used to transform electrocompetent JRG3503 by  
electroporation as the chemical method of (Hanahan, 1983) did not work with it. 
After transformation, the bacteria have been plated out on kanamycin+ 
ampicillin-containing M9 glucose minimal medium plate without any 
supplementation of acetate and/or succinate and incubated for 48 hours at 37°C. 
The results showed many CFUs representing a successful transformation and E3 
complementation by the multicopy pLpd1 plasmid. However, the 
complementation of the missing wild type chromosomal lpd gene by a 
multicopy plasmid carrying lpd gene has been previously shown to be possible 
by (John et al., 2003). 
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     A single colony from the M9 glucose minimal plate was sub-cultured in 5 ml 
LB then plasmid prepared prior to sequencing, to check the integrity of the 
plasmid after transformation, as recommended by the gene synthesis company. 
Three primers were used for sequencing to cover the complete lpd gene. The 
sequence after transformation was identical to the sequence received from the 
company. 
5.2.3. Lpd random mutagenesis and cloning 
     Three sets of mutagenesis experiments were performed using three sets of 
primers to include three parts of lpd gene in random mutagenesis. The first set 
of mutagenesis covers the region from NcoI to AflII (Figure 5.3). The range of 
mutagenesis was extended to involve a more extensive section of the gene in the 
second set by using the same forward primer of the first set but with different 
reverse primer to cover the part between NcoI and EagI sites. The third 
mutagenesis experiment was targeted between restriction sites AflII and XbaI. 
Thus, the whole length of the lpd gene was included by these three sets of 
random mutagenesis experiments. 
     In each set of mutagenesis experiments, the forward primer was designed to 
initiate synthesis about 80bp upstream the 5ʹ restriction site while the reverse 
primer position is situated nearly 80bp downstream of the 3ʹ restriction site so 
that the error-prone PCR amplicon is produced with restriction sites at both 5ʹ 
and 3ʹ ends. This facilitated trimming of the PCR product to produce sticky ends 
for efficient ligation back into pLpd1 that is in turn double digested by the same 
restriction enzymes. Therefore, the protocol is to double digest both of the error-
prone PCR amplicon and pLpd1 by the same restriction enzymes, then separate 
the bands by agarose gel electrophoresis (Figure 5.4) to recover the bands of 
interest (the mutation-containing insert and the vector) and ligate them together 
then transform JRG3503 (Figure 5.5). 
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Figure 5.4: Agarose gel showing the DNA fragments related to the E3 error-
prone PCR and cloning. : (1) and (2), uncut pLpd1; (3) and (4), error-prone 
PCR products; (5), hyperladder I; (6), pLpd1 cut with AflII; (7), pLpd1 cut with 
XbaI; (8) and (9), pLpd1 cut with AflII and XbaI; (10), hyperladder I; (11), 
error-prone PCR product cut with AflII and XbaI.     
 
5.2.4. PDH and ODH activity test 
     As mentioned previously, JRG3503 is able to grow normally on LB without 
any additional nutritional supplements, therefore, LB plates with 100 µg/ml 
ampicillin and 25µg/ml kanamycin were used to plate out the transformed 
JRG3503 just after electroporation so that all the clones of active and inactive of 
both or either PDH and ODH enzyme complexes were recovered (Figure 5.5). 
However, testing the PDH and ODH activity was by sub-culturing each clone in 
5ml LB overnight then precipitating the cells by centrifugation at 4500 rpm 
removing the LB then washing the cells three times with M9 glucose minimal 
media to remove of the LB traces completely. The activity of each clone then 
investigated by plating the washed bacterial cells on three M9 glucose plates all 
with 100 µg/ml ampicillin and 25µg/ml kanamycin. The first plate is only M9 
glucose, the second is M9 glucose+acetate and the third is M9 
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glucose+succinate. The incubation was done at 37°C for 48 hours. The possible 
complexes inactivation and activity phenotypes are illustrated in table 5.1. The 
clones of active PDH and ODH grow normally on the first plate that has no 
additions with normal growth on both M9 glucose+acetate and M9 
glucose+succinate plates because such clone are able to use the glucose as a 
carbon source. Clones of inactive PDH and ODH give no growth at all on all 
three plates but they grow only when both acetate and succinate are supplied to 
the M9 glucose medium. Clones of inactive ODH and active PDH are not able 
to grow on both M9 glucose and M9 glucose+acetate plates but they show 
visible normal growth on M9 glucose+succinate. Finally, clones of inactive 
PDH and active ODH would not grow on M9 glucose and M9 
glucose+succinate but grow on M9 glucose+acetate (Figure 5.6). 
 
Table 5.1: Illustration of the probable activity patterns regarding PDH and ODH 
with the growth behaviour on different minimal media replicates in addition to 
LB: 
Possible 
activity 
pattern 
Growth phenotype on M9 glucose media ofdifferent supplementations in 
addition to LB 
M9 
glucose 
only 
M9 
glucose+acetate 
M9 
glucose+succinate 
M9 
glucose+acetate+succinate 
LB 
Active PDH 
Active ODH 
+ + + + + 
Inactive PDH 
Inactive ODH 
- - - + + 
Active PDH 
Inactive ODH 
- - + + + 
Inactive PDH 
Active ODH 
- + - + + 
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Figure 5.5: LB plate containing ampicillin and kanamycin showing the CFUs of 
the mutant clones after the error-prone PCR, ligation and JRG3503 
electroporation transformation.  
 
5.2.5. DNA sequencing 
     After the PDH and ODH activity test, DNA plasmid minipreps were 
prepared from randomly chosen clones obtained from each set of error-prone 
PCR mutagenesis and cloning then sent for sequencing to determine the 
nucleotide changes in lpd gene and the consequent amino acid change in the 
dihydrolipoamide dehydrogenase. The total clones that were screened (activity 
test and sequenced) numbered 248. The sequencing data showed that 49 clones 
(19.75%) showed no change in nucleotide sequence at all; most of them occur 
in the first set of the mutagenesis experiments as this set involves the shortest 
length of the DNA among the three sets. In view of the full activity of both 
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PDH and ODH clones obtained after this set of mutagenesis experiments it 
seemed sensible to extend the mutagenesis target length, to increase the 
probability of capturing mutations.  However, the sequencing of the clones from 
the second and third mutagenesis sets of the DNA-extended mutagenesis range 
showed a significantly reduced number of clones that show no nucleotide 
change in addition to few clones showing enzyme inactivation.  
     The clones of unclear sequences (19 clones=7.66%), such as those with 
overlapped sequencing chromatogram peaks and Ns containing sequences, have 
been ignored. The deletion and insertion occurred with 11 (4.43%) and 1(0.4%) 
clone respectively. The point mutations that are of amino acid changes are 
represented by 152 clones; 3 of them appeared to have the same mutational 
pattern of other 3 clone. Amino acid changes of the clones of point, deletions 
and insertions mutations with their activity data are all illustrated in Appendix 
3. 
     Comparisons between the sequences of DNA and amino acids for the clones 
of amino acid-changing point mutations showed that the number of amino acid 
changes are not necessarily the same number of nucleotide changes; for 
example, a clone of single amino acid change does not necessarily have a single 
nucleotide change that caused the single amino acid replacement but it could 
have two, three or even four nucleotide changes and only one of these point 
mutations is sense causing the amino acid change while the other(s) is/are silent. 
The statistics of the mutagenesis silencing are illustrated in table 5.2. 
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Table 5.2: Correlation between the nucleotide changes and amino acid changes 
showing the mutagenesis silencing:  
Amino acid change 
Per clone 
Clones 
obtained 
Nucleotide base change 
1 2 3 4 5 6 7 8 
0 16 14 2 0 0 0 0 0 0 
1 52 36 11 3 2 0 0 0 0 
2 50 - 31 16 3 0 0 0 0 
3 27 - - 18 6 2 1 0 0 
4 13 - - - 8 2 2 1 0 
5 4 - - - - 1 3 0 0 
6 3 - - - - - 1 1 1 
Total 165 50 44 37 19 5 7 2 1 
 
     The clones of point mutations have been statistically analysed and grouped 
according to the numbers of both amino acids and nucleotides changes to figure 
out the rate of mutagenesis silencing. When grouped according to the amino 
acid changes, the results showed that all the groups of mutant clones have 
significant incidence of silent mutations when no match is seen between the 
number of amino acids changes and the number of nucleotide changes. For 
instance, 16 clones appeared with no amino acid change at all but they do show 
nucleotide changes in their DNA sequences represented by 14 and 2 clone of 
single and double nucleotide changes respectively.  
     Most of the point mutations clones were of single and double amino acid 
change constituting 52 and 50 clones respectively. 36 of the single amino acid 
change mutant clones appeared with single nucleotide change while the 11, 3 
and 2 clones of them showed double, triple and quadruple nucleotide changes 
respectively. The rate of mutational silencing in the double amino acid change 
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clones is slightly higher than the rate of single amino acid change clones 
especially when 31 of them were noticed with double nucleotide change while 
19 of them are divided as 16 of triple and 3 of quadruple nucleotide changes. 
     18 out of 27 of the triple amino acid change mutant clones have the same 
number of nucleotide mutations which is three while the nucleotide changes 
exceeded the amino acid changes by one, two and three nucleotides in 6, 2 and 
1 clones. The number of nucleotide changes in most of the quadruple amino 
acid change clones (8 out of 13) match the number of sense mutations while 1, 2 
and 3 silent mutations appeared in 2, 2 and 1 clones respectively. The minority 
of the mutant clones are those which contain five and six amino acids changes 
which are represented by 4 and 3 clones respectively with only one clone in 
each group that match in its amino acid changes the number of nucleotide 
changes while the rest of the clones in both two groups appeared excessive 
changes in nucleotides to be more than the amino acid changes.  
 
5.2.6. Mutation position and activity 
     The present mutagenesis work is intended to test the activity of 
dihydrolipoamide dehydrogenase (E3) indirectly by testing the activity of two 
enzyme complexes in E. coli: PDH and ODH in which E3 is a main component. 
The activity test showed that the vast majority of the mutant clones retained 
active PDH and ODH by their ability to grow on minimal glucose M9 medium 
without nutritional supplements of acetate and succinate. On the other hand, 
only 7 clones appeared with different activity phenotype; in all of them, ODH 
activity appeared to be affected. Six clones were found with ODH-affected 
activity beside a fully active PDH while only one clone showed affected activity 
of both PDH and ODH (Figure 5.6). All clones of affected ODH and PDH 
showed partial activity of both complexes except one clone that appeared with 
168 
 
completely inactive ODH beside a completely active PDH (See Appendix 3). 
The interaction between E3 and the other complexes components must be 
looked at in term of PDH and ODH activity rationalisation after E3 
mutagenesis.   
 
 
Figure 5.6: Activity test of PDH and ODH complexes after E3 mutagenesis. 
(A): Mutant clone 31 that has completely inactive ODH beside active PDH 
showing no growth at all on M9 glucose and M9 glucose+acetate while on M9 
glucose+succinate, it shows normal growth. (B): Mutant clone 69 that has very 
weak ODH complex beside active PDH showing very weak growth on M9 
glucose and M9 glucose+acetate while normal strong growth on M9 
glucose+succinate. ‘’C’’ are controls which are clones expressing two active 
complexes of PDH and ODH showing normal growth on M9 glucose alone as 
well as on the other M9 variants of acetate or succinate supplements.   
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5.2.7. E3 interaction within PDH 
     In eukaryotic and prokaryotic PDH complexes, E2 is composed of a multi-
domain structure of three domains linked to each other by an alanine and 
proline rich inter-domain hinge regions which are 20-30 amino acid long as 
follows: (1) lipoyl domains, to which, lipoic acid is bound. In E. coli, E2 
contains three lipoyl domains which are ~80 amino acids each, while in human, 
there are two domains with the same amino acids length of those in E. coli. (2) 
The C-terminal catalytic domain, which is about 250 amino acid in size, 
represents the internal cubic core of the E2, in which, acetyl co A is formed. (3) 
Peripheral subunit-binding domain (PSBD) which is ~45 amino acids in length 
and represents the part of E2, to which, E3 and E1 is bound in E. coli. However, 
in human, E2 binds E1 and E3 differently by a specific E1-binding domain and 
E3-binding protein respectively (Bleile et al., 1979; Stephens et al., 1983a; 
Patel et al., 2014). 
     In E. coli and most prokaryotic PDH complexes, there are 24 copies of E2 
assembled together by interactions between their catalytic domains to form the 
central core of the complex which contains the PSBD where both muticopies of 
E1 (12 dimers) and E3 (6 dimers) are bound non-covalently via the PSBD to 
form an octahedral symmetrical PDH complex with a molecular mass of 4.5 
MDa. Therefore, the E3 only interacts with E2 and there is no direct interactions 
between E1 and E3 (Reed and Hackert, 1990; Perham, 2000). 
     Mutagenesis studies demonstrated that the interactions of both E1 and E3 
with the E2 core is electrostatically controlled by the charges of certain residues 
in E2 PSBD so the mutational inverse charge such as changing Arg-129 and 
Arg-150 into Glu strongly affects the interaction of E3 and E1 with the PSBD of 
E2 and therefore preventing the functional assembly of PDH complex in E. coli. 
However, E1and E3 interact with E2 by non-identical but overlapping positions 
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especially when some mutations, such as R129A, in E2 PSBD only prevent E3-
E2 interaction with no effect on E1-E2 interaction while other E2 PSBD 
mutations like R150A and R150K only affect E1-E2 interaction without 
affecting E3-E2 interaction. This suggests different modes of interaction for E1 
and E3 with E2 (Park et al., 2004; Chandrasekhar et al., 2013).   
     E3 is homodimer (50554 Da) of two identical subunits with two active sites 
located in the interface cleft between the two subunits. Each subunit is 
composed of four domains; FAD-binding domain (residue 1-149), NAD+-
binding domain (residue 150-282), the central domain (residue 283-350) and the 
interface domain (residue 351-474) (Figure 5.7). Each molecule of E3 tightly 
holds two molecules of FAD which are involved in the electrons transfer from 
the two thiol groups of the E2 dihydrolipoamide. 
     One of the E2 interaction peptides which is located in the α-helix H1 is 
involved in the E3 interactions in all 2-oxoacids enzyme complexes of resolved 
structures except the 2-oxoglutarate dehydrogenase complex (Nakai et al., 
2008), the Arg-333 within this peptide of 3-lip E2 (corresponds to Arg-129 in 1-
lip E2) is highly conserved within the all recognised peripheral subunit binding 
domains of E2 and considered as the hot spot key residue of interaction with E3 
(Mande et al., 1996). In the whole PDH complex, E1 is also bound to the E2 
PSBD with no competition between E3 and E1 on binding as they have 
different but, at the same time, overlapping binding loci on the E2 PSBD (Song 
and Jordan, 2012).  
     The available crystal structure of E3 helped the study and identification of 
the interaction loci between E3 and E2 in E. coli PDH by applying hydrogen/ 
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Figure 5.7: E3 homodimeric functional structure from E. coli showing the four 
domains. FAD-binding domain (red), NAD+-binding domain (yellow), the 
central domain (blue) and the interface domain (cyan). FAD molecules are 
shown as pale yellow spheres. Developed from (Chandrasekhar et al., 2013), 
PDB code is 4JDR. 
 
deuterium peptide specific exchange mass spectroscopy which showed that 
there are significant deuterium uptakes by two peptides from E2 and three 
peptides from E3 when E2 and E3 are bound in a sub-complex proving the 
involvement of these peptides in the E2 and E3 interaction. The two peptide of 
E2 are both situated within the PSBD and represented by residues 325-338 in 
the wild 3-lip E2 (325YVHATPLIRRLARE338) which corresponds to residues 
121-134 in 1-lip E2, and residues 363-393 of the 3-lip E2 
(363YVKEAIKRAEAAPAATGGGIPGMLPWPKVDF393) which represent 
residues 159-189 of the 1-lip E2. The three interaction peptides of E3 are two 
peptides from the FAD-binding domain 
(33VIVERYNTLGGVCLNVGCIPSKALL57 and 
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89WKEKVINQLTGGLAGMAKGRKVKVVNGLGKFTGANTL125) and one 
from the interface domain (458VFEGSITDLPNPKAKKK474). (Chandrasekhar et 
al., 2013). 
     To understand the allosteric basis of E3 and PSBD interactions within PDH 
complex, a structural model of E3-PSBD in E. coli has been postulated based on 
the available structure of the complexed E3-PSBD of Thermus thermophilus 
(PDB code 2EQ8) (Nakai et al., 2008). According to this proposed model, the 
PSBD positively charged basic Arg-129 forms electrostatic interactions via its 
positively charged guanidinium nitrogen with the negatively charged oxygen 
atoms of carboxyl or carbonyl of E3 Asp-343 and Glu-430, therefore, the E2 
variant that has R129E mutation shows no binding to E3 because of the charge 
repulsion between the same charge residues of E2 and E3. The same scenario 
occurs with the E2 mutant that contains R150E mutation as Arg-150 is in 
electrostatic interaction with the nucleophilic carbonyl oxygen of the E3 Met-
431 backbone. Beside the electrostatic interactions, the main chain carbonyl 
oxygen and the guanidinium nitrogen of PSBD Arg-129 are involved in 
hydrogen bonding with hydroxyl group of E3 Tyr-341 and the carboxylate 
oxygen of E3 Asp-343 respectively. Such hydrogen bonds are important in 
strengthen the electrostatic interactions (Chandrasekhar et al., 2013).  
     In the present random mutagenesis work, an active E3 mutant variant 
containing M431V mutation beside I218N was obtained. In spite of the role of 
Met-431 in the interaction with the E2 Arg-150, it seems that M431V E3 variant 
is still able to bind PSBD the same as the wild type because the wild type 
methionine in this position is participating in interaction with E2 by its main 
chain as mentioned above so there is no particular specific R-group required in 
such interaction, furthermore, valine has the same hydrophobic properties as 
methionine, therefore, M431V E3 mutant maintains the wild type binding and 
consequently PDH complex activity.       
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     The present activity data showed that PDH complex is extremely resistant 
toward the E3 mutagenesis so only one mutant clone shows partially active 
PDH beside partially active ODH (See Appendix 3). This demonstrates that the 
E3 binding with E2 in PDH complex is challenging to be affected by E3 random 
mutagenesis. This could be because the presence of many residues which are 
outspread throughout an expanded E3 regions within three peptides as 
mentioned above which makes it hard to affect such binding by few point 
mutations within those three peptides as E3 will still has many other interacting 
residues to be bound to E2 and form a sub-complex within PDH and does not 
face any interaction distortion with the E2 PSBD. The only one mutant clone 
that shows a partially affected PDH has R273H, V357I, K365Q, G426D 
mutations which are all out of the ranges of E2-interacting residues. This clone 
shows a partially affected ODH activity as well which means that residues at 
these points are of NAD binding (R273) and catalysis (V357, K365, G426). 
 
5.2.8. E3 interaction within ODH complex 
     The structural arrangement of 2-oxoglutarate dehydrogenase complex 
(ODH) is comparable to that of PDH complex where 24 copies of 
dihydrolipoamide succinyltransferase (E2 of the ODH which is distinguished as 
E2o from the E2p of PDH) form an octahedral core, to which, both 2-
oxoglutarate decarboxylase (E1o) and dihydrolipoamide dehydrogenase (E3) 
bind (Reed, 1974). Proteolysis experiments on E. coli ODH have revealed that 
E2o has a multi-domain structure represented by the large domain or the C-
terminal domain (~300 residue) where E1o binds and the succinyl transfer 
occurs , the N-terminal domain (~80 residue) which contains a single lipoate 
arm linked to a lysine residue, and the middle domain (~50 folded residues) 
which is between N and C terminal domains where E3 binds (Packman and 
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Perham, 1986). The latter domain is flanked by interdomain segments which are 
usually rich in alanine and proline as well as some residues of charged side 
chains. Such linkers are believed to be important in domains separation as well 
as providing flexibility for domains movement when required during the 
enzyme catalysis (Radford et al., 1989; Perham, 1991). 
     The binding of E2o and E3 is studied but less extensively than the cognate 
binding of E2p and E3 in PDH. According to nuclear magnetic resonance 
spectroscopy data, the three-dimensional solution structure obtained by (Robien 
et al., 1992) clarified the E3-binding positions in the dihydrolipoamide 
succinyltransferase (E2o) to be only within the region between residue 115-149 
which are folded as two parallel helices, an irregular loop structure, two short 
strands, and a helix-like turn. The 115-149 peptide chain has been reproduced as 
a synthetic peptide in term of NMR and binding study. Compared with E2p 
which has two E3-binding peptides as mentioned above, E2o has only one 
peptide to bind E3 and this suggests that the binding of E2o-E3 sub-complex is 
likely to be weaker than the binding of E2p-E3 sub-complex. The E3 parts that 
are involved in binding with E2o have not been determined by any structural or 
spectroscopy study yet.  
     The current random mutagenesis study has revealed many clones of affected 
ODH complex only rather than PDH (See Appendix 3) suggesting that E3 could 
interact differently with E2p and E2o respectively otherwise, both PDH and 
ODH would have been affected if E3 interacts with E2o by the same E3 three 
peptides involved in E2p interaction. Evidently, two interesting mutant clones 
that express completely inactive and very weak ODH beside completely active 
PDH have mutations (Q300H, I409N, G423S, A471V) and (R302H, G328S, 
P380L, T397I) respectively. All the latter mutations are out of the range of the 
E3 three peptides which are involved in the E2p interaction suggesting the 
importance of all or some E3 residues among Q300, I409, G423, R302, G328, 
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P380, T397 and A471 in the specific sub-complex formation with ODH only 
rather than PDH.    
5.2.9. E3 structural annotations and random mutagenesis impact 
     In additions to the sequence variations among the E3 from different sources 
which are considered as moderate variations (28-47%), the comparison of the 
tertiary structures of E3 from E. coli with many other E3 of resolved structures 
showed similar conformational properties and folding, however, the differences 
that have been reported to date (including deletions, insertions or small 
differences in folding) are only within the regions 36-42, 126-136, and 251-264 
of E. coli E3. The regions mentioned do not participate in FAD or NAD 
cofactors binding with few exceptions that showed some of those regions to be 
participating in few interactions but, in general, they are constituting parts of 
surface loops that could be crucial in maintaining the surface interactions of E3 
with the other components of 2-oxoacid complexes in their related organisms 
(Chandrasekhar et al., 2013).  
     The crystal structure of E. coli E3 has shown that there are three proline 
residues (Pro-318, Pro-355, and Pro-446) arranged in a suitable positions to 
form peptide bonds of cis conformation. The multiple sequence alignments 
(MSA) shows that Pro-318 is not conserved and it is not always found in cis-
conformation in the other known structures of E3, but only within E3 from E. 
coli, Neisseria meningitides, and Thermus thermophilus. Such cis-conformation 
is responsible for the proper orientation so that the Gln-317 forms a hydrogen 
bond between its OE1 atom and the main chain nitrogen atom of the Met-319. 
Prolines at the same positions from other E3 enzymes, such as Pseudomonas 
putida E3(Pro-310), is in trans-conformation so the OE1 and OE2 of preceding 
Glu-309 is not involved in any hydrogen bonding because such hydrogen 
bonding is only maintained when cis-conformation is there.  
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     The present random mutagenesis has reached Pro-318 in two mutant clones 
of active E3; one of them has the mutation P318A in addition to three other 
mutations (K61R, L232P, K299Q), the other is a double mutant clone which 
appeared P318S and I425V mutations. Such mutational changes in Pro-318 
abolish the cis-conformation and the hydrogen bonding built on it which seems 
not that important for the enzyme activity especially when both PDH and ODH 
remain active in both of these mutant clones. 
      Proline at position 355 is located in the tight β-turn of anti-parallel β-sheet 
of the interface domain. This residue is highly conserved and of peptide 
bonding of the cis-conformation which is featuring a specific hydrogen bonding 
between the oxygen of Thr-353 carbonyl and the nitro of the Glu-356 amide 
(Chandrasekhar et al., 2013). The current random mutagenesis has not hit the 
Pro-355 but does hit both Thr-353 and Glu-356 in three clones; two of them, 
which are of three and five mutations, included changing Thr-353 into Ala and 
Ile respectively, and the third clone is of single mutation of changing Glu-356 to 
Asp. All these three mutant clones express fully active E3. Although Thr-353 
seems to be conserved in more than 70% of the aligned E3 enzymes, T353A 
mutation seems to be tolerant mutation. However, when looking at MSA of 
some E3 variants, Ala is seen to replace Thr at 353 position many times, while 
Ile is not seen as a replacement at this particular position. Although the MSA 
does not show Asp replacement to the Glu-356, the full activity of mutant clone 
of E356D single mutation could be because the replacement is just between two 
amino acids of the same acidic properties and only one hydrocarbon unit is the 
difference between their side chains. As mentioned above, the hydrogen 
bonding between Thr-353 and Glu-356 occur between their backbone moieties 
and does not include any of their side chains, therefore, changing these residues 
(side chain change) should not affect the hydrogen bonding as long as the newly 
introduced side chains do not affect the proper conformation for the backbones 
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interactions. Such hydrogen bonding is not present in E3 of Pisum sativum 
(Faure et al., 2000) and Bacillus stearothermophilus (Mande et al., 1996) as 
their resolved crystal structures show no cis-conformation at proline 
corresponding to Pro-355 of E. coli E3 (Chandrasekhar et al., 2013). Such 
hydrogen bonding absence in these enzymes could explain the enzyme tolerance 
when this interaction is abolished by mutation(s). 
     The proper catalytic orientation of active site residue His-445 is maintained 
by hydrogen bonds between the latter ND1 atom and OE1 and OE2 atoms of the 
Glu-450 as well as between His-445 carbonyl oxygen and the N3 atom of the 
Pro-446 aromatic ring (Chandrasekhar et al., 2013). The MSA shows that both 
Glu-450 and Pro-446 are highly conserved due to their important role 
mentioned above, however, neither His-445 nor Glu-450 and Pro-446 have been 
hit by the present random mutagenesis work. This could explain the results of 
E3 full activity, which has been obtained most of the time, as the gene 
mutagenesis randomisation has been away from such sensitive points of the 
enzyme. 
     Finally, the role of primary structure in the formation of secondary structure 
elements in each E3 monomer are shown in Figure 5.8. In this figure, all of the 
mutagenesis and functional screening data are mapped to evaluate the role of 
the mutagenesis-targeted residues in protein secondary structure. Furthermore, 
to evaluate the importance of residues to the enzyme function, positions of 
mutations in E3 mutant clones of affected enzyme complexes activity were 
mapped directly into the E3 three dimensional structure (Figure 5.9). 
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Figure 5.8: Combination of E3 primary and secondary structures showing the 
secondary structure elements and their relevant amino acid residues. β-strands 
are shown in yellow arrows, α-helices are the red zigzags, loops are represented 
by green arcs, and the black lines are the regions of undefined secondary 
structure. PDB code 4JDR. 
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Figure 5.9: Dihydrolipoamide dehydrogenase three dimensional views 
highlighting (in magenta) positions of mutations within E3 mutant clones that 
affect the ODH and/or PDH activity. The ID of each mutant clone is written on 
each image. The highlighted residues are distributed equally within the two 
monomers of E3, but here, they are shown only within a single monomer for 
simplicity. Details of the residue changes and activity profiles are all included in 
the appendices. The four domains are distinguished by different colours: FAD-
binding domain in red, NAD+-binding domain in yellow, the central domain in 
blue and the interface domain in cyan. Developed from the 3D structure which 
was resolved by Chandrasekhar et al. (2013), PDB code 4JDR.  
 
5.2.10. E3-FAD interactions and mutagenesis impact 
     As a homodimer, E3 molecule binds two FAD molecules which are shown 
with an elongated conformation with about 31.2 angstrom between the nearest 
points of them. The E3 FAD-binding hot spots are distributed between β-strand 
and α-helix of the FAD-binding domain. The latter secondary structures are 
joined by a characteristic sequences of small residues (GAGPAG corresponding 
to residue number 13-18) which are highly conserved probably because the 
flexibility of such hinge region is required for the FAD binding. The sequencing 
data showed no mutation within this hinge region. The residues that have been 
5thlpd93 9.8.15 
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found in appropriate distances for direct interactions with FAD are Gly-117, 
Arg-37, Glu-36, Val-44, Ala-17, Asp-313, Cys-45, Met-319, Leu-320, Ala-321, 
His-445, His-322, and  Lys-54; six of them have been reached by the current 
random mutagenesis in 7 mutant clones of the following mutational patterns: 
R37C; R37C, G73G; E36G; V44I, A55G; K228T, Q317H, A321S, M396T; 
Q300L, H322Q; and M206R, R225H, A266V, V289I, H322Y. All these clones 
showed full E3 activity as each of which involves only a single mutation in one 
of the FAD-binding residue and this is most likely tolerated by the enzyme 
which is still able to bind FAD as the latter interacts with 13 residues in a 
manner where disrupting such interactions needs a major mutational change that 
causes alterations in the residue and their interacting atoms distances from the 
FAD ligand. 
5.2.11. Subunits interaction and mutagenesis impact 
     E3 is only functional as a dimer so any mutation(s) that abolish the 
dimerization must be inhibitor for the enzyme activity, therefore, the quaternary 
structure is maintained by interactions between several residues from both 
subunits. Refer to (Chandrasekhar et al., 2013) to find the list of these residue 
and their moieties which are involved in the two subunits interactions. The 
current random mutagenesis has alighted on some of these residue in 16 mutant 
clones (Table 5.3). Each clone has a single mutation in a residue participating in 
the two subunits interactions. All the mutations are not effective to disturb the 
E3 subunits assembly as 15 mutant clones express normal activity in both PDH 
and ODH complexes while one clone is of inactive ODH beside an active PDH. 
The inactivity of the ODH in the latter mutant clone does not mean that the 
interaction of the E3 subunits was affected as long the PDH complex is still 
active which means that E3 is still dimer to work with PDH but not with ODH. 
This is because of an interaction reasons that makes E3 interacts with PDH in a 
different way than interacting with ODH as mentioned previously. Being active 
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after hitting some of the inter-subunits interaction residue means that there is no 
hot spot or key residue among those residues covered in random mutagenesis.  
Table 5.3: E3 Inter-subunit interacting residues random mutagenesis and 
activity data. (interacting residues of interest are in bolditalic).   
Clone ID Activity Clone mutational pattern 
4th lpd4 
21.7.15 
Active PDH 
and ODH 
D27N, K216E, I248F, F288K 
5th lpd59 
9.8.15 
= V210A, I218T, K220N, A259E, V267I, L454M, T464P, D465I, L466C, P467R, 
N468I, P469R, A471P, K474I + two deletions changed the ORF so that one 
additional amino acid (I) added to the C-terminal 
1st lpd59 
4.7.15 
= H58Y, K61E 
1st lpd47 
4.7.15 
= V9I, H72Q, W163L 
4th lpd39 
21.7.15 
= R37C, G73G 
4th lpd55 
21.7.15 
= V10I, G73D, K109I, A196V, D202N, V325I 
4th lpd60 
21.7.15 
= K6I, G73D, G286D 
1st lpd3 4.7.15 = V75I, V112D 
4th lpd64 
21.7.15 
= R108P 
4th lpd7 
21.7.15 
= Q300L, H322Q 
5th lpd66 
9.8.15 
= M206R, R225H, A266V, V289I, H322Y 
5th lpd9 9.8.15 = G419D, G461V, P467L 
5th lpd60 
9.8.15 
= M206K, T353A, G419S 
5th lpd57 
9.8.15 
= I218T, G293D, E420G 
5th lpd65 
9.8.15 
= V204M, D291N, E420V 
5th lpd31 
9.8.15 
Active  PDH, 
inactive ODH 
Q300H, I409N, G423S, A471V 
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     However, few residues has been shown to have more than one inter-domain 
interaction beside the catalytic activity that they perform such as the active site 
residue His-445 which is found in one subunit and facing the FAD molecule 
situated nearby on the other counterpart subunit and makes interactions with it 
(Chandrasekhar et al., 2013). 
 
5.2.12. Other structural features of E3 and mutagenesis impact 
     The longest helix structure (Gly-43 to Ala-70) contains catalytically 
important intra disulfide bridge formed between the R groups sulphur atoms of 
Cys-45 and Cys-50. On the other hand, Met-431 and Cys-433 are in orientations 
which make them in a suitable conformation to form a deformed rectangle 
cluster of four sulphur atoms (Figure 5.10). This cluster includes two pairs of 
sulphur atoms from Met-431 and Cys-433 in each peptide chain (subunit). 
     Another sulphur cluster conformation has only been found in the lipoamide 
dehydrogenase of Neisseria meningitides, while all the E3 variants of the to date 
resolved structures do not show such conformation (de la Sierra et al., 1997; 
Chandrasekhar et al., 2013). The random mutagenesis has not changed Cys-45 
nor Cys-50 while  both Met-431 and Cys-433 have been mutated within two 
mutant clones of double amino acids change (I388F, C433S and I218N, 
M431V) which are both expressing active E3 indicating that such a rectangular 
sulphur cluster is not important for the enzyme catalysis. 
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 Figure 5.10: The rectangular sulphur cluster formed by the arrangement of 
Met-431 and Cys-433 in both E. coli E3 subunits. The distances between 
sulphur atoms are clearly indicated as 3.5 °A, 6.7 °A respectively.  
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Chapter 6 
General discussion 
     Mutagenesis has been widely used in the investigation of genetics since the 
work of Muller and colleagues in investigating the impact of X-rays on 
drosophila genetics (Muller, 1928). It would take a further 50 years before the 
method of targeted mutagenesis, known commonly as site-directed mutagenesis 
would be introduced. By the end of the last century, precision approaches for 
site directed mutagenesis had become commonplace in the molecular biologist’s 
experimental repertoire, while random mutagenesis using reactive chemicals 
such as nitrosoguanidine, hydroxyurea or controlled ionising radiation became 
less popular. As a result, it could be argued that progress in the understanding of 
gene function has become more incremental and less ground-breaking.  
     The development of the polymerase chain reaction (PCR) in the 1980s has 
undoubtedly revolutionised molecular biology research as well as providing 
major advances in the analysis of disease related genes, the origins of bacterial 
and viral infections, forensic sciences and many other areas of Biomedical 
Science and Biotechnology. The early emphasis was on the development of 
high fidelity enzymes for the efficient amplification of DNA, with Taq 
polymerase being replaced by enzymes such as Pfu DNA polymerase where 
fidelity was a priority. In fact today both types of enzymes enjoy widespread 
usage, with users making an informed choice based on the need for fidelity and 
the economics of the experiment.  
     While site directed mutagenesis became increasingly robust and 
reproducible, in particular following the introduction of the “quick change” 
technology by Invitrogen in the early 1990s, random methods based on PCR (in 
an attempt to avoid the use of hazardous reagents and radiation), were far less 
popular, largely owing to the effort required to optimise conditions for obtaining 
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reasonable yields of mutant PCR “libraries”. The development of DNA 
sequencing technologies (and a little later, the higher throughput approaches), 
has also had a major impact upon the knowledge base for understanding the 
evolutionary relationships between genes and genomes.  
     Random mutagenesis is a key tool that has been used very successfully over 
the last decade in directed evolution experiments to provide libraries of protein 
variants descending form a parent protein (ancestral gene) sequence in a way 
that is not dissimilar to Natural Selection that underpins protein evolution. 
However, while there are a range of different mechanisms associated with 
evolution beyond single base changes, such as gene (and genome) duplication, 
deletion, insertion etc., random mutagenesis using error prone PCR provides a 
limited, but simple and efficient method to exploring the relationship between 
primary structure and protein function. 
     In contrast, site directed evolution is generally used to verify a hypothesis 
about the role of a small number of key residues in protein function (Wilkinson 
et al., 1983; Fersht, 1987; Boucher et al., 2016). An excellent example of the 
application site directed mutagenesis is provided by the work of Ptashne on the 
specificity determinants of bacterial repressors and by Rutter’s group in the 
1980s on the catalytic properties of serine proteases (Wharton and Ptashne, 
1985; Craik et al., 1987; Sprang et al., 1987). 
     PCR based methods of random mutagenesis have massively compressed the 
time scales required by Nature to evolve protein variants. In addition, the 
methods applied in this work enable the analysis of “off pathway” mutants, i.e. 
mutants where there is a complete loss of function, many (if not most) of which 
are not revealed by BLAST analysis and genome sequencing projects.  
     The introduction of the double mutant from Connolly’s laboratory (Biles and 
Connolly, 2004) has made it possible to derive random libraries of mutants with 
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limited bias, that can then be screened directly for different characteristics, 
depending on the reason for the experiments. 
     It became possible to derive a robust strategy for investigating the influence 
of primary structure on protein function for a “stand alone” gene as illustrated in 
Figure 3.9 which is reused below: 
 
Figure 3.9: The general strategy of Error prone PCR random mutagenesis and 
cloning which is applied in this study on M.HhaI and the other two enzymes’ 
models (chapter 4 and 5). The green part represents the gene ORF. The red dots 
represent the mutations (errors) that are generated by EPM. RS1 and RS2 refer 
to restriction site 1 and 2 respectively.  
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     In the current study, this approach has been used to stress test protein 
function, as a result of primary structural changes brought about by the 
introduction of point mutations distributed along the polypeptide chain in a 
random manner by error-prone PCR. This strategy will ultimately inform the 
rational design of proteins with potentially novel functions. This is because 
structural analysis of a given protein is limited in respect of dynamics that may 
be essential for the transitions in structure during catalysis. Moreover, high 
resolution structures can provide elegant explanations of enzyme mechanisms, 
but they possibly “over-emphasise” stereochemical precision. Moreover, having 
a protein crystal structure represents a single (clearly important) snap shot from 
the whole pathway of catalysis, but it limits understanding to these well-defined 
stages. 
     Three enzyme targets have been subjected to error-prone PCR random 
mutagenesis : A DNA Cytosine-5-methyl transferase, M.HhaI (Chapter 3), 
chloramphenicol acetyltransferase type I (CATI) (Chapter 4) and 
dihydrolipoamide dehydrogenase (E3) (Chapter 5), which contributes to the 
activity of a number of metabolic enzymes including the pyruvate 
dehydrogenase (PDH) and 2-oxoglutare dehydrogenase (ODH) multienzyme 
complexes. 
     The DNA sequences encoding these three enzymes have been synthesised 
with some modifications especially the “silent” introduction of restriction sites 
to aid experimental manipulation of the gene during mutagenesis. The 
engineered restriction sites have been designed to yield cohesive ends thus 
optimising downstream ligation and efficient recovery of libraries of mutant 
clones in conjunction with the use of high transformation efficiency E. coli 
competent cells. This strategic implementation of gene design and synthesis has 
proven to be of considerable value in this work, in particular when short DNA 
segments of the gene were amplified and cloned, but where sequencing data 
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showed no evidence for mutation. The presence of other restriction sites within 
the ORF provided a convenient level of flexibility in extending the length of the 
DNA to undergo mutagenic PCR amplification and cloning. In this way, the 
probability of increasing mutation frequency (as the S-PhoEP tends to introduce 
more mutations as the length of the target DNA is increased) was observed.  
     All of the three enzymes examples selected in this study are amenable to 
relatively simple screening protocols. In the case of M.HhaI and CAT (and 
although with some difficulties, E3), it even proved possible to distinguish low 
from high levels of enzyme activity (see the relevant sections). 
     For all three enzymes, such general activity screening does not require the 
enzyme to be over expressed and purified, but rather expressing a clean 
phenotype on agar plates. In the case of M.HhaI variants, the analysis of 
encoding plasmids by strategic restriction mapping adds information about 
intermediate levels of activity and/or enzyme stability. Hence, it was possible to 
explore a reasonably representative sequence diversity space within a 
convenient time scale. One significant observation was that functional screening 
indicated that different enzymes exhibit different levels of tolerance to 
mutational inactivation, as illustrated comparatively in Figure 6.1. 
     CATI tends to be the most intolerant of mutations out of the three targets. 
This could be because CATI is smaller in size with higher number of conserved 
residues which could imply that there are more “hot-spots” for inactivation, 
compared with the other two target enzymes. In other words, structural 
flexibility appears to be lower in CATI than in M.HhaI and E3. 
     However, the most recent random mutagenesis that compares the activity of 
mono-specific and multi-specific C5-methyltransferases by using the same S-
PhoEP revealed that no partial activity occurs with M.HhaI (Alfageih, 2011), 
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Figure 6.1: A comparative illustration for the effect of random mutagenesis on 
the activity of M.HhaI, CATI and E3. Active, inactive, and partially active 
clones are represented in numbers underneath the graphs.  
 
     While in the current study, four mutant clones have shown partial plasmid 
digestion by HhaI reflecting M.HhaI partial activity, (See Figure 3.10, Figure 
6.1 and Appendix1). On the other hand, inactivating PDH and ODH complexes 
by mutating their E3 components proved more challenging in this work. This 
observation is similar to classic work on cytochrome c and globins from the 
1970s (Stryer, 1968). This could be explained by the low chance of reaching the 
sensitive residues (especially the catalytic ones which are discussed in chapter 
5) of E3 by random mutagenesis especially with the large size of the enzyme’s 
monomeric subunit where such important residues are actually few in the 
middle of too many other residues of no or less importance. 
     However, alteration of key catalytic residues in E3 should abolish the 
enzyme’s activity, and as a consequence, this would abolish the activity of all 
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complexes comprising E3. E3 possesses several amino acids residues that are 
involved in the formation of interactions network necessary to attach the 
enzyme to the surface of the E2 components within the complexes.  
     The network of interactions that form the basis of the interaction between E2 
and E3 in PDH and ODH complexes has been shown to be controlled by many 
amino acids residues from both sides of E3 and E2 respectively (see chapter 5 
for more details). It is clear from the amino acid numbering that the interface 
comprises widely distributed primary E3 structure elements. The second 
observation is that some interactions are shared by both complexes, but others 
are unique.  
     A detailed analysis of the evolution of globin genes over the last decades 
(Itano and Robinson, 1960; Jeffreys, 1979; Engel and Dodgson, 1980), led to a 
proposal for the evolutionary constraints on the development of a set of “pseudo 
homomeric” haemoglobin tetramers. These ideas have been largely confirmed 
by genomic data. Amongst the Hb variants, the variations in primary structure 
that have emerged through Natural Selection, to generate a diverse group of 
oxygen transporters with sequence in which the chains are essentially equivalent 
in function, but where subtle functional variants are found that can be 
accommodated in the tetrameric complex, without loss of function. It should be 
noted that whilst Hb is a sophisticated and highly regulated oxygen transporter 
protein, it is not an enzyme. Nevertheless, it is interesting to see how alpha 
polypeptides can interface successfully with beta and epsilon classes of 
polypeptides in such a way as to provide functional oxygen transporters that 
meet different cellular and physiological demands. 
     A quite different scenario occurs in the genome organisers, the histones. 
Again, this is a class of binding proteins, this time to DNA, but the four histone 
variants that make up the octameric core are stringently conserved across a wide 
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range of species. It is clear here that sequences must be preserved in order to 
ensure faithful packaging of the genome. The wider roles of the histones and 
their interaction with remodelling factors and modifying enzymes has been 
discussed in an evolutionary context elsewhere (Allfrey et al., 1963; Littau et 
al., 1965; Govin et al., 2004; Saffarzadeh et al., 2012). 
     Coming to the conservation of enzymes in Nature, it is clear from BLAST 
analysis that there are relatively few examples similar to that of the globin 
family (and therefore few examples of heterogeneous quaternary structures 
amongst enzymes exist). Most enzymes are homomeric oligomers, some are 
monomeric and several are heteromeric oligomers. The evolution of multi-
protein complexes in relation to symmetry and structural organisation has been 
reviewed by Marsh and Teichmann recently (Marsh and Teichmann, 2015). The 
enzyme M.HhaI represents an example of a monomeric enzyme, and one that 
has homologues in E. coli, such as the product of the dcm gene and in some 
strains a variant of the dcm enzyme, EcoRII occurs (Palmer and Marinus, 1994). 
Extensive comparisons (summarised by the multiple sequence alignments in 
Appendix 4) have consistently revealed a common set of motifs and this has 
been reviewed in chapter 3. The data obtained here in respect of the relationship 
between primary structure and catalytic competence (a combination of 
structural integrity and catalytic activity) reveal that M.HhaI is more tolerant 
toward the mutagenesis active when single domain of its primary structure is 
targeted by mutagenesis but when the mutational range is extended to include 
more than one domain the activity is more reduced. This however depends on 
residue conservation and the number of amino acid changes (see data in chapter 
3 for more details). 
     The enzyme CATI is a trimeric enzyme, in which activity is a function of 
primary structure, expressed through a combination of tertiary and quaternary 
structure and catalytic activity. Hence a greater set of constraints exist. On the 
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other hand, comparisons between CATI sequences shows more conserved 
points within its primary structure explaining the common inactivation 
phenotypes which have been observed after CATI gene mutagenesis. 
     In Chapter 5, the gene encoding the E3 polypeptide of the two TCA cycle 
enzymes’ complexes ( PDH and ODH) was investigated by random 
mutagenesis. After screening a considerable number of clones (around tenfold 
more than with M.HhaI or CATI ) a small number of mutants were finally 
isolated that exhibited differential activity with the two multienzyme 
complexes. The experiment was designed to explore the extent of promiscuity 
that could be tolerated by changes to the sequence of the E3 orf. 
     It is clear from the results presented in Chapter 5, that the E3 sequence 
contains redundant elements that render the enzyme much more tolerant of 
changes in its primary structure. In a similar way to the C5 MTase family of 
enzymes, in which catalytic methyl-transfer is carried out by one module and a 
separate, but interactive module (the TRD) presents a cytosine from within a 
specific DNA sequence to the active site, E3 is able to engage its catalytic 
activity with several subunits from PDH, ODH and indeed other oxo-acid 
dehydrogenases.  
     The E3 experiments have enabled us to push the boundaries and extend the 
approach of error-prone PCR and directed evolution from testing the direct 
effect of mutations on the protein activity to the testing and evaluating the 
protein interactions. Such extended approach could be invested in the 
development of drugs and vaccines where the protein-protein interaction is 
required to be clarified and better understood especially in developing 
antibodies to tackle the continuously changing (mutating) viruses and bacterial 
antigens. Thus, we now have a promising tool to fight pathogens in the same 
way that they are fighting us.  
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     Our data are consistent with the general observations in protein evolution: 
where there are key residues involved in catalysis or substrate recognition, 
mutations are likely to abolish activity. This is not surprising. However, such 
residues and regions are supported by regions of primary structure that vary 
considerably among these classes of enzymes and our results shed light on 
residues that are not immediately apparent for structural studies. In the absence 
of an understanding of how a set of conserved residues can be supported by a 
wide range of different residues, requires strong functional correlations with 
mutations to support BLAST analysis. It is clear from these experiments that we 
are beginning to gain insight into less transparent patterns of amino acid 
distributions in proteins and the constraints imposed by primary structure on the 
“successful” evolution of proteins. 
     One of the consequences of random mutation is the possibility of introducing 
nonsense mutations. The three canonical stop codons; Amber (TAG), Ochre 
(TAA), and Opal (TGA) are observed at an expected frequency in the 
translational reading frames of both M.HhaI and CATI genes, while no such 
mutants were recovered from E3 gene randomisation experiments. The activity 
profiles of M.HhaI and CATI mutant clones containing Ochre and Opal stop 
codons were always inactive, while more than 50% Amber mutants appeared 
with full enzyme activity (see mutations and activity data tables of M.HhaI and 
CATI in the appendices). These phenotypic observations emphasize the 
previously reported underrepresentation and weakness of the TAG stop codon 
compared with the higher efficiency of both TAA and TGA in terminating the 
poly peptide chain elongation during protein translation in bacteria (Korkmaz et 
al., 2014). It has been shown that the difference in stop codon efficiency is 
closely related to the level of expression of releasing factors (RF1 and RF2), 
which are the key proteins responsible for ribosomal subunit dissociation and 
polypeptide release. Ochre is the most efficient stop codon as it can be 
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recognized by either releasing factors, while Amber and Opal are exclusively 
recognized by RF1 and RF2 respectively (Scolnick et al., 1968; Brown et al., 
1993; Bonetti et al., 1995). In E. coli, RF2 is five times more abundant than 
RF1 (Adamski et al., 1994; Mora et al., 2007), therefore, it is normal to expect 
the ribosome to pass over and read through the TAG codon occasionally. It has 
been demonstrated that when the Lys codon; a catalytically essential residue in 
firefly luciferase, is changed by mutation into TAG, the enzyme remains highly 
active emphasising a TAG  read through, which is most likely recognized by an 
aminoacyl-tRNA charged with lysine (Kramer and Farabaugh, 2007).  
     Therefore, it seems likely that read through accounts for the residual activity 
of M.HhaI and CATI mutants of this type, containing in-frame Amber stop 
codons. In summary, the observations made here are fully consistent with the 
relationships between primary structure and activity in nonsense mutations 
analysed elsewhere.  
     Ever since the finding that a single amino acid substitution in haemoglobin 
results in the disease sickle cell anaemia (Clancy, 2008), it is clear that the 
network of interactions that maintain the structural and functional integrity of 
proteins can “be on the edge”. However, the last 50 years of direct and indirect 
comparative analysis of primary structures of proteins has shown that single 
amino acid substitutions rarely abolish protein activity. In the case of M.HhaI, 
the substitution of the catalytic Cys at position 81 can be explained by the 
critical role that this side chain plays, not in stabilising the base-flipped DNA 
substrate, but rather inducing the necessary reactivity of the carbon atom at 
position 6 of cytosine, for methyl transfer (See Chapter 3). There are similar 
critical catalytic residues in CATI and E3 and, under appropriate growth 
conditions (i.e. where an absence of these activities can be compensated), such 
mutants are expected to arise in the random mutagenesis protocol used here. 
The probability of recovering such mutants is purely statistical. However, what 
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is clear from an evolutionary perspective, is that the vulnerability of an enzyme 
to inactivation by random mutagenic change, is offset by the length of most 
polypeptide chains. It could be argued that key residues are buffered by much of 
the “non-essential” nature of the majority of the primary structure of a protein. 
This could possibly provide a notional index for protein robustness, in which 
the histones would represent one extreme of such an index and the globin genes 
would be towards the other end of the spectrum. 
     It is clearly difficult to generalise in terms of evolutionary robustness in 
proteins from this isolated study. This is especially true in organisms where 
stable and transient protein interactions form the basis of such complexity (i.e. 
eukaryotes versus prokaryotes). Furthermore, in the spirit of Systems Biology, 
the degree of resilience with respect to catalytic enhancer residues or stabilising 
residues versus folding elements etc. which will be revealed in the differential 
conservation found in protein BLAST searches. 
     The published structural and biochemical work that has been drawn upon to 
rationalise the contribution of certain amino acid residues in supporting enzyme 
structure and function has not always been satisfactory (See Chapter 3, 4, and 
5). Indeed, the role and importance of the majority of those missense mutations 
that abolish activity of the protein remain unclear in all three cases (Chapters 3-
5). It, therefore, seems that the main outcome of this work has been to 
demonstrate that there are amino acids whose contribution to protein structure 
and function remains obscure and that the conclusions drawn from structural 
analysis combined with mechanistic studies and site directed mutagenesis are 
limited in their ability to provide a comprehensive relationship between primary 
structure and protein function.  
 
     On the other hand, mutations elsewhere in all three targets (M.HhaI, CATI 
and E3) had no observable impact on enzyme activity because they apparently 
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do not participate directly or indirectly in any interactions essential for catalysis, 
and or they play no role in structure determination or stabilisation. Furthermore, 
some residues that would be expected to be conserved from BLAST analysis, 
can be changed without effect on function, in the screens applied here. Such 
data reflect our limited understanding of correlating the protein structure to its 
function and how large or small is the “structural window” of the protein in 
supporting the proper folding required for the catalysis. It is also the case that 
the method we have employed here could be extended to identify compensatory 
mutations that might restore activity to a mutant where a point mutation has led 
to inactivation. Such patterns of synergistic mutation in which a second 
mutation mitigates against the deleterious effect of the first are difficult to 
identify by comparative sequence analysis alone (Kern and Kondrashov, 2004).  
 
     Finally, I believe that the approach which has been dealt with in this study 
will provide molecular enzymologists with a simple and efficient methodology 
to explore the hidden depths of their enzymes of interest and will throw up new 
ideas about enzyme mechanism. Ideally, a complementary ability to determine 
the structures of such mutants in real time will be developed in order to move 
towards more robust frameworks for predicting function from primary structure, 
a key element of genome annotation work. 
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Appendices 
Appendix 1: Amino acid changes and activity of M.HhaI mutants: 
Sample ID Activity Amino acids changes 
2nd1 1.10.14 PA V36I, G92S, T99N, V108L 
2nd3 1.10.14 IA K7Q, V48F, P57S 
2nd4 1.10.14 A K56I 
2nd5 1.10.14 A V2I, L9S, R13C 
2nd11 1.10.14 IA E40K 
2nd13 1.10.14 IA K5N, C35Y, D60V, C76S 
2nd14 1.10.14 A T10I, F93I 
2nd16 1.10.14 A V48M 
2nd19 1.10.14 A K56Q 
2nd22 1.10.14 A Q8E 
2nd25 1.10.14 IA D73N, Q82H, S87F, N120Y 
2nd28 1.10.14 PA A45T, F84L 
2nd29 1.10.14 A I15N, E66A 
2nd31 1.10.14 A F14Y, G59D, V115I 
2nd32 1.10.14 A E47K, G54D 
2nd33 1.10.14 A V48L, G92S 
2nd34 1.10.14 IA G20S, A45T 
2nd35 1.10.14 A E3K, E58D 
2nd36 1.10.14 A N39D 
2nd38 1.10.14 A F102Y 
2nd40 1.10.14 A A45P 
2nd41 1.10.14 A R109H 
2nd42 1.10.14 A V48A 
2nd44 1.10.14 IA Q46H, Q90L, E119D 
2nd45 1.10.14 IA G23V, E47D, K67E, P70H, A83T, F102Y 
2nd46 1.10.14 A L17M, N65Y, A83V, V116L 
2nd51 1.10.14 A Y37H 
2nd52 1.10.14 A I4N, R13L, K91I, I104V, R109H 
2nd54 1.10.14 A F18Y, K112E 
2nd57 1.10.14 IA A19V, G88E 
2nd58 1.10.14 A E50G, A34V 
2nd63 1.10.14 A D60N, L100P 
2nd71 1.10.14 IA G11C, L21R, M51V, T99N 
2nd73 1.10.14 A N52K, V64I 
2nd75 1.10.14 IA G88V 
2nd76 1.10.14 IA A19V, G88E 
2nd78 1.10.14 A A27T, K89E 
2nd80 1.10.14 IA G20S, D73V 
2nd81 1.10.14 A K5N, M51L, D73V 
2nd83 1.10.14 IA L26Q, E40D, L75M, C76Y, V116L 
2nd85 1.10.14 A D95Y 
2nd86 1.10.14 IA D6N, F18C, Y49N, S87T 
2nd87 1.10.14 A T10A, L100M 
2nd88 1.10.14 A I4L 
2nd92 1.10.14 A C31Y 
2nd95 1.10.14 A D103V, R106L 
2nd97 1.10.14 IA S87Y, V121M 
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2nd98 1.10.14 IA G20R, Q63L 
2nd99 1.10.14 IA G88E 
2nd100 1.10.14 A K43R 
2nd104 1.10.14 A I107F 
2nd108 1.10.14 IA G20C, R25S, K122Q 
2nd109 1.10.14 IA G20S, D60N, D73E, D95E, R106L 
2nd110 1.10.14 IA K7I, F14Y, I15N, L21M, N65S, R109C 
2nd111 1.10.14 A A83T 
2nd113 1.10.14 A E47K, G54D 
2nd114 1.10.14 A I15N 
2nd115 1.10.14 IA S30C, A33S, E40-, K43I, A105T 
2nd116 1.10.14 A I4F, F84Y 
2nd117 1.10.14 A A19V 
2nd119 1.10.14 IA C35-, I86M, L100M 
2nd120 1.10.14 A E3D, I15V, W41- 
2nd121 1.10.14 A F14I, I107V 
2nd122 1.10.14 A I61M, P70H 
2nd124 1.10.14 A Q90- 
2nd125 1.10.14 IA A45G, E50I, F53Y, R106H 
2nd126 1.10.14 PA  F24Y, A83T, V108F 
2nd127 1.10.14 PA V121M 
2nd6 8.5.14 IA G22D, E29D, G32C, D71V, D73V, F79L, P80Q, 
Q90H 
2nd11 8.5.14 A Y37F, K89R, R97C 
2nd12 8.5.14 IA G20C, F79L, P80Q, D95Y, S96I, E119D, F117C 
2nd14 8.5.14 IA G59V, K91N, M118T, F124C 
2nd16 8.5.14 IA F24L, A45T, K89E 
2nd17 8.5.14 IA F18S, D42V, V116M, D103G, V121M 
2nd19 8.5.14 IA G23D, E29V, K91N 
2nd20 8.5.14 IA G23S, K56I, I104N, K111K 
2nd22 8.5.14 IA G22C, F24C, R25S, T62S, V64D, F93C, E94D, 
F101L 
2nd24 8.5.14 A K5N, E29D, F79I 
2nd25 8.5.14 IA P57T, S85I 
2nd28 8.5.14 A G11S, S38G, M51V 
2nd29 8.5.14 IA I4F, L9S, L17M, G32C, K91R, V115I 
2nd31 8.5.14 A D6H 
2nd32 8.5.14 IA Q46F, N52S, T99I 
2nd37 8.5.14 A N120I 
2nd42 8.5.14 IA G20C, C35F, G59D, I86F 
2nd45 8.5.14 A Q46H, Q90H 
2nd51 8.5.14 A V2I, E55G, F53S 
2nd53 8.5.14 IA E40K, D60N, T62I, A77V, G92S, F101S 
2nd54 8.5.14 A E3G, F53Y, R109C 
2nd55 8.5.14 IA I4F, G11I, N65H, P80T, V121A 
2nd59 8.5.14 A S96N, I104N 
3rd2 8.8.14 A D128F, R245H 
3rd3 8.8.14 IA E142K, F171L, F186C 
3rd4 8.8.14 IA M168I, R240L, I247T 
3rd6 8.8.14 A I177T 
3rd9 8.8.14 A T222I, R245S 
3rd10 8.8.14 A Q181K 
3rd12 8.8.14 A G158S, I219V 
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3rd13 8.8.14 A D156V, N189K 
3rd16 8.8.14 A L155F 
3rd17 8.8.14 A L143P, S146N 
3rd19 8.8.14 IA V136A, P183L, N189S 
3rd22 8.8.14 IA L205V, G230D, K234T 
3rd23 8.8.14 A N138I, V192M, S200G 
3rd24 8.8.14 A Q161H 
3rd26 8.8.14 A V206I 
3rd27 8.8.14 A A149G, I177T 
3rd28 8.8.14 A H148Y, H204Q 
3rd29 8.8.14 A F191I 
3rd30 8.8.14 A N176D, F171I 
3rd32 8.8.14 IA N131K, I207F, Q237K 
3rd34 8.8.14 A M139I, V213A, T222I 
3rd35 8.8.14 IA E142D, G158D, H204L 
3rd37 8.8.14 A T226I 
3rd38 8.8.14 IA P160T, I207T, K234T 
3rd43 8.8.14 A E164V, I231F 
3rd45 8.8.14 A H127Y, L229Q 
3rd47 8.8.14 IA H127L, R163G, I169L, L188Q, P198S, T226I, 
I231V, Q237H 
3rd49 8.8.14 A I247F 
3rd50 8.8.14 A D144Y 
3rd51 8.8.14 A N138T, V206I, Q217H, T226I 
3rd53 8.8.14 A N173I, H204L 
3rd55 8.8.14 A N179Y 
3rd57 8.8.14 IA A154T, Y157H, D174V, N189D, V227D, Q237K 
3rd58 8.8.14 A M214I 
3rd59 8.8.14 A M140I, A149T 
3rd60 8.8.14 A K137E, T139S 
3rd61 8.8.14 IA L143M, K150I, G230D, I247F 
4th7 23.6.14 IA P286S, C279Y 
4th9 23.6.14 A Q297K 
4th15 23.6.14 A  A253V 
4th16 23.6.14 IA A253P, V282D, D287E, S294N, N323Y 
4th19 23.6.14 A P276Q 
4th23 23.6.14 IA G256R, H275N, S294N, Q301R, G319S 
4th24 23.6.14 A F324S 
4th25 23.6.14 IA S296N, K300E, V307M 
4th39 23.6.14 IA S252R, P286S, Y316C, L322M 
4th42 23.6.14 A A253V 
4th5 1.7.14 A Y313C, N317D 
4th6 1.7.14 A C279G, Y313C 
4th7 1.7.14 A L322P 
4th8 1.7.14 A G257S 
4th10 1.7.14 A M283I 
4th11 1.7.14 A S294G 
4th15 1.7.14 A S288R 
4th16 1.7.14 A R281C 
4th17 1.7.14 IA E278G, G303D 
4th19 1.7.14 IA T271I, C279R, S294N, P326S 
4th23 1.7.14 IA F259V, S288I, Q301H, K325T 
4th26 1.7.14 A L266M 
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4th28 1.7.14 IA G255D 
4th32 1.7.14 A D287N 
4th36 1.7.14 A K325R 
4th38 1.7.14 A A280G 
4th42 1.7.14 IA G256D, V310M 
4th44 1.7.14 A P293H, Q297R, A315V 
2nd2 15.4.14 A Q82H 
2nd1 16.4.14 A K7Q 
4th4 15.4.14 IA K261Q, K273I, R281C, Q312L 
4th1 25.4.14 IA G263D, G264S, S288N, T295I, G319D 
4th5 25.4.14 IA H275R, V291D 
4th6 25.4.14 IA K273I, R281C, Q312L 
*Red-shaded are mutations within highly conserved and relatively conserved 
residues. 
*Yellow-shaded are mutations within the TRD. 
*Green-shaded are mutations within the hinge region.  
*Not-shaded are mutations of not conserved residues within catalytic domain. 
*Hyphens (-) indicate that the codons of the mentioned residue were changed by 
mutations into TAG stop codon.  
* A= Active, IA= Inactive, PA= Partially active. 
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Appendix 2: Amino acid changes and activity of CATI mutants: 
Sample ID Activity Amino acids changes 
4thAt1 15.2.15 IA F95S, T101I, T172K 
4thAt5 15.2.15 A R203G 
4thAt6 15.2.15 IA V124A, S155T, G180S, Q190R, G202D 
4thAt10 15.2.15 IA Y133F, G137C, F153I 
4thAt13 15.2.15 PA C196Y 
4thAt15 15.2.15 IA H110Q, W215C, L208P, V201D 
4thAt16 15.2.15 IA E129D, S146R, H192R 
4thAt17 15.2.15 IA V88D, R114C, Y120F, F166I, Q190K 
4thAt19 15.2.15 PA R203H 
4thAt23 15.2.15 IA S155C, F167V, F171L 
4thAt24 15.2.15 IA E81V, F171L, F167Y, D181V 
4thAt27 15.2.15 A D181V 
4thAt28 15.2.15 A E129V 
4thAt30 15.2.15 A N162K 
4thAt33 15.2.15 A A147V, D164E, A219T 
4thAt36 15.2.15 IA A132E, Y176N, V191D 
4thAt37 15.2.15 A F113I, E214K 
4thAt43 15.2.15 IA E97V, I139T, C196R 
4thAt47 15.2.15 IA Q190R 
4thAt49 15.2.15 IA Y120C, N130K, F171L, H193Y 
4thAt53 15.2.15 IA A161V, M204V 
4thAt 5515.2.15 IA F116L, F143I, S146I, F166I, L117P 
4thAt56 15.2.15 IA V94G, Y127F, D164V, W215R, G217A, A219T 
4thAt57 15.2.15 IA W85G, S155I 
4thAt58 15.2.15 IA T93I, E108D, F167L, Q190H 
4thAt60 15.2.15 IA S103N, D111N, H193N 
4thAt63 15.2.15 IA R74C, C91Y, L205M 
4thAt65 15.2.15 PA A125V, K136N 
4thAt67 15.2.15 IA Q115H, T154N, M185K 
4thAt71 15.2.15 IA S107P, P135S, H200Y 
4thAt82 15.2.15 A E97V 
4thAt84 15.2.15 IA A132V, T154I, M163L 
4thAt87 15.2.15 IA I84F, A161V 
4thAt88 15.2.15 A D86E 
4thAt91 15.2.15 A R114S 
4thAt93 15.2.15 IA S103T, F113Y, I189T, C196Y 
4thAt94 15.2.15 PA D111N, N162S 
4thAt95 15.2.15 IA F167L, Y176C, K175I 
4thAt96 15.2.15 IA V83D, N141T, A168T 
4thAt97 15.2.15 A S121I 
4thAt98 15.2.15 IA E97A, T99N, C126Y, Y127C, Y133F, A168S, E207D, Y211H 
4thAt100 15.2.15 IA T101I, S155T, M204T 
4thAt103 15.2.15 PA D79N, A147T, C196S 
4thAt105 15.2.15 A G217S 
4thAt106 15.2.15 A G137C 
4thAt107 15.2.15 IA G202D 
4thAt109 15.2.15 PA H96L, E97K, L158P, V183L, H200Q 
4thAt110 15.2.15 IA F95L, G198C 
4thAt111 15.2.15 PA A76G, C212Y 
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*Red-shaded are mutations within highly conserved and relatively conserved 
residues. 
*A=Active, IA=Inactive, PA=Partially active. 
4thAt112 15.2.15 PA S152R, H100Q 
4thAt113 15.2.15 PA G128A, N130S 
4thAt115 15.2.15 A D79Y, E81D, V191I 
4thAt118 15.2.15 IA F116L* 
4thAt119 15.2.15 IA D164Y, D197C 
4thAt120 15.2.15 A M77K, A125S, M185L, L208V 
4thAt121 15.2.15 IA V88D, Q98H, S103R, Q122P 
4thAt122 15.2.15 IA C196R 
4thAt127 15.2.15 IA V88D, V183F, M204I 
4thAt129 15.2.15 IA F143S 
4thAt130 15.2.15 PA N148D 
4thAt132 15.2.15 A N165I 
4thAt137 15.2.15 A D111E, S121G, P169S, Q179H 
4thAt139 15.2.15 IA F167L, V195I 
4thAt141 15.2.15 A V83F, T99S, H118R, Q122H, D181N 
4thAt144 15.2.15 A Q98H 
4thAt145 15.2.15 IA V83L, S103R, N130H, M142V, M173K, Q216L 
4thAt146 15.2.15 IA A76V, F102I, G128D, F144L, V160M 
4thAt147 15.2.15 IA F102Y, N162H 
4thAt148 15.2.15 PA C91S, P169T 
4thAt153 15.2.15 A M204L, W215C 
4thAt154 15.2.15 PA A147T 
4thAt156 15.2.15 A V88L 
4thAt157 15.2.15 IA V94G, R114S, F171L 
4thAt159 15.2.15 IA K78E, F171L, G118S 
4thAt161 15.2.15 A N130K 
4thAt164 15.2.15 A V195I 
4thAt165 15.2.15 A D79Y, A132T 
4thAt166 15.2.15 IA D157V, H193L 
4thAt167 15.2.15 IA H96R, L117V, F153L, M185V 
4thAt168 15.2.15 IA D112V, F153Y, F156L 
4thAt171 15.2.15 A W215R 
4thAt172 15.2.15 IA W106R, D213E 
4thAt173 15.2.15 A T178I 
4thAt174 15.2.15 IA F171L, T172M, R203H 
4thAt175 15.2.15 A H118R, D164E, Q210H 
4thAt177 15.2.15 PA D157V 
4thAt178 15.2.15 IA R74S, G128D, L131R, E140D, F144Y, S146R, F153L 
4thAt179 15.2.15 IA D79V, G80D, V83A, D111E, D197G, M204I 
4thAt186 15.2.15 IA Y109C, Q115R, P149S, F171L, G217D 
4thAt187 15.2.15 PA H89L, A168S, K182I 
4thAt192 15.2.15 A V201I, Q216TAG, G217D 
4thAt193 15.2.15 IA M77V, W85R, Q98H, T154I, P169S 
4thAt196 15.2.15 IA Y133D, G174S, D197E 
4thAt198 15.2.15 IA N162Y, F166L, G174C 
4thAt199 15.2.15 IA M173K, G198S 
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Appendix 3: Amino acid changes in E3 mutant clones and activity impact 
on PDH and ODH enzymes complexes: 
Sample ID Activity Amino acidschanges and comments 
1st lpd7 22.6.15 Active PDH and ODH V62D 
1st lpd8 22.6.15 = E65D 
1st lpd3 4.7.15 = V75I, V112D 
1st lpd4 4.7.15 = G121R, G132C 
1st lpd6 4.7.15 = I63V, M104K 
1st lpd9 4.7.15 = G99D, I136T 
1st lpd10 4.7.15 = G29S 
1st lpd15 4.7.15 = V11M, F76L 
1st lpd18 4.7.15 = L116R 
1st lpd19 4.7.15 = R37C 
1st lpd22 4.7.15 = E78K 
1st lpd23 4.7.15 = V44I, A55G 
1st lpd25 4.7.15 = E31D 
1st lpd26 4.7.15 = R161H 
1st lpd29 4.7.15 = G77S, K133R 
1st lpd31 4.7.15 = V62I, G107D 
1st lpd33 4.7.15 = V93L 
1st lpd34 4.7.15 = N140S, F154L 
1st lpd35 4.7.15 = L28M, L69P, N140D 
1st lpd36 4.7.15 = K85T 
1st lpd38 4.7.15 = T81P 
1st lpd39 4.7.15 = V59A, T166I 
1st lpd40 4.7.15 = H157Y, L169M 
1st lpd41 4.7.15 = E78V 
1st lpd44 4.7.15 = E31D, L46M 
1st lpd45 4.7.15 = A102T, Q151R, D164G 
1st lpd47 4.7.15 = V9I, H72Q, W163L 
1st lpd53 4.7.15 = E71K, K118I, P160A 
1st lpd56 4.7.15 = K67N 
1st lpd57 4.7.15 = G103D, T134I 
1st lpd59 4.7.15 = H58Y, K61E 
4th lpd1 21.7.15 = K61R, L232P, K299Q, P318A 
4th lpd2 21.7.15 = I5T, N114H 
4th lpd3 21.7.15 = E36G 
4th lpd4 21.7.15 = D27N, K216E, I248F, F288K 
4th lpd5 21.7.15 = V62A, K229N 
4th lpd6 21.7.15 = V241L 
4th lpd7 21.7.15 = Q300L, H322Q 
4th lpd8 21.7.15 = H326Y 
4th lpd9 21.7.15 = G121D, N131S, I150N 
4th lpd10 21.7.15 = T88I, N276K 
4th lpd11 21.7.15 = V241I 
4th lpd13 21.7.15 = G129S 
4th lpd18 21.7.15 = Q96H, A145V, E288D 
4th lpd20 21.7.15 = I94N 
4th lpd21 21.7.15 = K237R 
4th lpd22 21.7.15 = R148H 
4th lpd23 21.7.15 = G77C 
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4th lpd24 21.7.15 Active PDH and ODH E65A, G77D, T223I, K256N, N279I, R296P 
4th lpd26 21.7.15 = E78K 
4th lpd27 21.7.15 = V210I 
4th lpd28 21.7.15 = I51F, S227R 
4th lpd29 21.7.15 = E176D, A196V, G254D 
4th lpd30 21.7.15 = G77D, G283R, K299E 
4th lpd31 21.7.15 = K85I 
4th lpd32 21.7.15 = Q96L 
4th lpd33 21.7.15 = K118N, R296H 
4th lpd35 21.7.15 = L178P, G272S 
4th lpd39 21.7.15 = R37C, G73G 
4th lpd42 21.7.15 = V180L, V193I 
4th lpd45 21.7.15 = V193I 
4th lpd46 21.7.15 = A22S 
4th lpd47 21.7.15 = T98A 
4th lpd50 21.7.15 = V10I, H157Y, K237I 
4th lpd51 21.7.15 = V62I, M252V 
4th lpd52 21.7.15 = V9I, R24P, L46Q, T192A 
4th lpd54 21.7.15 = V180E 
4th lpd55 21.7.15 = V10I, G73D, K109I, A196V, D202N, V325I 
4th lpd56 21.7.15 = T134I 
4th lpd57 21.7.15 = A22V, V33F 
4th lpd59 21.7.15 = S53G, F222S 
4th lpd60 21.7.15 = K6I, G73D, G286D 
4th lpd62 21.7.15 = N123Y, N140I, V267F 
4th lpd63 21.7.15 = L188M, V193A 
4th lpd64 21.7.15 = R108P 
5th lpd4 9.8.15 = G254D, I311S 
5th lpd5 9.8.15 = T441I 
5th lpd6 9.8.15 = E327Q, M396I 
5th lpd7 9.8.15 = K323N, K365R 
5th lpd8 9.8.15 = L362P 
5th lpd9 9.8.15 = G419D, G461V, P467L 
5th lpd10 9.8.15 = V204A, V221L, R263P, K403E 
5th lpd11 9.8.15 = S349R 
5th lpd12 9.8.15 = K224I, G293D, A351T 
5th lpd14 9.8.15 = 
D202N + A deletion has changed the ORF so that 29 
additional amino acids 
(NLDSGDPWASWAFRSLPAFQSGNLSCQLH) 
added to the C-terminal 
5th lpd15 9.8.15 = L280R, Q300E 
5th lpd17 9.8.15 = G198A, I271T, R302C 
5th lpd18 9.8.15 = A184A, P261S, V458L 
5th lpd20 9.8.15 = D291E, A387T 
5th lpd21 9.8.15 = F294S 
5th lpd22 9.8.15 = K244N, S349I 
5th lpd23 9.8.15 = K228N, G272S, R302H 
5th lpd24 9.8.15 = A243T, A257S, I409N, L422M 
5th lpd25 9.8.15 = G272A 
5th lpd26 9.8.15 = A310S 
5th lpd27 9.8.15 = I425T, S462C 
5th lpd28 9.8.15 = G254C, L454M, F459Y 
5th lpd29 9.8.15 = P318S, I425V 
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5th lpd31 9.8.15 Active  PDH, inactive ODH Q300H, I409N, G423S, A471V 
5th lpd32 9.8.15 Active PDH and ODH A389G 
5th lpd33 9.8.15 
Active PDH, partially active 
ODH 
K256I 
5th lpd35 9.8.15 Active PDH and ODH L190M, Q205E, V240A, I289V 
5th lpd36 9.8.15 
Active PDH, partially active 
ODH 
T192N, G286D, V360I, I442F 
5th lpd41 9.8.15 Active PDH and ODH Y264S 
5th lpd42 9.8.15 = 
Q200H, G418S, E457V, A471S, K472Q + A 
deletion has changed the ORF so that 29 
additional amino acids 
(NLDSGDPWASWAFRSLPAFQSGNLSCQLH) 
added to the C-terminal 
5th lpd43 9.8.15 = 
T363I, T378I + A deletion changed the ORF so 
that 29 additional amino acids 
(NLDSGDPWASWAFRSLPAFQSGNLSCQLH) 
added to the C-terminal 
5th lpd44 9.8.15 = 
Q200H, D402G, G461C + A deletion changed 
the ORF so that 29 additional amino acids 
(NLDSGDPWASWAFRSLPAFQSGNLSCQLH) 
added to the C-terminal 
5th lpd46 9.8.15 = I186T, V274I 
5th lpd47 9.8.15 = A257S, G337D 
5th lpd49 9.8.15 = V219I, I226N 
5th lpd50 9.8.15 = A213P, R296H, I438T 
5th lpd52 9.8.15 = V174M, V204L, E366D 
5th lpd54 9.8.15 = T303I 
5th lpd55 9.8.15 = T397I, I429V 
5th lpd57 9.8.15 = I218T, G293D, E420G 
5th lpd59 9.8.15 = 
V210A, I218T, K220N, A259E, V267I, L454M, 
T464P, D465I, L466C, P467R, N468I, P469R, 
A471P, K474I + two deletions changed the ORF 
so that one additional amino acid (I) added to the 
C-terminal 
5th lpd60 9.8.15 = M206K, T353A, G419S 
5th lpd61 9.8.15 = V180I, I185F, P261S, V287F, N304K, T441S 
5th lpd62 9.8.15 = A358T, A214V 
5th lpd64 9.8.15 = I388F, C433S 
5th lpd65 9.8.15 = V204M, D291N, E420V 
5th lpd66 9.8.15 = M206R, R225H, A266V, V289I, H322Y 
5th lpd67 9.8.15 = P258S, I388T 
5th lpd68 9.8.15 = D208E, V241L, G337S, E369K, K472Q 
5th lpd69 9.8.15 
Active PDH and very weak 
ODH 
R302H, G328S, P380L, T397I 
5th lpd70 9.8.15 Active PDH and ODH T441S 
5th lpd71 9.8.15 = P258S 
5th lpd72 9.8.15 = 
R292S, A439V + A deletion has changed the 
ORF so that 29 additional amino acids 
(NLDSGDPWASWAFRSLPAFQSGNLSCQLH) 
added to the C-terminal  
5th lpd73 9.8.15 
Active PDH and partially 
active ODH 
V193I, A351E 
5th lpd74 9.8.15 Active PDH and ODH I218T 
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5th lpd75 9.8.15 Active PDH and ODH 
R302H, V360G + an insertion has changed the 
ORF so that two additional amino acids (II) 
added to the C-terminal 
5th lpd76 9.8.15 = M181I, R292H, H340D 
5th lpd78 9.8.15 = M190I, V287F 
5th lpd79 9.8.15 = M206T, V357I, I335T, T378S 
5th lpd80 9.8.15 = V203A, K368E, E404G, A456S 
5th lpd81 9.8.15 = 
D437N + A deletion has changed the ORF so that 
29 additional amino acids 
(NLDSGDPWASWAFRSLPAFQSGNLSCQLH) 
added to the C-terminal 
5th lpd83 9.8.15 = E205Q 
5th lpd84 9.8.15 = Y194F, V221A, H326Y, T353I, T447A 
5th lpd85 9.8.15 = A439T 
5th lpd86 9.8.15 = 
A214V, K224T, K368N + A deletion has 
changed the ORF so that 29 additional amino 
acids 
(NLDSGDPWASWAFRSLPAFQSGNLSCQLH) 
added to the C-terminal 
5th lpd87 9.8.15 = K228T, Q317H, A321S, M396T 
5th lpd88 9.8.15 = I211T, D291Y, R302C 
5th lpd90 9.8.15 = A240T, T397S 
5th lpd93 9.8.15 
Active PDH and partially 
active ODH 
G415D 
5th lpd94 9.8.15 Active PDH and ODH A336V, S405N 
5th lpd96 9.8.15 = P461L, Q317H, H326Q 
5th lpd97 9.8.15 = G385S, T397I 
5th lpd98 9.8.15 
partially active PDH and 
partially active ODH 
R273H, V357I, K365Q, G426D 
5th lpd99 9.8.15 Active PDH and ODH H307R, F379V, G432D 
5th lpd100 9.8.15 = V193I 
5th lpd102 9.8.15 = V210I, H326Y, K368E 
5th lpd103 9.8.15 = A214T, M233L, M252T, K278I, I335V 
5th lpd104 9.8.15 = I218N, M431V 
5th lpd105 9.8.15 = E356D 
5th lpd106 9.8.15 = L427M 
5th lpd107 9.8.15 = 
A deletion has changed the ORF so that 29 
additional amino acids 
(NLDSGDPWASWAFRSLPAFQSGNLSCQLH) 
added to the C-terminal 
5th lpd108 9.8.15 = V250I, R263C 
5th lpd109 9.8.15 = P261L 
5th lpd110 9.8.15 = V346I, G385C 
*E3 mutant clones of affected ODH and/or PDH are yellow shaded. 
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Appendix 4: Multi sequence amino acids alignments of some bacterial C5-
Mtases. 
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Appendix 5: Multi sequence amino acids alignments of some CATs: 
 
P62577        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
P00484        1      MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKFYPVMIYLIAQAVNQF 
P22616        1      MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITAFRTALAETDYKFYPVMIYLISRVVNQF 
P22615        1      MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAETGYKFYPLMIYLISRAVNQF 
P00485        1      MNFNKIDLDNWKRKEIFNHYLN QQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRVINSN 
P26826        1      MVFEKIDKNSWNRKEYFDHYFASVPCTYSMTVKVDITQ    IKEKGMKLYPAMLYYIAMIVNRH 
P00486        1      MTFNIIKLENWDRKEYFEHYFN QQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEVVNKN 
P00487        1       MFKQID ENYLRKEHFHHYMTLTRCSYSLVINLDITKLHAILKEKKLKVYPVQIYLLARAVQKI 
P36882        1      MTFNIIKLENWDRKEYFEHYFN QQTTYSITKEIDITLFKDMSKKKGYEIYPSLIYAIMEVVNKN 
P58777        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
P06135        1      MTFNIIKLENWDRKEYFEHYFN QQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEVVNKN 
P36883        1      MTFNIINLETWDRKEYFNHYFN QQTTYSVTKELDITLLKSMIKNKGYELYPALIHAIVSVINRN 
P20074        1 MDAPIPTPAPIDLDTWPRRQHFDHYRRRVPCTYAMTVEVDVTAFAAALRRSPRKSYLAQVWALATVVNRH 
P25309        1      MTFNIIKLENWDRKEYFEHYFN QQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEVVNKN 
P49417        1      MEFRLVDLKTWKRKEYFTHYFESVPCTYSMTVKLDITT    IKTGKAKLYPALLYAVSTVVNRH 
P26825        1      MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANIEITGLLREIKLKGLKLYPTLIYIITTVVNRH 
P22782        1      MQFTKIDINNWTRKEYFDHYFGNTPCTYSMTVKLDISK    LKKDGKKLYPTLLYGVTTIINRH 
P11504        1      MVFEKIDKNSWNRKEYFDHYFASVPCTYSMTVKVDITQ    IKEKGMKLYPAMLYYIAMIVNRH 
Q03058        1      MTFNIIELENWDRKEYFEHYFN QQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEVVNKN 
P62579        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
P07641        1 MDTKRVGILVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFIYIISLLVNKH 
Q02736        1      MNFNLIDINHWSRKPYFEHYLNNVKCTYSMTANIEITDLLYEIKLKNIKFYPTLIYMIATVVNNH 
P62580        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
W9BPG6        1     MAHYRIIDTASWPRRDHFTFYRQFANPSFNLCVPIAAQRLYECAKDRRVSFFQLALYALLRAANGV 
P62578        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
Q81QL5        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
U6A0V2        1      MKFHVIDRENWNREQYFEHYLK LKCSFSMTANVDITMMLEKIHQKEIKFYPTFIYIISRMINKH 
Q79PA8        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
Q8A9W3        1    MNQIEKIIDIATWNRKEHFEHFSAFDDPFFGVTVHVDCTRSYQEAKDKGVSFSLLLLHRIITAASKV 
Q8A336        1       MKQIIDIENWERKENFNFFRHFQNPQLSITSEVECGGARQRAKAAGQSFFLHYLYAVLRAANEI 
B2TPT1        1        MKLIDIENWKRKDHYNFFRQVDYPHFNICGNIDITKFYKYIKENELPFFISILYASTKTANSI 
G0EL70        1       MFNKIDLNNYNRKEHYEMYMNNIPCTYSITVPLNITKFKKAVKDKNIKFYASVIYLISKVVNKY 
A4W932        1 MKTTTLEYTPVDLSRWARKEHFEVFQSFAQSTINQTVLVDITVLLKYIKESGWKFYPTIIFLLSKIVNSH 
B2IQC4        1      MNFNKIDLDNWKRKEIFNHYLN QQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRVINSN 
D6BAH5        1 MDAPIPTPAPIDLDTWPRRQHFDHYRRRVPCTYAMTVEVDVTAFAAALRRSPRKSYLAQVWALATVVNRH 
A0A0B4S6D3    1       MFKKID GNYPRKEHFHHYMKVTRCSYSLVIDLDITKLHAISKEKKLKVYPVQIYLLARAVQKI 
B1IES5        1      MNFRIINKKDWDRKEYFEHYFSEVSCTYSMTVKLDITK    IKNSNQKLYPTILYFITKVVNKH 
B1LRU3        1      MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAKTGYKFYPLMIYLISRAVNQF 
B7NGK6        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
A8FC48        1       MFKQID ENYLRKEHFHHYMKVTRCSYSLVIDLDITKLHSIIKEKKLKVYPVQIYLLARAVQKI 
C3F1K4        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
S5P3T0        1      MEYKKFDINSWNRKEHFEHYRN LQCSFSLTSEIEITTFLQYLKENKYKFYSSIIYFISKLVNST 
C0QYG6        1       MFNKIDLNNYNRKEHYEMYMNNIPCTYSITVPLNITKFKKTVKDKNIKFYASVIYLISKVVNKY 
C3GIT7        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
C2NHL6        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHEKGIKFYPTFIYIISRIINKH 
C2UVB4        1      MKFHVIDRENWNREQYFEHYLK LKCSFSMTANVDITMMLEKIHQKEIKFYPTFIYIISRMINKH 
Q6HIX0        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
D3H356        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
A0A0B5SI36    1      MKFHVIDRENWNREQYFEHYLK LKCSFSMTANVDITMMLEEIHQKEIKFYPTSIYVISRVINKH 
Q3Y3U5        1      MTFNIINLETWDRKEYFNHYFN QQTTYSVTKELDITLLKSMIKDKGYELYPALIHAIVSVINRN 
C3G2Z8        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
A0A060LRK5    1      MTFTVINRRTWKREEVFSHYIK QKTSFSLTTELEVDVLYKRVKQKGYTFYPAFLYLVTSVVNKH 
C2TGH5        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
C3AWY0        1    MNLKFNIINRDNWYRKEYFEHYLQ QQTTFSLTNEINITILMKNLKKKNYKLYPAFIFMVTKIVNSH 
A0A0E2JL01    1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
D2AC90        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
A4SU29        1     MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISK    LKKDGKKLYPTLLYGVTTILNRH 
Q738F1        1      MKFHVIDREKWNRKQYFEHYLK LKCTFSMTVHVDITRLLKELHQKGIKFYPVFIYLISKVVNNH 
B4ET40        1 MDTKRVGYTVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFIYIISLLVNKH 
B0VCL0        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
D1BEB9        1   MTSPSATPIDLSTWPRRQHFEHYRSAVPCTYALTVDLDATAFVEALRDSTRKTYIAQIWALATAVNQH 
A8ESX3        1      MEYKKFDINSWNRKEHFEHYRN LQCSFSLTSEIEITTFLQYLKENKYKFYSSIIYLISKLVNST 
C2PF27        1      MKFHIIDRENWNREQYFEHYLK LKCTFSMTVNVDITRLLKELHQKGIKFYPVFIYLISRVVNNH 
B3ZJ81        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
C3C2A9        1      MKFHVMDREDWNREQYFEHYLK LKCTFSMTVNVDITMLLEEVYQKGIKFYPVFIYLISRVVNNH 
A0A076LVL9    1      MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAKTGYKFYPLMIYLISRAVNQF 
A0A0B5NJK6    1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
A0A068NDJ0    1      MKFHVMDREDWNREQYFEHYLK LKCTFSMTVNVDITMLLEEVYQKGIKFYPVFIYLISRVVNNH 
C2VBS1        1      MKFHVIDRENWNREQYFEHYLK LKCSFSMTANVDITMLLEKIHQKEIKFYPTFIYIISRMINKH 
F0PPC1        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIEKVHQKGIKFYPTFIYIISRIINKH 
Q5J470        1      MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAKTGYKFYPLMIYLISRAVNQF 
A0RE09        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
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C3HIG0        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
M7CMF0        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
C2MKR8        1      MKFHVIDRENWNREQYFEHYLK LKCTFSMTVNVDITMLLEEVYQKGIKFYPVFIYLVSKVVNNH 
K4V802        1 MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAH 
R9VXF1        1 MKKTTPEYTTVDLSRWARKEHFEAFQTFAQCTFSQTVQLDITALLKHIKAVGWKIYPTLIFLIAKIVNKH 
D0ZHK9        1      MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKFYPVMIYLIAQAVNQF 
D8GXV5        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
C2VTN4        1      MKFHVIDRENWNREQYFEHYLK SKCTFSMTVNVDITMLLDEVYQKGIKFYPVFIYLISRVVNNH 
Q7N4A3        1      MNYSKVDIDLWDRKEHFLHYRNVVQCGFSLTAKIDITHLLSSLVEKQYKFYPTMIYLISTVVNSY 
Q63BG1        1      MKFHVIDRENWNREQYFEHYLE LKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRIINKH 
G8LN29        1 MKKTIPEYTPVDLSRWARKEHFEVFQSFAQSTFNQTVQIDITALLKDIKELGWKFYPTMISLLSKIVNNH 
A9VF66        1      MKFHVIDRENWNREQYFEHYLK LKCSFSMTANVDITMMLEEIHQKEIKFYPTFIYVISRVINKH 
C3I0P6        1      MKFHVIDRENWNREQYFEHYLK LKCTFSMTVNVDITLLIEKVHQKGIKFYPTFIYIISRIINKH 
R9TXA1        1      MNFQTIDLDTWYRKSYFDHYMKEAKCSFSITTNVNVTNLLAVLKKKKIKLYPVFIYIVSRAIHSR 
consensus     1      m f  id  qw Rke fehy     ctysltv ldit  l  vk    kfyp  iyii rlmn h 
 
P62577       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
P00484       66 DELRMAIK DDELIVWDSVDPQFTVFHQETETFSALSCPYSSDIDQFMVNYLSVMERYKSDT     KLF 
P22616       66 PEFRMAMK DNALIYWDQTDPVFTVFHKETETFSALFCRYCPDISEFMAGYNAVMAEYQHNT     ALF 
P22615       66 PEFRMALK DNELIYWDQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTAEYQHDT     RLF 
P00485       65 TAFRTGYNSDGELGYWDKLEPLYTIFDGVSKTFSGIWTPVKNDFKEFYDLYLSDVEKYNGSG     KLF 
P26826       62 SEFRTAINQDGELGIYDEMIPSYTIFHNDTETFSSLWTECKSDFKSFLADYESDTQRYGNNH     RME 
P00486       65 KVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLLEYKDKE     EMF 
P00487       64 PEFRMDQV NDELGYWEILHPSYTILNKETKTFSSIWTPFDENFAQFYKSCVADIETFSKSS     NLF 
P36882       65 KVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLLEYKDKE     EMF 
P58777       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
P06135       65 KVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLFEYKDKE     EMF 
P36883       65 KVFRTGINSEGNLGYWDKLEPLYTVFNKETENFSNIWTESNASFTLFYNSYKNDLIKYKDKN     EMF 
P20074       71 EEFRMCLNSSGDPAVWPVVHPAFTVFNPERETFACLWAPYDPDFGTFHDTAAPLLAEHSRAT     DFF 
P25309       65 KVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLFEYKDKE     EMF 
P49417       62 EEFRMTVDDEGQIGIFSEMMPCYTIFQKDTEMFSNIWTEYIGDYTEFCKQYEKDMQQYGENK     GMM 
P26825       66 KEFRTCFDQKGKLGYWDSMNPSYTVFHKDNETFSSIWTEYDENFPRFYYNYLEDIRNYSDVL     NFM 
P22782       62 EEFRTALDENGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAFGERM     GMS 
P11504       62 SEFRTAINQDGELGIYDEMIPSYTIFHNDTETFSSLWTECKSDFKSFLADYESDTQRYGNNH     RME 
Q03058       65 KVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDKNFISFYNNYKNDLLEYKDKE     EMF 
P62579       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
P07641       71 AEFRMAMK DGELVIWDSVNPGYNIFHEQTETFSSLWSYYHKDINRFLKTYSEDIAQYGDDL     AYF 
Q02736       66 KEFRICFDHKGSLGYWDSMNPSYTIFHKENETFSSIWTEYNKSFLRFYSDYLDDIKNYGNIM     KFT 
P62580       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
W9BPG6       67 PQLRQRVRNDEV IEYDSLAVMTPVMTV GEGFRQVWCDNAPEFTAFSAAATPKIVAARETSP      A 
P62578       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
Q81QL5       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLL 
U6A0V2       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKGDKSFSSIWTDYSSDFHIFYKNYEEDMKCFANVH     GLF 
Q79PA8       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
Q8A9W3       68 EEFRYRIEGDKV VCYDSLLPEA TVGRADHTFSFAAFEYDPDELTFIRKAKTEMERLQATT     GLN 
Q8A336       65 PEFRYRIDPDGRVVLYDTIDMLSPIKIKENGKFFTTRFPYHNDFDTFYQEARLIIDAIPEDGDPYAAENE 
B2TPT1       64 KEFKLRIRGDKV IEHETVNPSF TIITDEEVFSFCRSNYTDNFNEFKINTLKEIEKVKNNI     SIE 
G0EL70       65 KEFKMVLNDNKELGYYDIINPSYTIFHNDTKTFSSIHTEYNEKFDLFYKNYISDMETYGENK     TFL 
A4W932       71 AEFRMAIK NNELVIWNEIHPSYTIFHNETETFSSLWSHYDGNIHHFQDVYSEDVACYGNNL     SYW 
B2IQC4       65 TAFRTGYNSDGELGYWDKLEPLYTIFDGVSKTFSGIWTPVKNDFKEFYDLYLSDVEKYNGSG     KLF 
D6BAH5       71 EEFRMCLTASGDPAVWPVVHPAFTVFNPERETFACVWAPYDPDFGTFHDTAAPLLAEHSRAT     DFF 
A0A0B4S6D3   64 PEFRMDLV NDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYKSCVADIEAYSESN     KLF 
B1IES5       62 NEFRTSFNMNGQLGVFEEMIPCYTVFHKDTETFSNIWTEYSENYDIFCKSYEKDMQMFSSVK     GLI 
B1LRU3       66 PEFRMAMK DNELIYWEQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTAEYQHDT     RLF 
B7NGK6       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
A8FC48       64 PEFRMDLV NDELGHWELLHPSYTILNKETKTFLSIWTPYDENFAQFYKSCVADIETFSKSS     KLF 
C3F1K4       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLF 
S5P3T0       65 FEFKISIK NNEIVTWDVLHPSYTIFHKKEETFSSIWSEYSDDKTIFFNEFEKDCINYENNK     SLF 
C0QYG6       65 KEFKMALNDNKELGYYDIINPSYTIFHNDTKTFSSIYTEYNEKFDLFYKNYISDIETYGENK     TFL 
C3GIT7       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLF 
C2NHL6       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLF 
C2UVB4       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKGDKSFSSIWTDYSSDFHIFYKNYEEDMKCFANVH     GLF 
Q6HIX0       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDVRCYASVH     GLF 
D3H356       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
A0A0B5SI36   65 TEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMRCYANVH     GFF 
Q3Y3U5       65 KVFRTGINSEGNLGYWDKLEPLYTVFNKETEKFSNIWTESNASFNSFYNSYKNDLFKYKDKN     EMF 
C3G2Z8       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLF 
A0A060LRK5   65 VAFRMSFNQEGELGYWSQLEPVYTIFHEKTKLFSGIWTSMNRDFNHFHTSYLQDVMTYQGSK     ALF 
C2TGH5       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLF 
C3AWY0       67 REFRTSCNSEGNLGYWTEIFPSYTIFDKKTHTFSSIWSPNFANFSDFHSQYEKDVEKYNGTG     SLF 
A0A0E2JL01   71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
D2AC90       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
A4SU29       63 EEFRTALDKNGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAYGERK     GMF 
Q738F1       65 KEFRTSFNEEGALGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYRNYQEDMRLYTNVH     GLF 
B4ET40       71 AEFRMAMK DGELVIWDSVNPGYTIFHEQTETFSSLWSYYHKDINHFLKTYSEDIAQYGDDL     AYF 
B0VCL0       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
D1BEB9       69 DEFRMCLTPDGAPATWPVVHPSFTVFNAARETFASVWAPYDPSFAAFHDTAAALLTEHRTAT     EMF 
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A8ESX3       65 FEFRMSIK NNEIVTWDVLHPSYTIFHQKEETFSSIWSEYSDDKTIFFDEFEKDCTNYENNK     SLF 
C2PF27       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSNDFHIFYKNYEEDMRCYANVH     GLF 
B3ZJ81       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLF 
C3C2A9       65 KKFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMRCYANVH     GLF 
A0A076LVL9   66 PEFRMAMK DNELIYWEQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTAEYQHDT     RLF 
A0A0B5NJK6   65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLF 
A0A068NDJ0   65 KKFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMRCYANVH     GLF 
C2VBS1       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKGDKSFSSIWTDYSSDFHIFYKNYEEDMKCFANVH     GLF 
F0PPC1       65 KEFRTCFNDEGVLGYWEAMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEDDMRNYANVH     GLF 
Q5J470       66 PEFRMAMK DNELIYWEQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTAEYQHDT     RLF 
A0RE09       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLF 
C3HIG0       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVH     GLL 
M7CMF0       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
C2MKR8       65 KEFRTSFNDEGALGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEKDMRCYASVH     GLF 
K4V802       71 PEFRMAMK DGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENL     AYF 
R9VXF1       71 TEFRMAIK DNELVIWNDIHPCYTIFHDETETFSSLWSHYDGNIHHFLDIYSEDVARYGNNL     SYL 
D0ZHK9       66 DELRMAIK DDELIVWDSVDPQFTVFHQETETFSALSCPYSSDIDQFMVNYLSVMERYKSDT     KLF 
D8GXV5       65 KEFRTCFNDEGVLGYWEEMISSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMRCYANVH     GLF 
C2VTN4       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEKDMRCYASVH     GLF 
Q7N4A3       66 SEFRMAIK DEELIVWDGVNPAYTIFHKETETFSAIWTEFNSDLAEFMKNYSADYETYKDDL     CFF 
Q63BG1       65 KEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKKYEEDMRCYASVH     GLF 
G8LN29       71 SEFRMAMK NNELVIWNEIHPSYTIFHNETETFSSLWSHFDGNIDHFQNVYSEDVARYGNTL     SYW 
A9VF66       65 TEFRTCFNDEGVLGYWEEMIPSYTIFHKDNKSFSSIWTDYSSDFHIFYKNYEEDMRCYANVH     GFF 
C3I0P6       65 KEFRTCFNEEGVLGYWEKMIPSYTIFHKDDKSFSSIWTNYSSDFRIFYKNYEEDMRYYASVH     GLF 
R9TXA1       66 PEFRTTFNDKGQLGYWEQMHPCYTIFHQDDQTFSALWTEYSNDFSRFYRQYLQDAERFGDKK     GLW 
consensus    71  efr     dg lg wd v p ytvfhke  tFsslwsey  df  F   y  dv  yg         lf 
 
P62577      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
P00484      130 PQGVTPENHLNISALPWVNFDSFNLNVANFTDYFAPIITMAKYQQEG DRLLLPLSVQVHHAVCDGFHVA 
P22616      130 PQGALPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQED NRVLLPVSVQVHHAVCDGFHAA 
P22615      130 PQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEG DRVLLPVSVQVHHAVCDGFHAA 
P00485      130 PKTPIPENAFSLSIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKG NSIYLPLSLQVHHSVCDGYHAG 
P26826      127 GKPNAPENIFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYKED NKIILPLAIQVHHAVCDGFHIC 
P00486      130 PKKPIPENTIPISMIPWIDFSSFNLNIGNNSNFLLPIITIGKFYSEN NKIYIPVALQLHHAVCDGYHAS 
P00487      128 PKPHMPENMFNISSLPWIDFTSFNLNVSTDEAYLLPIFTIGKFKVEE GKIILPVAIQVHHAVCDGYHAG 
P36882      130 PKKPIPENTLPISMIPWIDFSSFNLNIGNNSNFLLPIITIGKFYSEN NKIYIPVALQLHHAVCDGYHAS 
P58777      135 PKGF IENMFFVSANPWVSFTSFDLNVAAMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
P06135      130 PKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSEN NKIYIPVALQLHHAVCDGYHAS 
P36883      130 PKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKD DKIYLPFPLQVHHAVCDGYHVS 
P20074      136 PQGNPPPNAFDVSSLPWVSFTGFTLDIRDGWDHLAPIFTLGRYTERD TRLLLPLSVQIHHAAADGFHTA 
P25309      130 PKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSEN NKIYIPVALQLHHAVCDGYHAS 
P49417      127 AKPNPPVNTFPVSMIPWTTFEGFNLNLQKGYGYLLPIFTFGRYYEEN GKYWIPLSIQVHHAVCDGFHTC 
P26825      131 PKTGEPANTINVSSIPWVNFTGFNLNIYNDATYLIPIFTLGKYFQQD NKILLPMSVQVHHAVCDGYHIS 
P22782      127 AKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEEG GKYYIPLSIQVHHAVCDGFHVC 
P11504      127 GKPNAPENIFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKIIKKD NKIILPLAIQVHHAVCDGFHIC 
Q03058      130 PKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSEN NKIYIPVALQLHHSVCDGYHAS 
P62579      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
P07641      135 PKEF IENMFFVSANPWVSFTSFNLNMANINNFFAPVFTIGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
Q02736      131 PKSNEPDNTFSVSSIPWVSFTGFNLNVYNEGTYLIPIFTAGKYFKQE NKIFIPISIQVHHAICDGYHAS 
P62580      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
W9BPG6      129 PLIVDGEHFICASCLPWLHFTSMTHAE YAVGAAVPALTWGKLQ     NGVIPVAGRFNHAFVDGLHAS 
P62578      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
Q81QL5      130 TKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEE NKIMLPVSLQVHHSVCDGYHVS 
U6A0V2      130 PKENIPPNVYPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNDG SKVMLPFSLQVHHAVCDGYHAS 
Q79PA8      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
Q8A9W3      131 KGGTFHPNAIHYSAVPWLAFTDMKHPSNMRSGDSVPKISTGKYFREG EKLMLPISVTCHHGLMDGYHVA 
Q8A336      135 EVADGDYGLILLSATPDLYFTSITGTQEKRSGNNYPLLNAGKAIIRE GRLVMPIAMTIHHGFIDGHHLS 
B2TPT1      127 DE PGQDDLLYITSIPWVSFTNITHPIQMNPVDSIPRIAWGKYFEEG GNIKLPISVDVHHALVDGVHIG 
G0EL70      130 AKPCDIKNIFNISSLPLSTFTSFNLNLPNSFEYLAPIFTIGKYYTDDKNNIIMPLALQIHHSVCDGYHVG 
A4W932      135 PKEESRENVFFVSAIPWVSFTSFNINVANMQNFFAPMFTIGKYYQQD GKVLLPLAVQVHHSVCDGFHVA 
B2IQC4      130 PKTPIPENAFSLSIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKG NSIYLPLSLQVHHSVCDGYHAG 
D6BAH5      136 PQGNPPPNAFDVSSLPWASFTGFTLDIRDGWDHLAPIFTLGRYTERD ARLLLPLSVQIHHAAADGFHTA 
A0A0B4S6D3  128 PKPHMPENMFNISSLPWIDFTSFNLNVSTDETYLLPIFTLGKFKVEE EKIILPVAIQVHHAVCDGYHAG 
B1IES5      127 AKPDIPANNFPVSMVPWTSFDGFNLNLQKGYEYLLPIFTIGKYYKEN GRYLLPLAIQVHHAVCDGFHVC 
B1LRU3      130 PQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFSPVFTMAKFQQEG DRVLLPVSVQVHHAVCDGFHAA 
B7NGK6      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
A8FC48      128 PKSHMPENMFNISSLPWIDFTSFNLNVSTDEAYLLPIFTIGKFKVEE GKIILPVAIQVHHAVCDGYHVG 
C3F1K4      130 TKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEE NKIMLPVSLQVHHSVCDGYHVS 
S5P3T0      129 PKFNIPENHFNISCLPWIKYSGFNLNLPHLNDYFQPIITIGKYDKNE NKIVLPITIQIHHAVCDGFHVA 
C0QYG6      130 AKPCSINNIFNISSLPLSAFTSFNLNLPNSFEYLAPIFTIGKYYTDDKNNIMMPLCLQIHHSVCDGYHVG 
C3GIT7      130 TKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEE NKIMLPVSLQVHHSICDGYHAS 
C2NHL6      130 TKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEE NKIMLPVSLQVHHSICDGYHAS 
C2UVB4      130 PKENIPPNVYPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNDG SKVMLPFSLQVHHAVCDGYHAS 
Q6HIX0      130 TKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEE NKIMLPVSLQVHHSICDGYHAS 
D3H356      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
A0A0B5SI36  130 PKENIPPNIFPISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDG SRVMLPVSLQVHHAVCDGYHAS 
Q3Y3U5      130 PKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKD DKIYLPFSLQVHHAVCDGYHVS 
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C3G2Z8      130 TKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEE NKIMLPVSLQVHHSICDGYHAS 
A0A060LRK5  130 PKKHMPENTVSVSMIPWTSFTGFNLMIQQDTNYLLPIVTAGKLIEKN QTLYLPVSLQVHHAVCDGYHAS 
C2TGH5      130 TKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEE NKIMLPVSLQVHHSVCDGYHVS 
C3AWY0      132 PKIPIPDNNIPISMIPWSSFTAFNLNINNGGDFFLPIITGGKYSQVN DELFLPISLQIHHAVCDGYHAS 
A0A0E2JL01  135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
D2AC90      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
A4SU29      128 AKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDG GKYYIPLSIQVHHAVCDGFHVC 
Q738F1      130 TKENIPPNVFPISSIPWASFTGFNLNINNEGDFLLPIITCGKYFNEE NKVMLPVSLQVHHSVCDGYHAS 
B4ET40      135 PKEF IENMFFVSANPWVSFTSFNLNVANINNFFAPVFTIGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
B0VCL0      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
D1BEB9      134 PQGPPPANSFDVSSLPWTSFTGFSLAVQPGFDHLAPIFTLGRYVERE GSLRLPVALQVHHAAADGFHAA 
A8ESX3      129 PKFNIPENHFNISCLPWIKYSGFNLNLPHLNDYFQPIITIGKYDKNE NKIVLPVTIQIHHAVCDGFHVA 
C2PF27      130 TKENVPPNVFPISSIPWASFTGFNLNINNDGDFLLPIITCGKYFNEE NKVILPVSLQVHHSVCDGYHAS 
B3ZJ81      130 TKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEE NKIMLPVSLQVHHSVCDGYHAS 
C3C2A9      130 TKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEE NKVILPVSLQVHHSVCDGYHAS 
A0A076LVL9  130 PQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFSPVFTMAKFQQEG DRVLLPVSVQVHHAVCDGFHAA 
A0A0B5NJK6  130 TKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEE NKIMLPVSLQVHHSICDGYHAS 
A0A068NDJ0  130 TKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEE NKVILPVSLQVHHSVCDGYHAS 
C2VBS1      130 PKENIPPNVYPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNDG SKVMLPFSLQVHHAVCDGYHAS 
F0PPC1      130 TKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEK NKVMLPVSLQVHHSVCDGYHAS 
Q5J470      130 PQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFSPVFTMAKFQQEG DRVLLPVSVQVHHAVCDGFHAA 
A0RE09      130 TKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEE NKIMLPVSLQVHHSICDGYHAS 
C3HIG0      130 TKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEE NKIMLPVSLQVHHSVCDGYHVS 
M7CMF0      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
C2MKR8      130 TKENIPPNVFPISSIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEE NKIMLPVSLQVHHSVCDGYHAS 
K4V802      135 PKGF IENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG DKVLMPLAIQVHHAVCDGFHVG 
R9VXF1      135 PKEESRENVFFVSANPWVSFTGFNINIANMQNFFAPMFTIGKYYQQG EKVLLPLAVQVHHAVCDGFHVS 
D0ZHK9      130 PQGVTPENHLNISALPWVNFDSFNLNVANFTDYFAPIITMAKYQQEG DRLLLPLSVQVHHAVCDGFHVA 
D8GXV5      130 TKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEE NKVILPVSLQVHHSVCDGYHAS 
C2VTN4      130 TKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEE NKIMLPVSLQVHHSICDGYHAS 
Q7N4A3      130 SKPELPENHFHISSVPWVSFDGFNLNMASVMDYFPPIFTMGKFYQNG NQTQLPLAIQVHHATCDGFHVG 
Q63BG1      130 TKENIPPNIFPISGIPWTSFTGFNLNINNDAGFLLPIITCGKYFNEE NKIMLPVSLQVHHSVCDGYHVS 
G8LN29      135 PKEESRENVFFVSAIPWSSFTSFNINVANMQNFFAPMFTMGKYVNQG GKVLLPLAVQVHHSVCDGFHVA 
A9VF66      130 TKENIPPNIFPISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDG SRVMLPVSLQVHHAVCDGYHAS 
C3I0P6      130 TKENIPPNVFPISSIPWTSFTGFNLNINNDENFLLPIITCGKYFNEG NKVMLPVSLQVHHSVCDGYHAS 
R9TXA1      131 AKPDIPPNAFSVSSIPWVRFTNFNLNLDNS EHLLPIITNGKYFSEG GETFLPVSLQVHHAVCDGYHAG 
consensus   141  k   p nmf vs lPw sft fnlnv n   fllPi t gkyy     kvllPl iqvhHavcDGfH   
 
P62577      203 RMLNEL   QQYCDEWQGGA                
P00484      199 RFINRL   QELCNSKLK                  
P22616      199 RFINTL   QMMCDNILK                  
P22615      199 RFINTL   QLMCDNILK                  
P00485      199 LFMNSIQELSDRPNDWLL                  
P26826      196 RFVNELQELINS                        
P00486      199 LFMNEFQDIIHKVDDWI 
P00487      197 QYVEYLRWLIEHCDEWLNDSLHIT            
P36882      199 LFINEFQDIIKKVDDWI 
P58777      203 RMLNEL   QQYCDEWQGGA                
P06135      199 LFINEFQDIINKVDDWI 
P36883      199 LFMNEFQNIIR                         
P20074      205 RLTNELQTLLADP AWL 
P25309      199 LFINEFQDIIKKVDDWI 
P49417      196 RFINELQDVIQSLQNHGGDEE               
P26825      200 RFFNEAQELASNYETWLGEK                
P22782      196 RFLDELQDLLNK                        
P11504      196 RFVNELQELIIVTQVCL 
Q03058      199 LFMNEFQDIIHRVDDWI 
P62579      203 RMLNEL   QQYCDEWQGGA                
P07641      203 RLLNEI   QQYCDEGCK                  
Q02736      200 RFINEMQELAFSFQEWLENK                
P62580      203 RMLNEL   QQYCDEWQGGA                
W9BPG6      193 RFYALVEEGFNDPERLWLPLTETAPSLLPPAAKER 
P62578      203 RMLNEL   QQYCDEWQGGA                
Q81QL5      199 RFIEDLQELSNSCNEWLK                  
U6A0V2      199 RFIEDLQELVNTCNEWL 
Q79PA8      203 RMLNEL   QQYCDEWQGGA                
Q8A9W3      200 KFIETLDL                            
Q8A336      204 LFYKKVEDFLK                         
B2TPT1      195 QYFNIIQEILDNPMKYL 
G0EL70      200 IFFEDLQHEFDEFDLLY                   
A4W932      204 RLFNEL   QEMCDDILRLSEEFNA           
B2IQC4      199 LFMNSIQELSDRPNDWLL                  
D6BAH5      205 RLTDELQTLLADP AWL 
A0A0B4S6D3  197 QYVEYLRWLIEHCEEWLSDSLYT             
B1IES5      196 RFVNELQELIKG                        
B1LRU3      199 RFINTL   QLMCDNILK                  
B7NGK6      203 RMLNEL   QQYCDEWQGGA                
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A8FC48      197 QYVEYLRWLIEHCDEWLNDSMPIT            
C3F1K4      199 RFIEDLQELSNSCNEWLK                  
S5P3T0      198 KFINKL   QEWCNEPEKHL                
C0QYG6      200 IFFEDLQMEFNEFNLLY                   
C3GIT7      199 RFIGDLQELSNSCNEWLK                  
C2NHL6      199 RFIEDLQELSNSCNEWLK                  
C2UVB4      199 RFIEDLQELVNTCNEWL 
Q6HIX0      199 RFIEDLQELSNSCNEWLK                  
D3H356      203 RMLNEL   QQYCDEWQGGA                
A0A0B5SI36  199 RFIEDLQELANTCNEWLK                  
Q3Y3U5      199 LFMNEFQNIIDNVNEWI 
C3G2Z8      199 RFIEDLQELSNSCNEWLK                  
A0A060LRK5  199 MFMNDCQQLANQAHEWIK                  
C2TGH5      199 RFIEDLQELSNSCNEWLK                  
C3AWY0      201 VFMNDLQKLANESTDWI 
A0A0E2JL01  203 RMLNEL   QQYCDEWQGGA                
D2AC90      203 RMLNEL   QQYCDEWQGGA                
A4SU29      197 RFLDELQDLLNK                        
Q738F1      199 RFLEDLQQLISNCNKWLK                  
B4ET40      203 RLLNEI   QQYCDEGCK                  
B0VCL0      203 RMLNEL   QQYCDEWQGGA                
D1BEB9      203 RLLETVQGLLLEP GWVA                  
A8ESX3      198 KFINKL   QEWCNEPEKYL                
C2PF27      199 RFIQDLQELSNSCNEWLK                  
B3ZJ81      199 RFIEDLQELSNSCNEWLK                  
C3C2A9      199 RFIEDLQELSNSCNEWLK                  
A0A076LVL9  199 RFINTL   QLMCDNILK                  
A0A0B5NJK6  199 RFIGDLQELSNSCNEWLK                  
A0A068NDJ0  199 RFPRGFTGIN                          
C2VBS1      199 RFIEDLQELVNTCNEWL 
F0PPC1      199 RFIEDLQELSNSCNEWLK                  
Q5J470      199 RFINTL   QLMCDNILK                  
A0RE09      199 RFIEDLQELSNSCNEWLK                  
C3HIG0      199 RFIEDLQELSNSCNEWLK                  
M7CMF0      203 RMLNEL   QQYCDEWQGGA                
C2MKR8      199 RFIEDLQELSNSCNEWLK                  
K4V802      203 RMLNEL   QQYCDEWQGGA                
R9VXF1      204 RLINDL   QTMCDDLLRHSGEPEA           
D0ZHK9      199 RFISRL   QELCNSKLK                  
D8GXV5      199 RFIEDLQELSNSCNEWLK                  
C2VTN4      199 RFIEDLQELSNSCNEWLK                  
Q7N4A3      199 RVINNL   QELCNDFI 
Q63BG1      199 RFIEDLQELSNSCNEWLK                  
G8LN29      204 RLFNEL   QAMCDDLRHHSGERQVQSKTHRA    
A9VF66      199 RFIEDLQELANTCNLK                    
C3I0P6      199 QFIEDLQQLSSTCNEWLK                  
R9TXA1      199 AFMNELERLAADCEEWLM                  
consensus   211 rfl el  l   c ewl                   
 
* All CATs are represented by their accession numbers on 
http://www.uniprot.org/; for example, P62577=CATI, P20074=CATIII which 
are yellow-shaded. 
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Appendix 6: pMJA01 whole nucleotide sequence: 
TCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCT 
GTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCTGG 
CTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGAT 
GCGTAAGGAGAAAATACCGCATCAGGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATC 
GGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTA 
ACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAATTCGAGCTCGGTACCCGGGGAT 
CCTCTAGATTAATACGGTTTGAAGTTCAGGCTGCTACCAATGTTATATGCGATATACTGCAGCACATTAA 
TCACCACGCTATTACCAAACTGTTTATATGCCTGGCTGGTGCTCGGATGAACTTTATAGCTATCAGGATA 
ACCCATAACACGTGCACATTCACGCGGATGCAGTTTACGGGTTTTACCATTAACCAGATAACCACCGGTT 
TTGGCAAAAATGCCACCACCATATGCACTTAAGGTAATTGCAATACCACGGGTGCTATAAATACGTTCAC 
CCTGACCACCTTTACCAACAATACCCAGACGAACGGTTTTCGGGGTGGTCTGTTCAATTTCTTGGTTGGT 
CATCACCAGGTCTTTACGATCAATAACCAGATGTTCAACTTCGCTATCCGGCAGCAGCAGATCTTTCACA 
AAGGTATTCAGTTCAAACGGTTTCGGAAACTGAAAATTCTGGATGTTCAGATCGTTGCGAAAGCAAATCA 
TATAAATGCGTTCGCGTTTCTGCGGAATACCATAATCTAATGCATTCAGCACTTTGGCATGAAAGCTATA 
ATCCAGTTCGTTCATGGTGTTTTTCACAACTTCCAGGGTATTGCCATTATCGTGGCTAGCAAAGTTTTTC 
ACATTTTCCATAAACACAACTTTCGGTTTTTTTTCACGAACAATGCGCGCAATATCAAAAAACAGGGTGC 
CACGGCTATCTTCAAAACCTTTCTGTTTTCCGGAAATGCTAAATGCCTGACACGGAAAGCCGGCACACAG 
AATATCATGATCAGGAATGGTTTTTTCGTTAACCTGGGTAATATCGCCTTCCGGTTTTTCACCAAAGTTC 
ATTTCATACACCTCTTGGGCATATTTATCCCACTCGTTGCTATAAACACATTCTGCACCACAGCTTTCCA 
GTGCCAGACGAAAACCACCCAGACCTGCAAACAGGTCAATAAAACGCAGACCGGTCAATTGTTTATCTTT 
GATCTCAACCATGGAAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCA 
CAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACT 
CACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGA 
ATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGC 
TGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGA 
ATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCC 
GCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGA 
GGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCC 
TGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCAT 
AGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCC 
CCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTT 
ATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTC 
TTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAG 
TTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTT 
TGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGG 
TCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCA 
CCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGA 
CAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCC 
TGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATAC 
CGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAG 
AAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGT 
TCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTG 
GTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAA 
AGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTT 
ATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACT 
CAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAA 
TACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCA 
AGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTT 
TTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGC 
GACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGT 
CTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCC 
GAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCAC 
GAGGCCCTTTCGTC 
*M.HhaI ORF is from ATG to TAA which are green and red-shaded 
respectively.  
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Appendix 7: pAtase2 whole nucleotide sequence: 
CTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAAC 
CAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGGCCGCT 
ACAGGGCGCTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGTTTCGGTGCGGGCCTCTTCG 
CTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCC 
AGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGACGTAATACGACTCACTATAGGGCGAATTGGCGG 
AAGGCCGTCAAGGCCACGTGTCTTGTCCAGAGCTCTACGCGAAGCTTCGGGCGTATTTTTTGAGTTATCG 
AGATTTTCAGGAGCTAAGGAAGCTACCATGGAGAAAAAAATCACCGGTTATACCACCGTTGATATTAGCC 
AGTGGCATCGTAAAGAACACTTTGAAGCATTTCAGAGCGTTGCACAGTGTACCTATAATCAGACCGTTCA 
GCTGGATATCACCGCATTTCTTAAGACCGTGAAAAAAAACAAACACAAATTCTATCCGGCATTCATCCAT 
ATTCTGGCACGTCTGATGAATGCACATCCTGAATTCCGTATGGCAATGAAAGATGGTGAACTGGTTATTT 
GGGATAGCGTTCATCCGTGTTATACCGTTTTTCATGAACAGACCGAAACCTTTAGCAGCCTGTGGTCAGA 
ATATCATGATGATTTTCGTCAGTTCCTGCACATTTATAGCCAGGACGTCGCATGTTATGGTGAAAATCTG 
GCATATTTTCCGAAAGGCTTTATCGAAAACATGTTCTTTGTTAGCGCAAATCCGTGGGTTAGCTTTACTA 
GTTTCGATCTGAATGTGGCCAACATGGATAACTTTTTTGCACCGGTTTTTACGATGGGCAAATATTACAC 
CCAGGGTGATAAAGTTCTGATGCCGCTAGCGATTCAGGTTCATCATGCAGTTTGTGATGGTTTTCATGTT 
GGTCGTATGCTGAATGAACTGCAGCAGTATTGTGACGAATGGCAGGGTGGTGCATAATCTAGACAGTGGG 
GATCCCAGTGGGGTACCTGGAGCACAAGACTGGCCTCATGGGCCTTCCGCTCACTGCCCGCTTTCCAGTC 
GGGAAACCTGTCGTGCCAGCTGCATTAACATGGTCATAGCTGTTTCCTTGCGTATTGGGCGCTCTCCGCT 
TCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGGTAAAGCCTGGGGTGCCTAATGAGCAAAAGGCCA 
GCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAG 
CATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTC 
CCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCT 
CCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGC 
TCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTC 
TTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGC 
GAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTA 
TTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAAC 
AAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCA 
AGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTG 
GTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCT 
AAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGAT 
CTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTA 
CCATCTGGCCCCAGTGCTGCAATGATACCGCGAGAACCACGCTCACCGGCTCCAGATTTATCAGCAATAA 
ACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAA 
TTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACA 
GGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAG 
TTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAA 
GTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTA 
AGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTT 
GCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGG 
AAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACT 
CGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGC 
AAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATA 
TTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAA 
CAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCAC 
 
*CATI ORF is from ATG to TAA which are green and red-shaded respectively.  
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Appendix 8: pLpd1 whole nucleotide sequence: 
 
CTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAAC 
CAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGGCCGCT 
ACAGGGCGCTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGTTTCGGTGCGGGCCTCTTCG 
CTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCC 
AGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGACGTAATACGACTCACTATAGGGCGAATTGGCGG 
AAGGCCGTCAAGGCCGCATAAGCTTGTTTAAAAATTGTTAACAATTTTGTAAAATACCGACGGATAGAAC 
GACCCGGTGGTGGTTAGGGTATTACTTCACATACCCTATGGATTTCTGGGTGCAGCAAGGTAGCAAGCGC 
CAGAATCCCCAGGAGCTTACATAAGTAAGTGACTGGGGTGAGGGCGTGAAGCTAACGCCGCTGCGGCCTG 
AAAGACGACGGGTATGACCGCCGGAGATAAATATATAGAGGTCACCATGGGTACGGAAATCAAAACCCAG 
GTTGTTGTGCTGGGTGCCGGTCCGGCAGGTTATAGCGCAGCATTTCGTTGTGCAGATCTGGGTCTGGAAA 
CCGTTATTGTTGAACGTTATAATACCCTGGGTGGTGTTTGTCTGAATGTTGGTTGTATTCCGAGCAAAGC 
ACTGCTGCATGTTGCAAAAGTTATTGAAGAAGCAAAAGCACTGGCCGAACATGGTATTGTTTTTGGTGAA 
CCGAAAACCGACATTGATAAAATTCGTACCTGGAAAGAAAAAGTGATCAATCAGCTGACCGGTGGTCTGG 
CAGGTATGGCAAAAGGTCGTAAAGTTAAAGTTGTTAATGGCCTGGGCAAATTTACCGGTGCAAATACACT 
GGAAGTTGAAGGTGAAAATGGTAAAACCGTGATCAACTTTGACAACGCAATTATTGCAGCCGGTAGCCGT 
CCGATTCAGCTGCCGTTTATTCCGCATGAAGATCCGCGTATTTGGGATAGCACCGATGCACTGGAACTTA 
AGGAAGTGCCGGAACGTCTACTAGTAATGGGTGGTGGTATTATTGGCCTGGAAATGGGCACCGTTTATCA 
TGCACTGGGTAGCCAGATTGATGTTGTGGAAATGTTTGATCAGGTTATTCCGGCAGCCGATAAAGATATT 
GTTAAAGTGTTTACCAAACGCATCAGCAAAAAATTCAACCTGATGCTGGAAACCAAAGTTACCGCAGTTG 
AAGCCAAAGAAGATGGTATTTACGTTACGATGGAAGGCAAAAAAGCACCGGCAGAACCGCAGCGTTATGA 
TGCAGTTCTGGTTGCCATTGGTCGTGTTCCGAATGGCAAAAATCTGGATGCAGGTAAAGCCGGTGTTGAA 
GTTGATGATCGTGGTTTTATTCGTGTGGATAAACAGCTGCGTACCAATGTTCCGCATATTTTTGCAATTG 
GCGATATTGTTGGTCAGCCGATGCTGGCACATAAAGGTGTTCATGAAGGTCATGTTGCGGCCGAAGTTAT 
TGCCGGTAAAAAACATTATTTCGATCCGAAAGTTATCCCGAGCATTGCATATACCGAACCGGAAGTTGCA 
TGGGTTGGTCTGACCGAAAAAGAGGCCAAAGAAAAAGGTATTAGCTATGAAACCGCAACCTTTCCGTGGG 
CAGCAAGCGGTCGTGCCATTGCAAGCGATTGTGCCGATGGTATGACCAAACTGATCTTTGATAAAGAAAG 
CCATCGTGTTATTGGTGGTGCCATTGTTGGCACCAATGGTGGTGAACTGCTGGGTGAAATTGGTCTGGCC 
ATTGAAATGGGTTGTGATGCAGAAGATATTGCCCTGACCATTCATGCACATCCGACCCTGCATGAAAGCG 
TTGGCCTGGCAGCAGAAGTTTTTGAAGGTAGCATTACCGATCTGCCGAATCCGAAAGCCAAAAAAAAATA 
ATCTAGACAGTGGGGATCCCTGGGCCTCATGGGCCTTCCGCTCACTGCCCGCTTTCCAGTCGGGAAACCT 
GTCGTGCCAGCTGCATTAACATGGTCATAGCTGTTTCCTTGCGTATTGGGCGCTCTCCGCTTCCTCGCTC 
ACTGACTCGCTGCGCTCGGTCGTTCGGGTAAAGCCTGGGGTGCCTAATGAGCAAAAGGCCAGCAAAAGGC 
CAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAA 
AATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAA 
GCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGG 
AAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTG 
GGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA 
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGT 
AGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATC 
TGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCG 
CTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCC 
TTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGA 
TTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATAT 
ATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATT 
TCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGC 
CCCAGTGCTGCAATGATACCGCGAGAACCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAG 
CCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCG 
GGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTG 
GTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGAT 
CCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGC 
AGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTT 
TCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCC 
CGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC 
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCC 
AACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCG 
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CAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAG 
CATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGG 
GTTCCGCGCACATTTCCCCGAAAAGTGCCAC 
 
*E3 ORF is from ATG to TAA which are green and red-shaded respectively. 
 
 
 
Appendix 9: Amino acid structures: 
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Appendix 10: Amino acids codons: 
 
 
 
 
